syndrome	score	normalized_score
DRAVET SYNDROME	2.9482030000000004	100.0
CHILDHOOD ABSENCE EPILEPSY	2.5207408499999997	85.50092547901211
AURICULOCONDYLAR SYNDROME	2.333878554	79.16274944432251
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	2.333333	79.14424481624907
TOWNES-BROCKS SYNDROME 1; TBS1	1.713722434	58.12769453121104
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	1.668477704	56.593040031503925
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	1.645175719	55.80266077335922
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	1.5640232699999999	53.05005354108926
CORNELIA DE LANGE SYNDROME 1	1.5093133490000001	51.19434954105942
OROFACIODIGITAL SYNDROME TYPE 4	1.350545554	45.809109956132595
MYOCLONIC-ASTASTIC EPILEPSY	1.3442351540000002	45.5950677073458
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	1.3129538500000002	44.53403819207836
PALLISTER-HALL SYNDROME	1.2801214339999998	43.42039656020972
LENNOX-GASTAUT SYNDROME	1.26705411	42.97716642985574
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	1.255422489	42.58263386205088
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	40.488867286275735
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	1.164156114	39.48697270846003
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	39.07859329903673
ALLAN-HERNDON-DUDLEY SYNDROME	1.1321738899999998	38.40216871090626
MYOPATHIC EHLERS-DANLOS SYNDROME	1.1292528	38.30308835585608
EARLOBE CREASE	1.125	38.15883777338263
TRISOMY 8P	1.1033231989999999	37.42358307755605
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	1.1014010799999998	37.35838678679859
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	1.081343814	36.67806504504608
HYPEREKPLEXIA-EPILEPSY SYNDROME	1.0686937	36.248986246876484
SLC35A2-CDG	1.052819604	35.710553309931505
BENIGN OCCIPITAL EPILEPSY	1.027027	34.83569482834119
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	1.022863704	34.69448012908201
ROLANDIC EPILEPSY	1.021574	34.650734701782746
JOUBERT SYNDROME 1	1.0164625740000002	34.4773604124275
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	1.0151217989999999	34.43188270956918
RETT SYNDROME; RTT	1.010342529	34.26977480858679
ATONIC-ASTATIC SYNDROME OF FOERSTER	1.00689655	34.15289076091435
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.0010869729999998	33.95583591089215
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	1.0	33.91896690967345
EARRING HOLES, NATURAL	1.0	33.91896690967345
CRYPTOTIA, FAMILIAL	1.0	33.91896690967345
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	33.91896690967345
HAIRY EARS	1.0	33.91896690967345
HEREDITARY ANGIOEDEMA TYPE 1	1.0	33.91896690967345
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	1.0	33.91896690967345
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	33.91896690967345
RELAPSING POLYCHONDRITIS	1.0	33.91896690967345
MYOCLONIC EPILEPSY OF LAFORA	0.93788904	31.812227312705392
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.92074085	31.230578423534606
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.9172414	31.111880694782545
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.8999999999999999	30.527070218706097
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.8876050639999999	30.106646794674578
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.842211884	28.56695702432973
LAFORA DISEASE	0.7888422099999999	26.75671281794367
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	26.138535914928518
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.75940841	25.758348729717728
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.750931904	25.470834403194075
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.74700873	25.337764394107186
EARLY MYOCLONIC ENCEPHALOPATHY	0.719145614	24.392676284502794
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.7	23.74327683677141
XQ12-Q13.3 DUPLICATION SYNDROME	0.68797398	23.335366662336344
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.6844867539999999	23.217083559035785
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.683184133	23.172900000440944
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.6749447700000001	22.89342931948716
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.673464634	22.84322463548134
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.672369074	22.80606437209378
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.666667	22.612655912771267
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.6467644	21.9375802819548
SPINOCEREBELLAR ATAXIA TYPE 10	0.6247341399999999	21.190336622003297
BILATERAL POLYMICROGYRIA	0.6240021039999999	21.165506717142605
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.6122079799999999	20.76546221545802
CENTRALOPATHIC EPILEPSY	0.6047009000000001	20.51082981734976
TRISOMY 18	0.602176874	20.425217462976597
ADNP SYNDROME	0.598979939	20.31678073049922
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5967571999999999	20.241387719909376
SCALP-EAR-NIPPLE SYNDROME	0.58473095	19.833469744111916
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.5840166	19.809239730099996
SCALP-EAR-NIPPLE SYNDROME; SENS	0.57965635	19.661344554632095
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.57496951	19.502371783761156
PERIORAL MYOCLONIA WITH ABSENCES	0.5657097099999999	19.18828893397096
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.5506308190000001	18.676828529107393
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.54281613	18.411762351507
BRACHYDACTYLY TYPE A2	0.537037	18.2157402322703
OTOONYCHOPERONEAL SYNDROME	0.5353489699999999	18.158483998557763
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	18.090104378836873
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.52753378	17.89340082755495
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	17.876211373504468
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.5259578189999999	17.839945858545015
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.521519964	17.689418401650087
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.516670419	17.524926845268116
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.515625	17.48946731280037
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.5140044939999999	17.43450142340944
PETERS-PLUS SYNDROME; PTRPLS	0.5128741330000001	17.396160746054463
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.512368214	17.379000496234482
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.507846503	17.225628730450378
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	17.198349299556373
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.506888193	17.19312384527117
PETERS PLUS SYNDROME	0.506868234	17.19244685661062
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.50512821	17.133427040132577
DISTAL MYOTILINOPATHY	0.50492611	17.126572016920136
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.5027027	17.051156246703496
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.50235294	17.03929274883717
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.501086973	16.996352456055433
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.500545554	16.977988082910166
MEDULLOBLASTOMA	0.500545554	16.977988082910166
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.500541419	16.977847827981993
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.500541419	16.977847827981993
PAROXYSMAL HEMICRANIA	0.5	16.959483454836725
CREST SYNDROME	0.5	16.959483454836725
PYKNOACHONDROGENESIS	0.5	16.959483454836725
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.5	16.959483454836725
INHALATIONAL ANTHRAX	0.5	16.959483454836725
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	16.959483454836725
BRACHYDACTYLY TYPE C	0.5	16.959483454836725
BRACHYDACTYLY, TYPE D	0.5	16.959483454836725
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	16.959483454836725
GASTROSCHISISABDOMINAL WALL DEFECTS, INCLUDED	0.5	16.959483454836725
HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY	0.5	16.959483454836725
MADELUNG DEFORMITY	0.5	16.959483454836725
POLAND SYNDROME	0.48888859999999995	16.582596245916577
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.48631315	16.49523964258906
EPILEPSY, JUVENILE ABSENCE	0.48251765999999996	16.366500542873062
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.47424667000000004	16.085957106752822
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.44171742	14.982598552406328
MYOCLONIC EPILEPSY OF INFANCY	0.43886191399999996	14.885742738881952
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.43886191399999996	14.885742738881952
PSEUDOAMINOPTERIN SYNDROME	0.43367648400000003	14.709858310299529
CZEIZEL-LOSONCI SYNDROME	0.43333299999999997	14.698207687869525
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.41217954	13.980704178104425
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.40699811999999996	13.804955764579303
BECKWITH-WIEDEMANN SYNDROME	0.4061966	13.777769034221862
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.40208787	13.638405157311078
NEUROFACIODIGITORENAL SYNDROME	0.4003117	13.578159305855126
DISTAL MONOSOMY 12Q	0.394864554	13.393397740928965
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3883056	13.170924797240893
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.383358539	13.003125598881757
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.380952	12.921498282173921
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.377781419	12.81395545015048
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.36420503000000004	12.353458360906627
ACITRETIN/ETRETINATE EMBRYOPATHY	0.35752487	12.1268742349153
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	12.12662967916388
SPINOCEREBELLAR ATAXIA TYPE 42	0.35743284000000003	12.123752672390605
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.3500228329999999	11.872412890157152
GLOMUVENOUS MALFORMATION	0.35	11.871638418385706
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.34948424299999997	11.854144473769274
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.346615073	11.756825191481045
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.346069519	11.738320563407607
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.345372854	11.714690406325479
NON-DISTAL MONOSOMY 20Q	0.344083579	11.670959530263008
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.34271197900000006	11.624436275249703
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.34166633	11.58896894141957
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	11.545176841621828
FRAXE INTELLECTUAL DISABILITY	0.34017264999999997	11.538304858925926
MARTSOLF SYNDROME	0.33947207	11.514541909088349
FG SYNDROME 2; FGS2	0.33879748	11.49166051320075
PRIMROSE SYNDROME; PRIMS	0.33872228	11.489109806889145
KEUTEL SYNDROME; KTLS	0.337458649	11.446248748814106
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.335509874	11.380148314074708
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.334419973	11.343179998120888
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.33395510400000006	11.327412121892557
COG4-CDG	0.333878554	11.324815624975619
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.333874419	11.324675370047448
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.333874419	11.324675370047448
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	11.306310996902178
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.333333	11.306310996902178
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	11.306310996902178
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.333333	11.306310996902178
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.333333	11.306310996902178
PLACENTAL INSUFFICIENCY	0.333333	11.306310996902178
BRACHYDACTYLY, TYPE A6	0.333333	11.306310996902178
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.333333	11.306310996902178
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.327464519	11.107258184053133
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.32742392000000003	11.105881107915568
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.3269231	11.088893810907864
RING CHROMOSOME 7 SYNDROME	0.32036969	10.866608913972339
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.31529217000000004	10.694384681109137
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.31314179999999997	10.62144635223558
JUVENILE MYOCLONIC EPILEPSY	0.31234589999999995	10.59445024647217
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.30897985	10.480277307905865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.30157222	10.229018151056762
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	10.219154311965625
SCHINZEL-GIEDION SYNDROME	0.2986447	10.129719697049353
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.298125454	10.112107409157375
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.29551881399999996	10.02369287325194
CHROMOSOME 1P36 DELETION SYNDROME	0.29456647299999994	9.991390450386215
SAETHRE-CHOTZEN SYNDROME	0.29416119899999993	9.977643974990864
ABLEPHARON-MACROSTOMIA SYNDROME	0.2911642	9.87598886508154
OTOONYCHOPERONEAL SYNDROME	0.28061503000000004	9.518171916927024
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.274006144	9.294005331383218
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.26975159400000004	9.149695390717667
ZIMMERMANN-LABAND SYNDROME	0.269013469	9.124658953267465
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.268915084	9.121321835708057
FOCAL FACIAL DERMAL DYSPLASIA TYPE II	0.2659091	9.019361963881048
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.26196832000000003	8.885694777462746
LANDAU-KLEFFNER SYNDROME	0.259858903	8.814145532041042
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.259541069	8.803364931112274
8Q24.3 MICRODELETION SYNDROME	0.257848933	8.745969426121606
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25693326	8.714910743934524
20Q13.33 MICRODELETION SYNDROME	0.25668048899999996	8.706337012749799
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.25564458	8.671200049657367
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.25531915	8.66016180025595
HYPEREKPLEXIA 1; HKPX1	0.2542735	8.62469443250685
LAING EARLY-ONSET DISTAL MYOPATHY	0.25344828	8.596703822633652
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25196464	8.546380286567784
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.25157535	8.533175971939515
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.25157535	8.533175971939515
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.251086973	8.516610728637069
EAR-PATELLA-SHORT STATURE SYNDROME	0.250545554	8.498246355491803
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.250541419	8.498106100563628
CRYPTOMICROTIA-BRACHYDACTYLY-EXCESS FINGERTIP ARCH SYNDROME	0.25	8.479741727418363
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25	8.479741727418363
VACTERL WITH HYDROCEPHALUS	0.25	8.479741727418363
HYPERPARATHYROIDISM 2	0.25	8.479741727418363
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	8.479741727418363
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25	8.479741727418363
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	8.479741727418363
DYSTONIA 6, TORSION	0.25	8.479741727418363
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.244961144	8.308828937491752
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	8.243840536082487
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.23972188400000002	8.131118650920579
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.23932652000000001	8.1177083124873
KOOLEN-DE VRIES SYNDROME; KDVS	0.238957923	8.105205883041295
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	7.957891773395522
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.23387798	7.9328994645212685
8Q22.1 MICRODELETION SYNDROME	0.231921994	7.866554440111484
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.22901783	7.76804819749522
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.226086973	7.668636555895233
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	7.663283362780648
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.225545554	7.6502721827499665
BRANCHIOOCULOFACIAL SYNDROME	0.224379069	7.610706216634335
PIERPONT SYNDROME	0.22318961299999998	7.570361097929822
CODAS SYNDROME	0.222744554	7.555265156435971
DISTAL 17P13.1 MICRODELETION SYNDROME	0.22135945	7.508283859693514
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.22098719400000003	7.495657320747588
DOWN SYNDROME	0.22033085	7.473394810330223
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.219299039	7.438396847164188
CLASSICAL EHLERS-DANLOS SYNDROME	0.21898046	7.427590976605069
AURICULOOSTEODYSPLASIA	0.21787023	7.389933121972943
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.21740343	7.374099748219508
COHEN-GIBSON SYNDROME; COGIS	0.217252574	7.3689828685473815
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.21685348299999999	7.355446114124434
WARBURG MICRO SYNDROME 2; WARBM2	0.21619997000000002	7.333279628302393
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.21507888900000002	7.295253718960329
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.214545704	7.277168634588595
8P INVERTED DUPLICATION/DELETION SYNDROME	0.21349769899999999	7.241621387672422
INTELLECTUAL DISABILITY, WOLFF TYPE	0.21349769899999999	7.241621387672422
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.21237721	7.20361555835877
FGFR2-RELATED BENT BONE DYSPLASIA	0.21175792000000002	7.1826098813412775
DEND SYNDROME	0.209883219	7.119021960156746
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20986120000000003	7.118275098424362
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.20810757300000002	7.058793882239452
SHELDON-HALL SYNDROME	0.20742912	7.035781457382682
BRANCHIOSKELETOGENITAL SYNDROME	0.20662026900000002	7.008346067078827
KAGAMI-OGATA SYNDROME	0.206406123	7.001082455990988
NEONATAL MARFAN SYNDROME	0.20612263	6.991466666304863
RENPENNING SYNDROME	0.20575696899999998	6.979063822945705
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.205467529	6.96924631716337
FAMILIAL LAMBDOID SYNOSTOSIS	0.20546448	6.969142898233262
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.20540101	6.966990061403505
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.20505564	6.95527546780191
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.20492611000000002	6.950881944018102
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.204129784	6.9238713887747885
MOMO SYNDROME	0.203977789	6.918715875399352
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.20376969	6.911657372304417
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.20368050000000001	6.908632139645743
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20344828	6.900755477149979
CODAS SYNDROME	0.203439913	6.9004716771538455
XQ25 MICRODUPLICATION SYNDROME	0.202718293	6.875995072252486
DISTAL TRISOMY 6P	0.202182384	6.857817592614889
RING CHROMOSOME 8 SYNDROME	0.20163132	6.839126071033778
1P21.3 MICRODELETION SYNDROME	0.20054555400000001	6.80229801000813
BECKWITH-WIEDEMANN SYNDROME	0.2	6.78379338193469
FAMILIAL CERVICAL ARTERY DISSECTION	0.2	6.78379338193469
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	6.78379338193469
RADIATION PROCTITIS	0.2	6.78379338193469
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	6.78379338193469
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.2	6.78379338193469
EAR PITS, POSTERIOR HELICAL	0.2	6.78379338193469
MUCKLE-WELLS SYNDROME	0.19444430000000001	6.595349777474617
TOWNES-BROCKS SYNDROME	0.19050465	6.461720919488921
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.18830818400000002	6.387219061916699
20Q11.2 MICRODUPLICATION SYNDROME	0.188182873	6.38296864225428
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.18796611400000002	6.3756164009059075
BRANCHIOGENIC DEAFNESS SYNDROME	0.1851855	6.281300846651332
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.184140403	6.245852236090934
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.18347614	6.223321121374614
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.18296851	6.2061028362022554
MOWAT-WILSON SYNDROME; MOWS	0.182635449	6.194805751164353
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.18213795400000002	6.177931234721625
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.179201484	6.078329205960376
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.17793815000000002	6.0354782218185115
UNILATERAL POLYMICROGYRIA	0.17776204999999998	6.029505091745716
3MC SYNDROME	0.17750715	6.020859147080442
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.17724381899999997	6.011927231605149
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.1769231	6.001048774456846
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.176753623	5.995300289701896
MONOSOMY 9Q22.3	0.175463843	5.951552284561138
PFAPA SYNDROME	0.17543893000000002	5.950707261338517
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.17465101400000002	5.923981964606915
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.17376924299999996	5.894073203236004
CEREBROOCULONASAL SYNDROME	0.17188255	5.830078525800292
ROIFMAN SYNDROME; RFMN	0.171066784	5.802408585840255
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.17086195	5.7954608281722795
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.17027323	5.775492053973216
MICROTRIPLICATION 11Q24.1	0.1693697	5.744845249801319
AREDYLD SYNDROME	0.16871618000000002	5.72267852654651
BRACHYDACTYLY, TYPE E	0.16871618000000002	5.72267852654651
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.167990874	5.698076896333122
TARP SYNDROME	0.167382213	5.677431744014913
GRANULOMATOSIS WITH POLYANGIITIS	0.167208419	5.6715368310798135
BRACHYDACTYLY, TYPE B1	0.166667	5.653172457934545
268650 RUDIGER SYNDROME	0.166667	5.653172457934545
PITYRIASIS RUBRA PILARIS	0.166667	5.653172457934545
PEMPHIGUS VULGARIS	0.166667	5.653172457934545
AURICULOOSTEODYSPLASIA	0.166667	5.653172457934545
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.166667	5.653172457934545
EXOSTOSES-ANETODERMIA-BRACHYDACTYLY TYPE E SYNDROME	0.166667	5.653172457934545
HOLT-ORAM SYNDROME	0.166667	5.653172457934545
BRACHYDACTYLY TYPE B2	0.166667	5.653172457934545
BRACHYDACTYLY TYPE E	0.166667	5.653172457934545
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	5.653172457934545
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	5.653172457934545
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.166667	5.653172457934545
BRACHYDACTYLY TYPE B	0.166667	5.653172457934545
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.166667	5.653172457934545
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.166667	5.653172457934545
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.166667	5.653172457934545
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.166667	5.653172457934545
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	0.166667	5.653172457934545
49,XYYYY SYNDROME	0.1666667	5.653162282244472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.1666667	5.653162282244472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.16594129999999999	5.628557463648194
JUVENILE ABSENCE EPILEPSY	0.16503685	5.5978794540267405
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.16323018399999997	5.536599209755908
ATYPICAL RETT SYNDROME	0.162472419	5.510896603795599
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.4102685602043
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.4102685602043
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.1594828	5.409491815862069
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.1594828	5.409491815862069
608028 THAI SYMPHALANGISM SYNDROME	0.15922214999999998	5.400650837137062
MOWAT-WILSON SYNDROME	0.157510249	5.342584923765425
EPILEPSY, IDIOPATHIC GENERALIZED	0.15622691	5.2990553906905316
DISTAL MONOSOMY 9P	0.15582844399999998	5.285539835621901
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.2539412652385185
TEEBI-SHALTOUT SYNDROME; TBSH	0.15466734000000001	5.246156387467213
CHARGE SYNDROME	0.1536391	5.21127954893201
FEBRILE CONVULSIONS, FAMILIAL, 9	0.15362399999999998	5.210767372531673
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.178131017436722
GLYCINE ENCEPHALOPATHY	0.15211625999999998	5.159626389363281
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.15181360400000002	5.149360610514269
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.14891951	5.051195931894784
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.035382570331826
OLIVER SYNDROME	0.14795135	5.018356944891515
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.147513204	5.003495485215909
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.147513204	5.003495485215909
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.14740676299999997	4.999885116459075
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.145058844	4.920246129591482
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.144158203	4.889697317314988
PHACE SYNDROME	0.14394397299999998	4.882430857033928
ALG11-CDG	0.14394397299999998	4.882430857033928
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.143244119	4.858692532366326
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	4.845561855815219
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	4.845561855815219
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	4.845561855815219
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14285699999999998	4.845561855815219
GANGLIONEUROMA	0.14285699999999998	4.845561855815219
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.141153799	4.787791037455698
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.140625	4.769854721672829
16P12.1P12.3 TRIPLICATION SYNDROME	0.14011800000000002	4.7526578054496245
C SYNDROME	0.139121479	4.718856842625829
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.13790635899999998	4.677641227554546
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.137708673	4.670935922662042
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	4.666120480848841
ATYPICAL JUVENILE PARKINSONISM	0.13756617899999998	4.666102673391214
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.13703700000000002	4.6481534684009205
CHRISTIANSON SYNDROME	0.13649015	4.629604881346365
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.13553973	4.597367616816073
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.13549420399999998	4.595823421928543
ZECHI-CEIDE SYNDROME	0.134640944	4.5668817242231965
CONGENITAL MYASTHENIC SYNDROME	0.133985949	4.544664970492194
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.133985949	4.544664970492194
TEMTAMY SYNDROME; TEMTYS	0.132643903	4.499144156626935
WHITE-SUTTON SYNDROME; WHSUS	0.13140643400000002	4.457170486564188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.13133251399999998	4.454663196530224
EHLERS-DANLOS SYNDROME, TYPE I	0.13090482	4.440156257896759
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.13081887	4.437240922690873
22Q11.2 MICRODUPLICATION SYNDROME	0.12952334299999999	4.393297985247283
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.129397449	4.389027790827157
LAURENCE-MOON SYNDROME	0.1286805	4.364709621420234
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.128380094	4.354520160246766
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.12750605899999998	4.324873796003869
HEART-HAND SYNDROME TYPE 2	0.12704918	4.309376932321146
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.12704918	4.309376932321146
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.12680505	4.301096294929487
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.126057584	4.275743020409381
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.125541419	4.258235236854449
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.125541419	4.258235236854449
FAMILIAL AVASCULAR NECROSIS OF FEMORAL HEAD	0.125	4.239870863709181
PARKINSON DISEASE, LATE-ONSET; PD	0.125	4.239870863709181
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.125	4.239870863709181
PERRY SYNDROME	0.125	4.239870863709181
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.125	4.239870863709181
SECKEL SYNDROME	0.12497225000000001	4.238929612377438
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.1238095	4.199490333603214
TRISOMY XQ28	0.12359800999999998	4.192316811291487
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.12318382900000002	4.178268219657873
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.12275444399999998	4.163703924051362
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.12240386899999998	4.151812782227003
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.12096990299999999	4.103174136923406
MENTAL RETARDATION, X-LINKED 21	0.12058098899999999	4.089982575826697
GALLOWAY-MOWAT SYNDROME	0.12045510299999998	4.085712652758306
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.11976801300000002	4.06240726978434
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.118300879	4.012643600186283
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.007636177020374
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.118109064	4.006137433548504
20P13 MICRODELETION SYNDROME	0.116629819	3.9559629713422035
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.11469522999999998	3.890343711067384
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE	0.11469522999999998	3.890343711067384
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.113955543	3.86525429219087
XIA-GIBBS SYNDROME	0.113461604	3.848500391594472
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.11340077400000001	3.846437100837358
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.11316017999999999	3.8382764009126906
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.11274232	3.824103021399815
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.1121951	3.8055418843275035
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61	0.11182266	3.792909104291665
MAST CELL SARCOMA	0.11111099999999999	3.7687703323007264
TETRAPLOIDY	0.11111099999999999	3.7687703323007264
STEINERT MYOTONIC DYSTROPHY	0.11111099999999999	3.7687703323007264
ULNAR-MAMMARY SYNDROME	0.11111099999999999	3.7687703323007264
TARP SYNDROME; TARPS	0.11053204400000001	3.7491327428945698
14Q12 MICRODELETION SYNDROME	0.11028266900000001	3.7406742005214704
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.11	3.7310863600640793
SAGLIKER SYNDROME	0.10961538000000001	3.718040447011281
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.109075683	3.6997344823270306
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.10899505400000001	3.6969996299440706
SPINOCEREBELLAR ATAXIA TYPE 29	0.108777964	3.6896361614176496
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.10833333	3.6745546354847343
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.10793651000000001	3.6610949110356374
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.107394603	3.6427139854345167
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.107320054	3.6401853603703676
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.10721061000000001	3.636473132955906
NAGER SYNDROME	0.1071242	3.6335421950252402
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	3.621150375330328
MATERNAL PHENYLKETONURIA	0.10673211300000002	3.6202430090465274
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.10657480000000001	3.6149071146050664
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.10615581300000002	3.6006955084164827
MICROTIA	0.10531915	3.5723167638049342
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 61	0.10492611	3.5589852530507566
TRISOMY 13	0.104648429	3.5495666004003112
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.104129784	3.5319746978074438
AICARDI SYNDROME; AIC	0.1036867	3.516945746273238
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.10361188900000001	3.5144082344397587
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.10358423	3.5134700697340038
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.10317752300000002	3.499674988459072
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.10310420000000001	3.4971879480483534
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.10270270000000001	3.4835694828341195
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.10270270000000001	3.4835694828341195
WEYERS ACROFACIAL DYSOSTOSIS	0.10204918	3.4614027595793093
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.10196464000000001	3.4585352501167663
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.10163132000000001	3.4472293800664335
NON-DISTAL TRISOMY 13Q	0.1008403	3.420398798861543
CONGENITAL TRACHEAL STENOSIS	0.10057470000000002	3.4113899212503345
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.100541419	3.4102610641126136
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.100541419	3.4102610641126136
LIPOID PROTEINOSIS	0.100541419	3.4102610641126136
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.10023615000000001	3.3999066550030648
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.1	3.391896690967345
ELLIS VAN CREVELD SYNDROME	0.1	3.391896690967345
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.1	3.391896690967345
METAPHYSEAL ANADYSPLASIA	0.1	3.391896690967345
ACUTE MYELOMONOCYTIC LEUKEMIA	0.1	3.391896690967345
LICHEN PLANUS PEMPHIGOIDES	0.1	3.391896690967345
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.1	3.391896690967345
KAPOSI SARCOMA	0.1	3.391896690967345
LEISHMANIASIS	0.1	3.391896690967345
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.1	3.391896690967345
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.1	3.391896690967345
JUVENILE XANTHOGRANULOMA	0.1	3.391896690967345
AA AMYLOIDOSIS	0.1	3.391896690967345
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.099348799	3.3698086257967983
WITTEVEEN-KOLK SYNDROME	0.099055293	3.359853205495008
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.3563870601854755
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.337417877941241
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.3281917832659413
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.3281917832659413
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.3281917832659413
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.3281917832659413
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.3281917832659413
49,XXXYY SYNDROME	0.09789425999999998	3.3204721655869687
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.09752158	3.307831244999072
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.09728178	3.2996974767341323
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.09682066	3.2840567627127433
ROBERTS SYNDROME; RBS	0.09672797000000001	3.280912813669886
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.09595502900000001	3.254695453467756
TETRASOMY 9P	0.09483284300000003	3.2166320636672583
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.09361180000000001	3.1752155465549694
ROBERTS SYNDROME	0.09350383400000001	3.1715534513735997
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.09325970400000001	3.163272813981941
3P25.3 MICRODELETION SYNDROME	0.09257182	3.139940499348247
MONOSOMY 13Q34	0.09252355400000002	3.1383033664913853
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.09248751000000001	3.1370807912480925
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.09199607300000001	3.1204117559069036
CHARGE SYNDROME	0.091811704	3.114158149896733
AICARDI SYNDROME	0.09146958999999999	3.102553996451397
UNVERRICHT-LUNDBORG DISEASE	0.0909091	3.0835427546881946
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.09063464000000002	3.0742333550301657
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.09051070400000001	3.0700295739472487
PSEUDOMYXOMA PERITONEI	0.09047619999999999	3.0688592339129963
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.090167594	3.0583916372108706
MEIER-GORLIN SYNDROME 5; MGORS5	0.08993019	3.0503391387906458
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.08982882300000002	3.046900874871914
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08979253	3.04566985380586
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.08962860300000002	3.040109619317259
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08928740400000001	3.028536501726645
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.08925271000000001	3.0273597170886806
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.08881885000000002	3.0126436341052503
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08868102000000001	3.00796858289609
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.08867000000000001	3.0075947958807454
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.08867000000000001	3.0075947958807454
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.08790998	2.9818157026500547
22Q11.2 DELETION SYNDROME	0.087191013	2.9574290847679072
ACROOTOOCULAR SYNDROME	0.08676967000000002	2.9431375654932856
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08645022000000001	2.93230215151399
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.086236449	2.925051260038742
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.08622765900000001	2.924753112319606
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.086158213	2.922397575743597
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.08587826000000001	2.9129018592003333
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.08528754	2.8928652470674505
TRICHOHEPATOENTERIC SYNDROME 1	0.0840473	2.8507975875473974
WILLIAMS-BEUREN SYNDROME; WBS	0.08388099	2.8451565241606493
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.08346845400000001	2.8311637292276006
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	2.826579445173891
POSTORGASMIC ILLNESS SYNDROME	0.08333330000000001	2.826579445173891
ALKAPTONURIA	0.08333330000000001	2.826579445173891
OROMANDIBULAR DYSTONIA	0.08333330000000001	2.826579445173891
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.08333330000000001	2.826579445173891
POLYDACTYLY, PREAXIAL IV; PPD4	0.08333330000000001	2.826579445173891
SCLEROSTEOSIS	0.08333330000000001	2.826579445173891
DIPROSOPUS	0.08333330000000001	2.826579445173891
ERMINE PHENOTYPE	0.08333330000000001	2.826579445173891
SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	0.08333330000000001	2.826579445173891
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.082877923	2.8111335277794645
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.082769773	2.8074651915081827
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.0822917	2.7912494492407744
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.08223111	2.7891942990357173
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.08223111	2.7891942990357173
FRIEDREICH ATAXIA	0.08222186000000001	2.788880548591803
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.082141554	2.786156652035155
PAPILLARY TUMOR OF THE PINEAL REGION	0.08184921	2.776240645572913
PINEOCYTOMA	0.08184921	2.776240645572913
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.08161245	2.768209990967379
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.081596	2.767652023961715
3MC SYNDROME 2	0.08095217400000002	2.7458141111721277
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.0807113	2.7376439139367266
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.080673794	2.736371749163812
NORMAL PRESSURE HYDROCEPHALUS	0.0803924	2.726827155389232
LOCKED-IN SYNDROME	0.08020053	2.720319123208273
3MC SYNDROME 3	0.07936511000000002	2.691982539872594
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0791926	2.6861311788910056
PRIMARY PROGRESSIVE FREEZING GAIT	0.07910191	2.683055067781967
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.07852350999999999	2.6634363373214116
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.077850554	2.6406103650257458
N SYNDROME	0.07746865400000001	2.627656711562942
PEDIATRIC-ONSET GRAVES DISEASE	0.07746865400000001	2.627656711562942
ETHYLMALONIC ENCEPHALOPATHY	0.07746451900000001	2.6275164566347704
DDOST-CDG	0.07746451900000001	2.6275164566347704
NEUROFIBROMATOSIS TYPE 1	0.07746451900000001	2.6275164566347704
7Q11.23 MICRODUPLICATION SYNDROME	0.077365189	2.6241472856516324
OKAMOTO SYNDROME	0.076983234	2.6111917666456477
DERMATOMYOSITIS	0.07692310000000001	2.609152083489502
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	2.609152083489502
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.07692310000000001	2.609152083489502
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.609152083489502
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.07692310000000001	2.609152083489502
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	2.609152083489502
CLASSIC MYCOSIS FUNGOIDES	0.07692310000000001	2.609152083489502
DERMOODONTODYSPLASIA	0.07692310000000001	2.609152083489502
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.609152083489502
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07689308	2.608133836102873
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.076616449	2.5987507983676834
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.5883258378069622
NOONAN SYNDROME 7; NS7	0.07567976900000001	2.5669795804427307
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.07542410000000001	2.558307552091901
URBAN-ROGERS-MEYER SYNDROME	0.07502633	2.5448156046242407
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07489701900000001	2.5404295090941837
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.07462507	2.531205279962065
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.07442027300000001	2.5242587772958647
COHEN SYNDROME	0.074356663	2.52210119181074
MIYOSHI MYOPATHY	0.07404541	2.5115438116032034
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.07394574999999999	2.5081634473609853
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.07394574999999999	2.5081634473609853
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.07394574999999999	2.5081634473609853
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07378154	2.502593613804748
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.07356325	2.495189442518035
MYOPATHY AND DIABETES MELLITUS	0.07356325	2.495189442518035
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.07339486900000002	2.489478132950818
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.07251557300000001	2.45965332102301
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.07251557300000001	2.45965332102301
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.07251557300000001	2.45965332102301
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07251557300000001	2.45965332102301
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.072426573	2.456634532968048
CRANIOECTODERMAL DYSPLASIA 1	0.07231184	2.452742908137601
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.4412889478777413
RABIES	0.07197001900000001	2.4411486929495694
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.07197001900000001	2.4411486929495694
VASCULAR EHLERS-DANLOS SYNDROME	0.07194529399999999	2.440310046492727
WALDENSTRÖM MACROGLOBULINEMIA	0.07142860000000001	2.4227843198043013
STEVENS-JOHNSON SYNDROME	0.07142860000000001	2.4227843198043013
TOXIC EPIDERMAL NECROLYSIS	0.07142860000000001	2.4227843198043013
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07142860000000001	2.4227843198043013
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	2.4227843198043013
ESOPHAGEAL ATRESIA	0.07142860000000001	2.4227843198043013
3MC SYNDROME 1	0.07142860000000001	2.4227843198043013
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.07133404	2.419576942293322
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.07110015	2.4116436351228185
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.070386854	2.387449371702016
JACOBSEN SYNDROME	0.070235983	2.382331983245387
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.07019710000000001	2.3810131120550384
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.07019710000000001	2.3810131120550384
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.07019710000000001	2.3810131120550384
2Q23.1 MICRODUPLICATION SYNDROME	0.070081994	2.377108835449933
PHAVER SYNDROME	0.06957387000000001	2.3598737943079224
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.069565194	2.359579513351014
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0694877	2.3569509969293154
SPONDYLO-OCULAR SYNDROME	0.0694118	2.354376547340871
HOLMES-GANG SYNDROME	0.06909417400000001	2.3436030015572196
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.06902777	2.3413506464785496
EPISODIC ATAXIA TYPE 1	0.06901964	2.341074885277574
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.068952349	2.338792444075255
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06871588	2.3307716598890913
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06871588	2.3307716598890913
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.06863134	2.327904150426548
YOU-HOOVER-FONG SYNDROME; YHFS	0.06851795399999999	2.324058214444527
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.068270473	2.3156639145947544
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.068177764	2.312519321091526
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.068132949	2.3109992425894688
TRISOMY 20P	0.06779683999999998	2.2995987725404246
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.0677507	2.2980337514072127
KLEEFSTRA SYNDROME	0.067599173	2.292894112108291
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06749318	2.2892989390486336
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.06734	2.28410323169741
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.067208119	2.279629964422395
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.279629964422395
PEHO SYNDROME	0.06707321399999999	2.2750541261914456
RING CHROMOSOME 10 SYNDROME	0.067056209	2.274477334159147
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.2612655912771267
TYROSINEMIA, TYPE I; TYRSN1	0.0666667	2.2612655912771267
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.2612655912771267
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.2612655912771267
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0666667	2.2612655912771267
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.2612655912771267
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0666667	2.2612655912771267
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.2612655912771267
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.2612655912771267
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.2612655912771267
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.2612655912771267
SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE	0.0666667	2.2612655912771267
DESMOID TUMOR	0.0666667	2.2612655912771267
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06653733399999999	2.2568776302038898
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.06609733000000001	2.2419531490877667
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.065834334	2.2330325964663897
SMITH-MAGENIS SYNDROME; SMS	0.06532929300000001	2.2159021274993616
BECKER MUSCULAR DYSTROPHY	0.06504991	2.206425744767236
MENTAL RETARDATION, X-LINKED 98; MRX98	0.06490376299999999	2.2014685895102875
CRYPTOCOCCOSIS	0.06486894900000001	2.200287734596295
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.198451056457103
FG SYNDROME TYPE 1	0.064568243	2.190088097732754
PERLMAN SYNDROME	0.064564384	2.18995720443945
DESMOSTEROLOSIS	0.06439297	2.184143018645595
ANGELMAN SYNDROME	0.06432941299999999	2.1819872308657167
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.06402941000000001	2.1718114390359142
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.06283113	2.1311670193673904
ACROCRANIOFACIAL DYSOSTOSIS	0.06256898000000001	2.12227516219202
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.062373160000000004	2.1156331500917678
WILLIAMS SYNDROME	0.06234121000000001	2.1145494390990036
AARSKOG-SCOTT SYNDROME	0.061731544	2.0938701982190504
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.06166614300000001	2.0916518638641914
DOORS SYNDROME	0.061520974000000006	2.086727881356881
AMISH INFANTILE EPILEPSY SYNDROME	0.061147400000000005	2.0740566372125664
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06109523	2.0722870847088886
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.06088126	2.0650294433592253
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.060869104	2.0646171243974716
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.060702009999999994	2.0589494685406664
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.05952815	2.0191333500440773
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.059499109999999994	2.0181483432450205
HYPERTELORISM, TEEBI TYPE	0.058779	1.9937229559836955
VELOCARDIOFACIAL SYNDROME	0.058742869999999996	1.9924974637092487
7P22.1 MICRODUPLICATION SYNDROME	0.058454094	1.982702480120941
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.05811118300000001	1.9710712932589785
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05790854	1.9641978520475012
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.057803064	1.9606202150937366
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	1.9597670174000905
NORRIE DISEASE	0.05774132900000001	1.958526227671568
17Q21.31 MICRODUPLICATION SYNDROME	0.057732474000000006	1.958225875219583
CHIME SYNDROME	0.057728339000000004	1.9580856202914114
YUNIS-VARON SYNDROME	0.057407410000000006	1.9472000401600569
AGNATHIA-OTOCEPHALY COMPLEX	0.057360650000000006	1.9456139892673605
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	1.944554021551433
ALPHA-MANNOSIDOSIS	0.057316824	1.944127456623577
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.05728379	1.9430069774706829
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.05728379	1.9430069774706829
SIMPSON-GOLABI-BEHMEL SYNDROME	0.056942483	1.931430196631643
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.056869403	1.928951398529884
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.056757249	1.9251472507150966
OGDEN SYNDROME	0.056591434	1.919522977216969
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0565438	1.9179072811471933
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.056485419	1.9159270579400398
MICROHYDRANENCEPHALY; MHAC	0.05646882000000001	1.9153640370083065
MONOSOMY 13Q14	0.056317950000000006	1.910246682470644
ATELOSTEOGENESIS TYPE II	0.0563121	1.910048256514222
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.056218954	1.9068888404224538
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.05621583	1.906782877569828
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.056097019000000005	1.9027529311923228
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.05572271000000001	1.8900567566073299
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.055605724	1.8860887123444348
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	1.8843885580470545
GITELMAN SYNDROME	0.055555600000000004	1.8843885580470545
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	1.8843885580470545
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	1.8843885580470545
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	1.8843885580470545
WILDERVANCK SYNDROME	0.055555600000000004	1.8843885580470545
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	1.8843885580470545
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	1.8843885580470545
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	1.8843885580470545
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	1.8843885580470545
CROSSED POLYSYNDACTYLY	0.055555600000000004	1.8843885580470545
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	1.8843885580470545
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	1.8843885580470545
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	1.8843885580470545
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	1.8843885580470545
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.055471664	1.8815415356405236
PURE MITOCHONDRIAL MYOPATHY	0.05544662	1.880692069033238
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.054872623999999995	1.8612227177029528
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.05468078	1.8547155674151334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.054595194	1.8518125787132023
SIFRIM-HITZ-WEISS SYNDROME	0.05458702000000001	1.8515353250776827
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.054524843	1.84942634547214
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.05426292	1.8405421879022574
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.05416457	1.8372062575066912
3Q27.3 MICRODELETION SYNDROME	0.05415799	1.8369830707044257
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.054135264	1.8362122282624362
TRICHOTHIODYSTROPHY	0.054080064	1.8343399012890222
HOLOPROSENCEPHALY	0.053892502999999994	1.8279780259364768
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.053721054000000004	1.8221626529787804
SLC39A8-CDG	0.05356896900000001	1.8170040868963229
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.053478300000000006	1.8139286880855896
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.053441419000000004	1.812677722666994
MONOSOMY 18P	0.053423134000000004	1.8120575143570505
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.053292754	1.807635159451367
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.05320941900000001	1.8048085223439498
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.052804109	1.7910608258657899
%601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	0.0526316	1.785209498803169
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0526316	1.785209498803169
PENILE AGENESIS	0.0526316	1.785209498803169
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.05260885900000001	1.7844381475766766
CARDIOFACIOCUTANEOUS SYNDROME	0.052239054	1.7718947440186446
SILVER-RUSSELL SYNDROME; SRS	0.051868253999999996	1.7593175910885372
DIASTROPHIC DWARFISM	0.0518518	1.758759488407006
20P12.3 MICRODELETION SYNDROME	0.051807133000000005	1.7572444299120515
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.05167888	1.7528942206489853
PERIVENTRICULAR NODULAR HETEROTOPIA	0.0515873	1.7497879216593972
PITT-HOPKINS SYNDROME	0.051423513000000004	1.7442324358261625
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.736010681761059
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.050919583	1.7271396508313706
LISSENCEPHALY, X-LINKED, 2	0.05083609900000001	1.7243079597978839
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.050795713	1.7229381084002693
GIANT AXONAL NEUROPATHY	0.05044494	1.7110402506204623
HISTIDINEMIA	0.05043863	1.7108262219392625
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.050292604	1.7058731708773103
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.05025664900000001	1.7046536144220734
BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2	0.05	1.6959483454836726
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.049920694	1.693258367893934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.049726704000000004	1.6866784275031264
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.04941234	1.6760155253895337
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.049404979999999994	1.6757658817930783
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.664636186856875
PYRIDOXINE-DEPENDENT EPILEPSY	0.048970853999999994	1.6610407763644495
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.048899293	1.6586135011734264
MEHMO SYNDROME	0.048657729	1.650419899850858
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.048606510000000006	1.6486826042847118
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.04840441	1.6418275810722665
DESMINOPATHY	0.04840441	1.6418275810722665
OCULOPHARYNGODISTAL MYOPATHY	0.04840441	1.6418275810722665
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.048388444	1.6412860308465869
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.04835373900000001	1.6401088730999867
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.04835373900000001	1.6401088730999867
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.048330040000000005	1.6393050275031944
XP22.13P22.2 DUPLICATION SYNDROME	0.04828666899999999	1.6378339279893543
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.048264879999999996	1.6370948676193597
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.04804403	1.6296038637773587
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.048007129	1.6283522199794245
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.04774224	1.619367458753688
ANOPHTHALMIA PLUS SYNDROME	0.047619	1.6151872852717402
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.04761567900000001	1.615074640382633
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.04757592	1.6137260561772713
DISTAL MYOPATHY WITH POSTERIOR LEG AND ANTERIOR HAND INVOLVEMENT	0.04753696	1.6124045732264705
ACROCEPHALOPOLYDACTYLY	0.04746115	1.609833176345048
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.047402563999999994	1.6078459997496777
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.047402563999999994	1.6078459997496777
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0473363	1.605598393326375
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.04731683	1.6049379910406436
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.04723343000000001	1.6021091492003772
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.04721556999999999	1.60150335645137
OCULODENTODIGITAL DYSPLASIA; ODDD	0.047146249	1.5991520597462248
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.046918213	1.5914173142080106
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.04685700999999999	1.5893413716762375
DUPLICATION/INVERSION 15Q11	0.046824869000000005	1.5882511821607943
WOLF-HIRSCHHORN SYNDROME	0.046767933	1.5863199718608247
16P13.11 MICRODELETION SYNDROME	0.046763204	1.5861595690663093
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04674574	1.5855672082281984
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.584278965864969
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.046659059999999995	1.5826271121764677
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.046376794	1.573052941062742
JUVENILE PRIMARY LATERAL SCLEROSIS	0.04635260000000001	1.5722323055773295
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.046340780000000005	1.5718313833884574
NEURONAL CEROID LIPOFUSCINOSIS	0.046244349000000004	1.5685605434903906
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.046103003999999996	1.5637662671125425
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04601606900000001	1.5608175217242504
FRYNS SYNDROME; FRNS	0.045984359	1.5597419512835446
HUNTINGTON DISEASE	0.04570293	1.5501961703451221
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.045662519	1.5488254709733351
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.045382349	1.539322394014252
MOHR-TRANEBJAERG SYNDROME	0.045358050000000004	1.538498197037314
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.04528335000000001	1.5359644502091614
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.045158184000000004	1.5317189487969451
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.045083863999999994	1.5291980911762177
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.045032824	1.5274668671051481
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.5238268870902034
MEHMO SYNDROME; MEHMO	0.044836343	1.5208024345677686
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.044653293999999996	1.5145936015939199
DIENCEPHALIC SYNDROME	0.044614259999999996	1.5132696086395676
ZELLWEGER SYNDROME	0.04452457900000001	1.5102277217681415
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.5075084721099596
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.044431554	1.5070724098713688
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.044316049999999996	1.5031546335174337
DE BARSY SYNDROME	0.044291424	1.5023193450383165
PGM3-CDG	0.04425729899999999	1.5011618602925234
OCULODENTODIGITAL DYSPLASIA	0.04420179899999999	1.4992793576290366
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.044192229000000006	1.4989547531157115
OCULO-PALATO-CEREBRAL SYNDROME	0.044129784	1.4968366832270368
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.044081028999999994	1.4951829639953553
COG1-CDG	0.04404964	1.494118281543028
AICARDI-GOUTIERES SYNDROME 6	0.044023854	1.493243647062295
ENDOCARDIAL FIBROELASTOSIS	0.044019719000000006	1.4931033921341237
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.044019719000000006	1.4931033921341237
6P22 MICRODELETION SYNDROME	0.043959319999999996	1.491054720451746
NOONAN SYNDROME	0.04385423	1.4874901762192088
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.043850780000000006	1.4873731557833705
HAMAMY SYNDROME; HMMS	0.04363133999999999	1.479929977684711
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.043589710000000004	1.478517931092262
SWEENEY-COX SYNDROME; SWCOS	0.043589244	1.4785021248536818
AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19	0.043478300000000004	1.4747390189888552
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.043478300000000004	1.4747390189888552
LAMELLAR ICHTHYOSIS	0.043478300000000004	1.4747390189888552
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.043478300000000004	1.4747390189888552
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.043443123	1.4735458514898734
OSGOOD-SCHLATTER DISEASE	0.04338761	1.4716629078798167
X-LINKED DYSTONIA-PARKINSONISM	0.04338761	1.4716629078798167
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.043303629	1.4688143591197755
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.043268413	1.4676198687810844
PROGRESSIVE SUPRANUCLEAR PALSY	0.04281613	1.4522788966702767
LISSENCEPHALY 2; LIS2	0.042790884	1.451422578431675
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.042756550000000004	1.4502580046217983
ALG13-CDG	0.0426748	1.4474851290769324
WEST SYNDROME	0.0426748	1.4474851290769324
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.04256882	1.4438903969638452
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.042525434	1.4424187886655022
HUNTINGTON DISEASE-LIKE 3	0.042472318999999994	1.4406171827380947
COG2-CDG	0.04221225399999999	1.4317960466087303
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.431655791680559
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.042208118999999995	1.431655791680559
SARCOSINEMIA	0.04219884399999999	1.4313411932624718
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.04216521	1.430200362729432
SHPRINTZEN OMPHALOCELE SYNDROME	0.042057460000000005	1.426545594044915
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.041904994	1.4213741048360644
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.4132914185352905
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	1.4132914185352905
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	1.4132914185352905
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.04158988300000001	1.4106858652541905
ISOLATED CEREBELLAR AGENESIS	0.041571448999999996	1.4100606030181773
MERRF	0.041517359999999996	1.408225960017
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.041474173	1.406761101593072
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.04144528	1.405781080882151
RICHIERI COSTA-DA SILVA SYNDROME	0.04137935	1.403544803393796
15Q13.3 MICRODELETION SYNDROME	0.041349853	1.4025442956268614
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.041266000000000004	1.3997000884945847
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.041222629999999996	1.3982290228997118
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.04120541	1.3976449382895273
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.041188763	1.3970802892473821
MASA SYNDROME	0.041164200000000005	1.39624713766318
PARKINSONIAN-PYRAMIDAL SYNDROME	0.041164200000000005	1.39624713766318
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.041079050000000006	1.393358937630821
TOWNES-BROCKS SYNDROME 2; TBS2	0.041079050000000006	1.393358937630821
QAZI-MARKOUIZOS SYNDROME	0.041044329000000004	1.3921812371807503
HSD10 DISEASE, ATYPICAL TYPE	0.041030029999999995	1.3916962298729085
LESCH-NYHAN SYNDROME	0.041030029999999995	1.3916962298729085
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.040989269999999994	1.3903136927816704
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.040928619000000006	1.3882564735196323
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.040928619000000006	1.3882564735196323
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.04090805300000001	1.3875588960461678
SPINOCEREBELLAR ATAXIA TYPE 11	0.04064041	1.378480721985562
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.040545554	1.3752633044603777
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.0405388	1.3750342157578699
MAL DE MELEDA	0.04051068	1.37408041440837
GERODERMA OSTEODYSPLASTICA	0.040484054	1.373177287995433
SHORT RIB-POLYDACTYLY SYNDROME	0.040389549999999996	1.3699718099466012
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.04030501	1.3671043004840575
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.040266550000000005	1.3657997770167116
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.040206929	1.3637774942905898
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.04018249	1.3629485486582842
9P13 MICRODELETION SYNDROME	0.04012755999999999	1.3610853798059355
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.040113833	1.3606197741471668
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.0399385	1.3546726599219931
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.03974616	1.3481486858265865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.039741823999999995	1.348001613186066
BRACHYDACTYLY TYPE A4	0.0397397	1.3479295693003501
WAISMAN SYNDROME; WSMN	0.039548473	1.341443347015114
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.03940891	1.336709514236299
CHAR SYNDROME	0.039387604	1.3359868367273215
MONOSOMY 9P	0.039254292999999996	1.331465065329626
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.039177794	1.328870298280003
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.039120539999999995	1.3269283017485562
DUBOWITZ SYNDROME	0.039098199	1.3261705181088275
CLEIDOCRANIAL DYSPLASIA; CCD	0.03908618	1.32576284604554
OTOFACIOCERVICAL SYNDROME	0.039006064	1.3230453940926046
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.039002919000000004	1.322938718941674
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.038978482999999994	1.322109875066269
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.03874215	1.3140937038596054
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.038742149999999996	1.314093703859605
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.038632240000000005	1.3103656702065631
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.038603953999999996	1.3094062383085558
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.038595194	1.3091091081584272
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.038550633	1.3075976450739653
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.3066027000176035
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.3045743457964054
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.3045743457964054
X-LINKED SPASTIC PARAPLEGIA TYPE 34	0.0384615	1.3045743457964054
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.3045743457964054
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.3045743457964054
SPASTIC PARAPLEGIA 16, X-LINKED	0.0384615	1.3045743457964054
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0384615	1.3045743457964054
CYCLIC NEUTROPENIA	0.0384615	1.3045743457964054
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.3045743457964054
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.0384615	1.3045743457964054
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.3045743457964054
DELTA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R6	0.0384615	1.3045743457964054
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.3045743457964054
BAZEX SYNDROME; BZX	0.0384615	1.3045743457964054
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.3045743457964054
LIP, HAMARTOMATOUS	0.0384615	1.3045743457964054
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.3045743457964054
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0384615	1.3045743457964054
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.3045743457964054
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0384615	1.3045743457964054
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.3045743457964054
MOSAIC TRISOMY 8	0.038460509999999996	1.3045407660191646
TEMPLE-BARAITSER SYNDROME	0.038439229	1.3038189364843598
BARDET-BIEDL SYNDROME 1; BBS1	0.038309034	1.299402856587555
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.038263999	1.297875315912778
RETT SYNDROME	0.038210349	1.296055563338074
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03820699999999999	1.2959419687178932
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.038109669	1.292640601749608
DISTAL TRISOMY 5Q	0.03808761	1.2918923832585476
BAKER-GORDON SYNDROME; BAGOS	0.038032024	1.2900069635639064
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.037936774	1.2867761819657602
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.2849610423705555
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.037708754	1.2790419791310161
JAWAD SYNDROME	0.037582554	1.2747614055070153
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.2747614055070153
ISOTRETINOIN-LIKE SYNDROME	0.03757725	1.2745814993065265
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.037521043999999996	1.2726750498524013
FLYNN-AIRD SYNDROME	0.037472419	1.2710257400864187
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.037422679	1.2693386106723314
BRAIN-LUNG-THYROID SYNDROME	0.037381293999999995	1.2679348742267744
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.037113294000000005	1.2588445910949824
SYNPOLYDACTYLY 1	0.037037	1.2562567774335756
BRACHYDACTYLY, TYPE A3	0.037037	1.2562567774335756
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.037037	1.2562567774335756
MCLEOD SYNDROME; MCLDS	0.037037	1.2562567774335756
CANAVAN DISEASE	0.037037	1.2562567774335756
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.037037	1.2562567774335756
CLEIDORHIZOMELIC SYNDROME	0.037037	1.2562567774335756
BRACHYDACTYLY-SYNDACTYLY, ZHAO TYPE	0.037037	1.2562567774335756
CLEIDORHIZOMELIC SYNDROME	0.037037	1.2562567774335756
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.037037	1.2562567774335756
BRACHYDACTYLY, TYPE A4	0.037037	1.2562567774335756
MYOCLONUS AND ATAXIA	0.037037	1.2562567774335756
BRACHYDACTYLY, TYPE A1, D	0.037037	1.2562567774335756
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.2562567774335756
BRACHYDACTYLY, TYPE A2; BDA2	0.037037	1.2562567774335756
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.036931	1.2526613669411502
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.036917530000000004	1.2522044784568769
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.03683574	1.2494302461533344
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036801273	1.248261161120859
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.036801273	1.248261161120859
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.036780129999999994	1.2475440124034876
HAREL-YOON SYNDROME; HAYOS	0.036653204	1.2432388136095105
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.036388	1.2342433679091973
PITT-HOPKINS SYNDROME	0.036157179	1.2264141580481396
THUMBS, CONGENITAL CLASPED	0.0361093	1.2247901518314712
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.036090284	1.2241451487567172
PHELAN-MCDERMID SYNDROME	0.036045813	1.222636738379277
MICROPHTHALMIA WITH LIMB ANOMALIES	0.036036000000000006	1.2223038915569926
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.035932563	1.2187954153767566
CHROMOSOME 17Q12 DELETION SYNDROME	0.03592785	1.218635555285711
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.035920563	1.2183883877738404
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.035884189999999996	1.2171546531904347
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.035770528999999995	1.2132993894925144
VESTIBULOPATHY, FAMILIAL	0.035714300000000004	1.2113921599021507
MALARIA	0.035714300000000004	1.2113921599021507
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.035714300000000004	1.2113921599021507
YOUNG-ONSET PARKINSON DISEASE	0.035714300000000004	1.2113921599021507
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.035714300000000004	1.2113921599021507
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	1.2113921599021507
SPINOCEREBELLAR ATAXIA TYPE 1	0.035714300000000004	1.2113921599021507
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.03543121	1.201790039559691
ALPERS-HUTTENLOCHER SYNDROME	0.035365604	1.199564751816615
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.03529794	1.1972696588396388
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.195859986574873
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.195859986574873
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.035256380000000004	1.195859986574873
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.195859986574873
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.195859986574873
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.035229109999999994	1.1949350163472456
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.035161549	1.1926434170238616
NEMALINE MYOPATHY 2; NEM2	0.034993869999999996	1.1869559185714142
COSTELLO SYNDROME	0.03496462	1.1859637887893066
MARSHALL-SMITH SYNDROME; MRSHSS	0.03485368	1.1822008186003472
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.034617714	1.1741970956545393
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	1.1696209521528877
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.0344828	1.1696209521528877
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0344828	1.1696209521528877
SPINOCEREBELLAR ATAXIA TYPE 37	0.0344828	1.1696209521528877
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0344828	1.1696209521528877
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.0344828	1.1696209521528877
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.034446634000000004	1.1683942387956325
SIALIDOSIS TYPE 1	0.034436738999999994	1.1680586106180608
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.03443441	1.1679796133441285
ZUNICH NEUROECTODERMAL SYNDROME	0.034283779	1.1628703654395576
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03422274	1.160799985618358
SCHWARTZ-JAMPEL SYNDROME	0.03415131	1.1583771538119998
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.033974330000000004	1.152374175048326
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.03394403	1.1513464303509628
FETAL HYDANTOIN SYNDROME	0.033922884	1.1506291798766908
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.033878854	1.149135727763658
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.033878854	1.149135727763658
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.033874719000000005	1.1489954728354865
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.033874719000000005	1.1489954728354865
KOOLEN-DE VRIES SYNDROME	0.033874243	1.1489793274072375
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.033828774	1.1474370659008213
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.03379519	1.146297931316127
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.033624523	1.1405090829905538
TRISOMY 12P	0.033553314	1.138093747275883
H SYNDROME	0.033518240000000005	1.1369040734304932
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.033353173	1.1313051713196138
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	1.1310304276876455
%155050 MAXILLONASAL DYSPLASIA, BINDER TYPE;;BINDER SYNDROME	0.0333333	1.130631099690218
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.03326377	1.1282727139209883
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.033249464	1.1277874691803784
DERMOCHONDROCORNEAL DYSTROPHY	0.0331536	1.1245358613365497
PEHO-LIKE SYNDROME; PEHOL	0.033016444	1.1198836715110865
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.033002519	1.1194113498968694
TRISOMY 4P	0.032996029999999996	1.1191912497205923
FRYNS MICROPHTHALMIA SYNDROME	0.032996029999999996	1.1191912497205923
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.03292872	1.1169081640579024
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.032920050000000006	1.1166140866147956
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.03290601	1.1161378643193836
FOUNTAIN SYNDROME	0.032889259	1.1155696877046797
MUCOLIPIDOSIS TYPE II	0.03284823	1.1141780264113426
CHILDHOOD APRAXIA OF SPEECH	0.0328042	1.1126845742983096
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.032803653999999995	1.1126660545423768
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.1126660545423768
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.1126660545423768
LEIGH SYNDROME	0.032799519	1.1125257996142055
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.1125257996142055
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.032799519	1.1125257996142055
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.1125257996142055
SANDHOFF DISEASE	0.032799519	1.1125257996142055
TUBEROUS SCLEROSIS-1	0.032799519	1.1125257996142055
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.1125257996142055
MENINGIOMA	0.03270391	1.1092828411069386
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.032655939999999994	1.1076557482642813
PITT-HOPKINS-LIKE SYNDROME	0.032651229000000004	1.1074959560111703
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.032522234	1.1031205788746568
15Q24 MICRODELETION SYNDROME	0.032521943	1.103110708455286
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.032520634	1.1030663085276013
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.032337370000000004	1.096850182975867
ALLAN-HERNDON-DUDLEY SYNDROME	0.03228124	1.094946311363227
DYSTONIA, JUVENILE-ONSET	0.0322581	1.094161426468937
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.094161426468937
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.094161426468937
DENT DISEASE	0.0322581	1.094161426468937
CONGENITAL ANALBUMINEMIA	0.0322581	1.094161426468937
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.094161426468937
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	1.094161426468937
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	1.094161426468937
MILD CANAVAN DISEASE	0.0322581	1.094161426468937
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.094161426468937
SECKEL SYNDROME 2; SCKL2	0.0322581	1.094161426468937
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.094161426468937
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.094161426468937
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.094161426468937
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.032220603	1.092889566966725
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.032140369	1.0901681125756943
TONNE-KALSCHEUER SYNDROME; TOKAS	0.031972584	1.0844770187127546
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.031949474	1.0836931513874721
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.031911	1.0823881530545894
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.03188151	1.081387882720423
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.031858759	1.0806161923042612
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.031762404	1.0773479302476796
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.031525183	1.0693016389983998
21Q22.11Q22.12 MICRODELETION SYNDROME	0.031407909	1.0653238260730347
NARP SYNDROME	0.031389972999999995	1.0647154554825429
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.031386759	1.0646064399228952
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.031368354	1.0639821613369227
COFFIN-LOWRY SYNDROME	0.031275709	1.060839738647576
11Q22.2Q22.3 MICRODELETION SYNDROME	0.031248273	1.0599091378714423
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.03122715	1.0591926675334091
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.03118225	1.0576697059191649
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.030989753000000002	1.0511404065459535
XQ28 (MECP2) DUPLICATION	0.030981663000000003	1.0508660021036544
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.030848553999999997	1.0463510823372744
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.030844418999999998	1.0462108274091029
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.030844418999999998	1.0462108274091029
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.030824463	1.0455339405054536
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.030677729	1.0405568748149294
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.030567110000000005	1.0368047926143484
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.030498773	1.034486872172642
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.030447213	1.0327380102387793
RENPENNING SYNDROME 1; RENS1	0.030427489000000002	1.032068992535453
LATHOSTEROLOSIS	0.030361082999999997	1.029816569618849
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.030309789	1.0280767301301843
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.030302999999999997	1.0278464542638344
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.030302999999999997	1.0278464542638344
MACHADO-JOSEPH DISEASE TYPE 3	0.030302999999999997	1.0278464542638344
MACHADO-JOSEPH DISEASE TYPE 2	0.030302999999999997	1.0278464542638344
MACHADO-JOSEPH DISEASE TYPE 1	0.030302999999999997	1.0278464542638344
CARIBBEAN PARKINSONISM	0.030302999999999997	1.0278464542638344
SPINOCEREBELLAR ATAXIA TYPE 26	0.030302999999999997	1.0278464542638344
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.030302999999999997	1.0278464542638344
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.030302999999999997	1.0278464542638344
SPINOCEREBELLAR ATAXIA 18	0.030302999999999997	1.0278464542638344
POLYRADICULONEUROPATHY ASSOCIATED WITH IGG/IGA/IGM MONOCLONAL GAMMOPATHY WITHOUT KNOWN ANTIBODIES	0.030302999999999997	1.0278464542638344
FREEMAN-SHELDON SYNDROME	0.030281890000000002	1.0271304248723714
EDINBURGH MALFORMATION SYNDROME	0.030130740000000003	1.0220035730239743
ROSSELLI-GULIENETTI SYNDROME	0.029957354	1.0161224990273734
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.029957354	1.0161224990273734
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.029930254000000003	1.0152032950241214
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.029914163	1.0146575049275777
MYOPATHY, DISTAL 3	0.0299107	1.0145400435451697
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.007765510041201
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.02966339	1.0061515438387383
EAR WAX, WET/DRY	0.0294118	0.9976178709539334
DARWINIAN TUBERCLE OF PINNA	0.0294118	0.9976178709539334
ALKAPTONURIA	0.0294118	0.9976178709539334
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	0.9976178709539334
OSSIFIED EAR CARTILAGES	0.0294118	0.9976178709539334
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	0.9976178709539334
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	0.9976178709539334
EAR FOLDING	0.0294118	0.9976178709539334
EAR MALFORMATION	0.0294118	0.9976178709539334
BLAU SYNDROME	0.0294118	0.9976178709539334
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	0.9976178709539334
AREDYLD	0.0294118	0.9976178709539334
DARWINIAN POINT OF PINNA	0.0294118	0.9976178709539334
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0294118	0.9976178709539334
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	0.9976178709539334
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.0294118	0.9976178709539334
OSTEOMA OF MIDDLE EAR	0.0294118	0.9976178709539334
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	0.9976178709539334
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0294118	0.9976178709539334
EAR WITHOUT HELIX	0.0294118	0.9976178709539334
MUSICAL PERFECT PITCH	0.0294118	0.9976178709539334
HAIRY EARS, Y-LINKED	0.0294118	0.9976178709539334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.029353104	0.9956269632722033
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.029301532999999998	0.9938777282297044
9Q33.3Q34.11 MICRODELETION SYNDROME	0.029202049000000004	0.9905033337256628
ACROCALLOSAL SYNDROME; ACLS	0.029130189	0.9880659167635334
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.029080913000000007	0.9863945257500926
SCHAAF-YANG SYNDROME; SHFYNG	0.028961273000000003	0.9823364605490192
GABRIELE-DE VRIES SYNDROME	0.02882784	0.9778105510373607
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.02882719	0.9777885037088694
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.02880755	0.9771223351987635
SHUKLA-VERNON SYNDROME; SHUVER	0.028805623000000002	0.9770569733495285
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	0.9708965088224928
DYSTONIA 28, CHILDHOOD-ONSET	0.028539494000000006	0.9680301526048241
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.028535359000000003	0.9678898976766526
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.028529854	0.9677031737638145
CHROMOSOME 18Q DELETION SYNDROME	0.028519059	0.9673370185160247
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.028400223000000002	0.9633062241643469
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.028400223000000002	0.9633062241643469
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.028360993	0.9619755830924803
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341364	0.9613097876910103
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.028340654	0.9612857052245044
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	0.9606989070969671
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	0.9606989070969671
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	0.9606989070969671
MENKES DISEASE	0.028319219000000003	0.9605586521687958
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.028143519999999998	0.9545991236017327
HENNEKAM SYNDROME	0.028131819	0.9542022377699226
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.028063704000000002	0.9518918473388704
CAP MYOPATHY	0.027993940000000005	0.9495255245313842
DISTAL MONOSOMY 7Q36	0.027935149000000003	0.9475313945477974
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.9421942790235273
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.9421942790235273
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	0.9421942790235273
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.9421942790235273
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	0.9421942790235273
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.9421942790235273
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	0.9421942790235273
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.9421942790235273
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.9421942790235273
NASAL BONES, ABSENCE OF	0.027777800000000002	0.9421942790235273
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.9421942790235273
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.9421942790235273
DWARFISM, LEVI TYPE	0.027777800000000002	0.9421942790235273
CLEFT CHIN	0.027777800000000002	0.9421942790235273
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	0.9421942790235273
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	0.9421942790235273
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	0.9421942790235273
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	0.9421942790235273
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.9421942790235273
OROFACIAL CLEFT 3	0.027777800000000002	0.9421942790235273
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	0.9421942790235273
DIMPLES, FACIAL	0.027777800000000002	0.9421942790235273
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.9421942790235273
GANGLIOCYTOMA	0.027777800000000002	0.9421942790235273
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.9421942790235273
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	0.9421942790235273
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.9421942790235273
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.027743873	0.9410435102331826
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.02759332	0.9359369080080306
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	0.9352325467411842
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.027563409000000004	0.9349223577887955
DISTAL MONOSOMY 10Q	0.027543303	0.9342403830401094
BRITTLE CORNEA SYNDROME	0.027257780000000002	0.9245557378511589
MUCOPOLYSACCHARIDOSIS TYPE 4	0.027257780000000002	0.9245557378511589
CEREBROFACIOTHORACIC DYSPLASIA	0.027245870000000002	0.9241517629552646
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.027197913	0.9225251110591773
NIEMANN-PICK DISEASE TYPE B	0.0271205	0.9198993420737986
APNEA, OBSTRUCTIVE SLEEP	0.027027	0.9167279186677443
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.9167279186677443
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.9167279186677443
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.027026354000000002	0.9167060070151207
MELAS	0.02688837	0.9120257322850563
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.026885169	0.9119171576719783
INFANTILE SIALIC ACID STORAGE DISEASE	0.026712733000000002	0.9060683066939421
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.026701364	0.9056826819591458
KEPPEN-LUBINSKY SYNDROME	0.026586139	0.9017743689969788
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.026484563	0.8983290160141617
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.026439254	0.8967921815424513
SECKEL SYNDROME 1; SCKL1	0.026411979	0.89586704171999
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.026336443999999997	0.8933049725544676
HURLER SYNDROME	0.026319694	0.8927368298587307
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.026186554000000004	0.8882208586043769
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.02616939	0.8876386734563393
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.026167179	0.8875636786205019
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.026162674	0.8874108736745739
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.026162440000000002	0.8874029366363171
AL KAISSI SYNDROME; ALKAS	0.026052393	0.8836702560848082
COFS SYNDROME	0.026042469	0.8833336442571966
AYMÉ-GRIPP SYNDROME	0.026041254	0.8832924327124012
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.02601911	0.8825413311091536
CRANIOFACIAL DYSSYNOSTOSIS	0.02601049	0.8822489496143923
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.025913600000000002	0.878962540910514
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.025818759	0.8757456321698335
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.025776010000000002	0.874295630253412
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.025641000000000004	0.8697162305309369
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.025641000000000004	0.8697162305309369
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.025641000000000004	0.8697162305309369
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0256073	0.8685731613460809
VERVERI-BRADY SYNDROME; VERBRAS	0.02557473	0.8674684205938329
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.025553933	0.8667630078390123
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.025513389	0.8653877972446264
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0254947	0.8647538856720516
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.02544385	0.8630291062046948
19P13.3 MICRODUPLICATION SYNDROME	0.025352614	0.8599344753397237
FRANK-TER HAAR SYNDROME	0.02526559	0.8569827111633763
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.025247954000000003	0.8563845162629575
SPINOCEREBELLAR ATAXIA TYPE 40	0.02508944	0.8510078851422375
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.02497197	0.8470234240993582
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.02497197	0.8470234240993582
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.024954454	0.8464292994749681
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.024924	0.8453963312567011
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.024924	0.8453963312567011
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.024878619	0.8438570546193732
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.024875134000000004	0.843738847019693
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.024755060000000002	0.8396660609869809
2P15P16.1 MICRODELETION SYNDROME	0.024740554	0.839174032452989
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.02467052	0.8367985515244372
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.024621134000000003	0.8351234294246359
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.024563314000000003	0.8331622347579186
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02455864	0.8330036975065828
RETT SYNDROME, CONGENITAL VARIANT	0.024555659000000004	0.832902585066225
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.02452519	0.831869108063454
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.0243656	0.8264559801343394
ASPARTYLGLUCOSAMINURIA; AGU	0.024350919000000002	0.8259580157811385
CLASSIC HOMOCYSTINURIA	0.024350919000000002	0.8259580157811385
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0243372	0.8254926814741046
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0242857	0.8237458546782565
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0242857	0.8237458546782565
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.02425478	0.8226970802214094
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.024228373	0.8218013820622255
TRISOMY 18P	0.02418685	0.8203929647992353
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.024164763000000002	0.8196437965771014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.024151954	0.8192093285299552
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.023949163000000002	0.8123308673113758
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.023925473000000003	0.8115273269852856
OCULOCEREBRORENAL SYNDROME OF LOWE	0.023880869000000002	0.8100144053852466
WEAVER SYNDROME	0.023855703000000002	0.8091608006639976
MUCOPOLYSACCHARIDOSIS TYPE 6	0.0238095	0.8075936426358701
HURLER-SCHEIE SYNDROME	0.0238095	0.8075936426358701
SCIMITAR SYNDROME	0.0238095	0.8075936426358701
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0238095	0.8075936426358701
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.023802843000000004	0.8073678440731523
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.023799364	0.8072498399872735
OHDO SYNDROME	0.023742229	0.8053118798128892
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.023667754	0.8027857647522914
CHROMOSOME 10Q26 DELETION SYNDROME	0.023580363	0.7998215523150881
ADAMS-OLIVER SYNDROME	0.023392498999999997	0.7934493995155691
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.023326333000000005	0.7912051171510239
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.02325381	0.7887452119138334
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.023242133	0.7883491401372292
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.023207859	0.787186601465367
BARAITSER-WINTER SYNDROME 1; BRWS1	0.023201433	0.7869686381840055
COCKAYNE SYNDROME	0.023084249	0.7829938779656623
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.023059784000000003	0.7821640504402174
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.023053753	0.781959485150785
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.02304886	0.781793519645696
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.022948299	0.7783825944142923
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.022904050000000002	0.7768817140475062
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.022811754	0.7737511290776109
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.022808529	0.7736417404093272
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.022744554	0.7714717745012809
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02271952	0.770622647083664
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.02262717	0.7674902304895557
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.02261903	0.767214130098911
DYSTONIA 12; DYT12	0.02261903	0.767214130098911
BRANCHIOOTORENAL SYNDROME 1	0.02256055	0.7652305489140332
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.02253232	0.7642730164781733
JOUBERT SYNDROME 3; JBTS3	0.02252453	0.7640087877259469
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.7636246215067278
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.02247053	0.7621771635128245
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.02247053	0.7621771635128245
BETA-UREIDOPROPIONASE DEFICIENCY	0.022456554	0.7617031120312949
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.022456554	0.7617031120312949
MYHRE SYNDROME	0.022435563000000002	0.7609911189968941
GLASS SYNDROME	0.022430953	0.7608347525594403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.022396883000000003	0.7596791333568278
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02231618	0.7569417709703165
RAPID-ONSET DYSTONIA-PARKINSONISM	0.022308269000000002	0.7566734380230941
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.022266242999999998	0.755247959519748
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.0222662	0.7552465010041709
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.02226572	0.7552302199000543
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.022182923	0.7524218311968341
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.02216733	0.7518929327458115
SMITH-MAGENIS SYNDROME	0.022150543	0.7513235350482989
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.022134899	0.7507929067299639
PEHO SYNDROME; PEHO	0.022063563	0.7483732633064955
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.022054003000000003	0.748048997982839
FRANK-TER HAAR SYNDROME; FTHS	0.02203391	0.7473674641807229
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.021977984	0.7454705120373325
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.7451199934332878
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.021958864	0.7448219813900196
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.02193308	0.7439474147472205
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.021911	0.7431984839578549
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.021873504000000002	0.7419266583746099
ASPARTYLGLUCOSAMINURIA	0.021807449	0.7396861410153913
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.02177467	0.7385743111990591
MAN1B1-CDG	0.021700113	0.7360454147831745
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.021643443000000002	0.7341232269284035
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.0216279	0.7335960244257262
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0216279	0.7335960244257262
9Q21.13 MICRODELETION SYNDROME	0.021596529	0.732531952514803
PHOCOMELIA, SCHINZEL TYPE	0.021593479999999998	0.7324285335846953
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.02158374	0.7320981628469952
PELGER-HUET ANOMALY; PHA	0.021570044	0.7316336086762003
CARTILAGE-HAIR HYPOPLASIA	0.02156183	0.7313549982820042
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.02143243	0.7269658839638924
MICROPHTHALMIA, SYNDROMIC 1	0.021412859	0.7263020558625033
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.021386563	0.7254101227086466
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.021324523	0.7233057900015705
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.021318604	0.723105023636432
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7220128329019405
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.021283833	0.7219256272380157
JABERI-ELAHI SYNDROME; JABELS	0.021278913	0.7217587459208202
MYOPATHY, SPHEROID BODY	0.02124328	0.7205501113729277
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.021225353000000002	0.719942046053138
14Q22Q23 MICRODELETION SYNDROME	0.021223324	0.7198732244692783
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.021100294	0.7157001739703812
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.021073984	0.7148077659509877
MENTAL RETARDATION, X-LINKED 104; MRX104	0.020988123	0.7118954495331562
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.020975423	0.7114646786534033
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.02097441	0.7114303187399238
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.020962254	0.7110179997781698
16P11.2P12.2 MICRODELETION SYNDROME	0.020847004000000002	0.7071088388418301
BEEMER LETHAL MALFORMATION SYNDROME	0.02083254	0.7066182349044485
MENTAL RETARDATION, X-LINKED 93	0.02082563	0.7063838548431026
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.020822319	0.7062715491436646
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.020795099	0.7053482748643835
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.02075321	0.7039274432595042
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7035082048285005
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7035082048285005
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7035082048285005
FETAL TRIMETHADIONE SYNDROME	0.020695374	0.7019657058893162
10Q22.3Q23.3 MICRODELETION SYNDROME	0.020652342999999997	0.700506138824226
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.020641714000000002	0.7001456141249431
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.020641714000000002	0.7001456141249431
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.020598054	0.6986647120296668
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.02056768	0.6976344573287524
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.02055111	0.697072420047059
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G	0.02055111	0.697072420047059
DISTAL MYOPATHY, WELANDER TYPE	0.02055111	0.697072420047059
TIBIAL MUSCULAR DYSTROPHY	0.02055111	0.697072420047059
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.02055111	0.697072420047059
ADENYLOSUCCINASE DEFICIENCY	0.020519143	0.6959881324318575
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.020510204	0.695684930786652
MEGAEPIPHYSEAL DWARFISM	0.02049922	0.6953123648541161
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.020402499999999997	0.6920317223746124
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.020397064	0.6918473388704915
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.02032355	0.6893538199370938
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.020301649999999997	0.6886109945617719
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.020286989999999998	0.6881137425068761
CORNELIA DE LANGE SYNDROME	0.020254649	0.6870167691980504
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.02022581	0.6860385801113423
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.020179114	0.6844547000325283
1P36 DELETION SYNDROME	0.020172442999999998	0.6842284266042737
TURNPENNY-FRY SYNDROME; TPFS	0.020150404	0.6834808864925516
BRADDOCK SYNDROME	0.02014982	0.6834610778158762
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0201355	0.6829753582097298
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.020122834	0.6825457405748517
MOEBIUS SYNDROME; MBS	0.020120930000000002	0.6824811588618559
SPINOCEREBELLAR ATAXIA 40; SCA40	0.01996123	0.677064299846381
BAND HETEROTOPIA; BH	0.019954873	0.6768486769737361
SOTOS SYNDROME	0.019921083000000003	0.6757025550818583
GABRIELE-DE VRIES SYNDROME; GADEVS	0.019902494	0.6750720354059744
MENTAL RETARDATION, BUENOS AIRES TYPE	0.01987247	0.6740536523434782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.019837003000000002	0.672850648344093
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.019804814	0.6717588307182374
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.019793533	0.6713761908525293
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.019793024	0.6713589260983724
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.019751594	0.6699536632993047
WRINKLY SKIN SYNDROME	0.019749723999999996	0.6698902348311834
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.019749273	0.6698749373771072
MONOSOMY 18Q	0.019738843000000002	0.6695211625522395
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.019735473	0.6694068556337538
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.019724959999999996	0.6690502655346322
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01967596	0.6673882361560584
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.019614843	0.6653152106554399
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0195983	0.6647540891858531
FRIAS SYNDROME	0.019592004	0.6645405353701899
KUSKOKWIM SYNDROME	0.01957728	0.6640411125014117
RAINE SYNDROME	0.019573003999999998	0.663896074998906
AASE-SMITH SYNDROME I	0.01956778	0.6637188823157699
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.019518279	0.6620398595347741
SUPRABULBAR PARESIS, CONGENITAL	0.019500019	0.6614204991990036
NANCE-HORAN SYNDROME	0.019444740000000002	0.6595454926272037
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.019440183000000003	0.6593909238949964
1Q41Q42 MICRODELETION SYNDROME	0.019423458999999997	0.6588236630923988
WARSAW BREAKAGE SYNDROME; WABS	0.019418274	0.6586477932489722
LYMPHEDEMA, HEREDITARY, III	0.019418274	0.6586477932489722
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.01941391	0.6584997708773784
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.6583440489002962
HHHH SYNDROME	0.019409319	0.6583440489002962
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.6583440489002962
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.01936954	0.6569947863155963
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.019303004000000002	0.6547379539332943
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.019224769	0.6520843035571159
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.01921181	0.6516447476649334
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.01921181	0.6516447476649334
KUFOR-RAKEB SYNDROME	0.01921181	0.6516447476649334
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01920604	0.6514490352258646
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.01920604	0.6514490352258646
PERMANENT NEONATAL DIABETES MELLITUS	0.019200004000000003	0.651244300341598
TRANSIENT NEONATAL DIABETES MELLITUS	0.019200004000000003	0.651244300341598
BOHRING-OPITZ SYNDROME	0.019180613	0.6505865776542523
DYSTONIA-APHONIA SYNDROME	0.019129043	0.6488373765307204
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.019110134	0.6481960027854256
SALT-AND-PEPPER SYNDROME	0.019082104	0.6472452541429473
RABSON-MENDENHALL SYNDROME	0.019046854000000002	0.6460496105593815
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.01904645	0.6460359072967498
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.01904645	0.6460359072967498
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.01897163	0.6434980901925681
SPINOCEREBELLAR ATAXIA 42	0.01897163	0.6434980901925681
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.018911083000000002	0.6414443985030881
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.01887272	0.6401431651755323
PFEIFFER-PALM-TELLER SYNDROME	0.01887272	0.6401431651755323
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.6399796757550276
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.6399796757550276
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.6399796757550276
KNUCKLE PADS	0.0188679	0.6399796757550276
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.6399796757550276
THROMBOCYTOPENIA 3	0.0188679	0.6399796757550276
TOE, MISSHAPEN	0.0188679	0.6399796757550276
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.6399796757550276
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.6399796757550276
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.6399796757550276
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.6399796757550276
RAYNAUD DISEASE	0.0188679	0.6399796757550276
TRACHEOBRONCHOMEGALY	0.0188679	0.6399796757550276
PUBIC BONE DYSPLASIA	0.0188679	0.6399796757550276
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.6399796757550276
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.6399796757550276
CARPAL DISPLACEMENT	0.0188679	0.6399796757550276
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.6399796757550276
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.6399796757550276
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.6399796757550276
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.6399796757550276
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.6399796757550276
LETTERER-SIWE DISEASE	0.0188679	0.6399796757550276
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.6399796757550276
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.6399796757550276
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.6399796757550276
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.6399796757550276
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.6399796757550276
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.6399796757550276
SPINAL ARACHNOIDITIS	0.0188679	0.6399796757550276
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.6399796757550276
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.6399796757550276
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.6399796757550276
MONOPHALANGY OF GREAT TOE	0.0188679	0.6399796757550276
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.6399796757550276
NEPHROSIALIDOSIS	0.0188679	0.6399796757550276
VAN DEN BOSCH SYNDROME	0.0188679	0.6399796757550276
VESICOURETERAL REFLUX 1	0.0188679	0.6399796757550276
48,XXYY SYNDROME	0.018847292999999998	0.63928070760392
COHEN SYNDROME	0.018836309	0.6389081416713841
SPINOCEREBELLAR ATAXIA TYPE 38	0.018826250000000003	0.6385669507832399
FREE SIALIC ACID STORAGE DISEASE	0.018820953	0.6383872820155192
HSD10 DISEASE	0.018820953	0.6383872820155192
MIETENS SYNDROME	0.018639193999999998	0.6322222045089838
MARSHALL-SMITH SYNDROME	0.01863731	0.6321583011753261
GORLIN-CHAUDHRY-MOSS SYNDROME	0.018559199999999998	0.6295088906700114
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.018543413	0.6289734119394085
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6287406260695073
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0185185	0.6281283887167878
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.0185185	0.6281283887167878
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0185185	0.6281283887167878
HYPEREKPLEXIA 4; HKPX4	0.018479873	0.6268182007819678
TRISOMY 17P	0.018479603999999997	0.626809076579869
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.018467139	0.62638627665734
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.018427214	0.6250320619034714
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.018415459	0.624633344447448
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.018400223000000004	0.6241165550676124
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.018400223000000004	0.6241165550676124
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.018400223000000004	0.6241165550676124
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01839085	0.623798632590768
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.018385794	0.6236271382940727
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.018365529	0.6229397704296481
LATHOSTEROLOSIS	0.018353869	0.6225442752754813
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.0183277	0.621656649830422
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.0183277	0.621656649830422
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.018279534	0.6200229088702507
CHOREOACANTHOCYTOSIS	0.018275399	0.6198826539420793
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.018275399	0.6198826539420793
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.01826711	0.6196014996253649
CRI-DU-CHAT SYNDROME	0.018263630000000003	0.6194834616205194
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.018259943	0.6193584023895233
SMITH-LEMLI-OPITZ SYNDROME	0.018245903000000004	0.6188821800941116
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.018211173	0.6177041743733386
JOUBERT SYNDROME 14	0.018118824000000002	0.6145717916981972
WIEDEMANN-STEINER SYNDROME; WDSTS	0.018115883	0.6144720360165158
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.018113993999999998	0.6144079630880233
WIEACKER-WOLFF SYNDROME	0.018075373000000002	0.6130979786670049
ZLOTOGORA-OGUR SYNDROME	0.018032719	0.6116511990524397
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01801618	0.6110902132587206
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.018008259000000002	0.6108215411218292
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.017984014	0.609999175769104
COFFIN-SIRIS SYNDROME 7; CSS7	0.017984014	0.609999175769104
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.01797794	0.6097931519640948
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.01797794	0.6097931519640948
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.01797794	0.6097931519640948
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.01794871	0.6088017005613249
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.017934049999999997	0.6083044485064291
ANTLEY-BIXLER SYNDROME	0.017934049999999997	0.6083044485064291
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.017921154	0.607867029509162
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.017864729000000003	0.6059531518012837
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.017864729000000003	0.6059531518012837
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.017846503	0.6053349447103878
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.017843083	0.6052189418435567
RIN2 SYNDROME	0.01783647	0.6049946357153831
MACS SYNDROME	0.01783647	0.6049946357153831
AL-RAQAD SYNDROME; ARS	0.017824614000000003	0.6045924924437022
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.017784633	0.6032363782276865
ACRO-RENAL-OCULAR SYNDROME	0.017760319999999996	0.6024117063852115
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.017725613	0.6012344808006775
MOEBIUS SYNDROME	0.01766471	0.5991687139589776
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.017662629000000003	0.5990981285888387
PELVIS-SHOULDER DYSPLASIA	0.01763723	0.5982366207482998
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.017582533	0.5963813550152414
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.017578200000000002	0.5962343841316219
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.017551353000000002	0.5953237616269978
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.017529264	0.5945745255669299
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.017442104	0.591618148411083
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.017395233	0.5900283325130595
MEIER-GORLIN SYNDROME 3; MGORS3	0.017388169999999998	0.5897887628497765
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.017381784	0.5895721563270914
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01738044	0.5895265692355648
GAPO SYNDROME; GAPOS	0.017305239	0.5869758290049905
CEREBELLAR ATAXIA, CAYMAN TYPE	0.017301664	0.5868545686982884
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.017301664	0.5868545686982884
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.017297529000000002	0.586714313770117
JUVENILE HUNTINGTON DISEASE	0.017297529	0.5867143137701168
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.017263314000000002	0.5855537763173024
HYPERPROLINEMIA, TYPE I	0.017254173	0.5852437230407811
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.01724419	0.5849051099941218
SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1	0.0172414	0.5848104760764439
269800 SENILE PLAQUE FORMATION	0.0172414	0.5848104760764439
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.5848104760764439
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.5848104760764439
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.5848104760764439
ALCOHOL DEPENDENCE	0.0172414	0.5848104760764439
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.5848104760764439
MOTION SICKNESS	0.0172414	0.5848104760764439
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.5848104760764439
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.5848104760764439
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.5848104760764439
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.5848104760764439
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.5848104760764439
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.5848104760764439
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.5848104760764439
TRANSSEXUALITY	0.0172414	0.5848104760764439
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.5848104760764439
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.5848104760764439
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.5848104760764439
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.5848104760764439
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.5848104760764439
PALMOMENTAL REFLEX	0.0172414	0.5848104760764439
BARTSOCAS-PAPAS SYNDROME; BPS	0.0172414	0.5848104760764439
JUMPING FRENCHMAN OF MAINE	0.0172414	0.5848104760764439
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.5848104760764439
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.5848104760764439
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.5848104760764439
CARDIAC ARRHYTHMIA	0.0172414	0.5848104760764439
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.5848104760764439
MOSAIC TRISOMY 15	0.0172414	0.5848104760764439
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.5848104760764439
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.0172414	0.5848104760764439
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.5848104760764439
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.5848104760764439
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.5848104760764439
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.5848104760764439
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.5848104760764439
CERVICAL RIB	0.0172414	0.5848104760764439
MYOPATHY, CONGENITAL	0.0172414	0.5848104760764439
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.5848104760764439
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.5848104760764439
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.5848104760764439
DIASTEMATOMYELIA	0.0172414	0.5848104760764439
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.5848104760764439
SICKLE CELL ANEMIA	0.0172414	0.5848104760764439
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.5848104760764439
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.5848104760764439
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0172414	0.5848104760764439
ERYTHERMALGIA, PRIMARY	0.0172414	0.5848104760764439
RHEUMATOID ARTHRITIS	0.0172414	0.5848104760764439
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.5848104760764439
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.5848104760764439
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.5848104760764439
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.017168064	0.5823229947191559
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.01712121	0.5807337554435701
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.01712121	0.5807337554435701
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.01712121	0.5807337554435701
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.01712121	0.5807337554435701
SPINOCEREBELLAR ATAXIA TYPE 12	0.01710526	0.5801927479213609
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.017102273999999997	0.5800914658861684
MUCOPOLYSACCHARIDOSIS TYPE 2	0.017033853	0.5777706962512419
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.016991792999999998	0.5763440645030209
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.016973164	0.5757121880684606
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.016945979	0.5747901009530212
FACIOCARDIORENAL SYNDROME	0.016899169999999998	0.5732023880309461
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.016894430000000002	0.5730416121277945
NEMALINE MYOPATHY 4	0.016894430000000002	0.5730416121277945
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.016894430000000002	0.5730416121277945
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.016894430000000002	0.5730416121277945
MENTAL RETARDATION, X-LINKED 9	0.016866303	0.572087573345526
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.016853483	0.5716527321897439
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.016839383000000003	0.5711744747563177
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.016812793	0.5702725694261893
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.01675611	0.5683499406248484
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.01675611	0.5683499406248484
UROCANIC ACIDURIA	0.01675611	0.5683499406248484
COFFIN-LOWRY SYNDROME; CLS	0.016739519	0.56778719104485
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.016732113	0.5675359871759169
DESBUQUOIS DYSPLASIA 1	0.016720199999999998	0.5671319105231218
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.016712754	0.5668793498955126
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.016712754	0.5668793498955126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016701364	0.5664930128624114
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016701364	0.5664930128624114
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.01668494	0.5659359277498869
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.01668354	0.5658884411962134
MARDEN-WALKER SYNDROME	0.016674553999999998	0.565583645359563
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.016674553999999998	0.565583645359563
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.016674553999999998	0.565583645359563
LINEAR VERRUCOUS NEVUS SYNDROME	0.016670419	0.5654433904313915
OCULOCEREBROCUTANEOUS SYNDROME	0.016670419	0.5654433904313915
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.01663864	0.564365479581969
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.016635843	0.5642706082315226
6Q TERMINAL DELETION SYNDROME	0.016631883	0.5641362891225603
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01662251	0.563818366645716
AU-KLINE SYNDROME; AUKS	0.016598324	0.5629980025120387
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.016597094	0.5629562821827397
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.01655401	0.5614949174124034
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.01655401	0.5614949174124034
ZIMMERMANN-LABAND SYNDROME 1	0.016488298999999998	0.5592660681778017
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0163957	0.5561252057609328
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.016373873999999997	0.5553848903891623
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.016364424000000002	0.5550643561518661
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.01633488	0.5540622541934866
WIEDEMANN-STEINER SYNDROME	0.016332479	0.5539808147539365
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.016320749	0.553582945272086
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.016316853000000003	0.553450796977006
GAUCHER DISEASE	0.016301509999999998	0.5529303782677107
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.5529303782677107
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.016293334	0.5526530567942574
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.016250340000000002	0.5511947447309429
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.016233654	0.550628772849088
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.016170554	0.5484884860370876
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.016166419	0.5483482311089162
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.016166419	0.5483482311089162
PENTALOGY OF CANTRELL	0.016128999999999998	0.547079017286123
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.016128999999999998	0.547079017286123
DIGITOTALAR DYSMORPHISM	0.016128999999999998	0.547079017286123
BARTSOCAS-PAPAS SYNDROME	0.016128999999999998	0.547079017286123
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.016128999999999998	0.547079017286123
LAURIN-SANDROW SYNDROME	0.016128999999999998	0.547079017286123
ACALVARIA	0.016128999999999998	0.547079017286123
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.016128999999999998	0.547079017286123
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.016128999999999998	0.547079017286123
TERMINAL TRANSVERSE LIMB DEFECT	0.016128999999999998	0.547079017286123
MECKEL SYNDROME, TYPE 1; MKS1	0.016128999999999998	0.547079017286123
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.016128999999999998	0.547079017286123
MECKEL SYNDROME	0.016128999999999998	0.547079017286123
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.016128999999999998	0.547079017286123
GORDON SYNDROME	0.016128999999999998	0.547079017286123
STUVE-WIEDEMANN SYNDROME	0.016128999999999998	0.547079017286123
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.016109964	0.5464333358320305
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.01609075	0.545781616801828
ROIFMAN-CHITAYAT SYNDROME	0.016042953999999998	0.5441604258594133
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.016031419999999998	0.543769204495077
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.01603002	0.5437217179414036
CATEL-MANZKE SYNDROME; CATMANS	0.015999683	0.5426927182422648
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.015846259	0.5374887346631151
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.01576651	0.5347837309710356
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.015733334	0.5336584353248403
NEMALINE MYOPATHY 7; NEM7	0.015643380000000002	0.5306072885754475
6Q16 MICRODELETION SYNDROME	0.015642334	0.53057180933606
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.015625	0.5299838579636477
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.015625	0.5299838579636477
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	0.015625	0.5299838579636477
TIBIAL MUSCULAR DYSTROPHY, TARDIVE	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	0.015625	0.5299838579636477
GNE MYOPATHY	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.015625	0.5299838579636477
MYOPATHY, DISTAL, INFANTILE-ONSET	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.015625	0.5299838579636477
GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	0.015625	0.5299838579636477
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID	0.015625	0.5299838579636477
46,XY GONADAL DYSGENESIS-MOTOR AND SENSORY NEUROPATHY SYNDROME	0.015625	0.5299838579636477
WELANDER DISTAL MYOPATHY; WDM	0.015625	0.5299838579636477
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.015625	0.5299838579636477
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01561356	0.5295958249822009
KEIPERT SYNDROME	0.01561158	0.5295286654277198
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.01556441	0.5279287077585906
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.01556441	0.5279287077585906
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.01556441	0.5279287077585906
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.01556441	0.5279287077585906
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.01556441	0.5279287077585906
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.01556441	0.5279287077585906
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 73	0.01556441	0.5279287077585906
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 60	0.01556441	0.5279287077585906
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 19	0.01556441	0.5279287077585906
SMITH-KINGSMORE SYNDROME; SKS	0.015548539	0.5273903798347671
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.015480023	0.525066387897984
RING CHROMOSOME 14 SYNDROME	0.015476224	0.524937529742694
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.52475877678708
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.52475877678708
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.52475877678708
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.015417573	0.5229481484144748
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.015374479000000002	0.5214864444544695
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.015372673	0.5214251868002304
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.015364374	0.5211436932938471
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.01535388	0.5207877476550969
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.01534392	0.5204499147446766
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.015248789999999998	0.5172232034225593
HENNEKAM-BEEMER SYNDROME	0.015232619	0.5166746998086631
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.01513899	0.5134989008558772
COFFIN-SIRIS SYNDROME 1; CSS1	0.015102033	0.5122453575957965
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.015087123000000001	0.5117396257991732
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01502789	0.5097305036322125
OROFACIODIGITAL SYNDROME TYPE 2	0.015016924000000001	0.5093585482410811
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.015013643	0.5092472601106504
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.014959674000000001	0.5074166873855023
ACROCRANIOFACIAL DYSOSTOSIS	0.01494989	0.507084824213258
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.014938604000000001	0.5067020147527155
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.014928303	0.5063526154745789
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.01492611	0.5062782311801459
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.50625414871364
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.50625414871364
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.50625414871364
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.014923059	0.5061747444121045
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.0148978	0.505317985226933
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0148978	0.505317985226933
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0148978	0.505317985226933
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.014884782999999999	0.5048764620346698
SCARF SYNDROME	0.01488284	0.5048105574819644
LAMB-SHAFFER SYNDROME	0.014875134000000002	0.5045491779229585
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.014845379	0.5035399190625611
JOUBERT SYNDROME 2	0.014831254	0.5030608136549619
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.014831254	0.5030608136549619
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.014831254	0.5030608136549619
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.014831254	0.5030608136549619
DEXTROCARDIA	0.014831254	0.5030608136549619
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.014831254	0.5030608136549619
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.014831254	0.5030608136549619
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.014831254	0.5030608136549619
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.014831254	0.5030608136549619
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.01480813	0.5022764714641427
SAY-BARBER-MILLER SYNDROME	0.014802593999999999	0.5020886960633307
GAUCHER DISEASE, PERINATAL LETHAL	0.014789139	0.5016323163635611
DISTAL MONOSOMY 10P	0.01476133	0.5006890638127699
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.014688443	0.49821681207162466
X SMALL RINGS	0.014683604	0.49805267819074867
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.014682933	0.49802991856395235
SMITH-FINEMAN-MYERS SYNDROME	0.014679989000000001	0.4979300611253702
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.01467102	0.49762584191115733
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.01467102	0.49762584191115733
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.014666644	0.4974774125119606
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.014652278999999999	0.4969901665523031
3Q29 MICRODELETION SYNDROME	0.014591444000000002	0.4949267062003533
NEONATAL ADRENOLEUKODYSTROPHY	0.014586369	0.49475456744328655
ACRODYSOSTOSIS	0.01457371	0.494325187241177
KBG SYNDROME	0.014552433	0.4936034933822399
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.014541569	0.4932349977257332
DISTAL ANOCTAMINOPATHY	0.01454149	0.49323231812734736
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.01454149	0.49323231812734736
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.014531803000000001	0.4929037450948933
ARGININEMIA	0.014531803000000001	0.4929037450948933
HURLER SYNDROME	0.014527794	0.4927677639565525
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.014525360000000001	0.4926852051910943
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.014523343000000001	0.49261679063483754
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.014477714	0.491069102093716
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.01444966	0.490117539396032
AMISH LETHAL MICROCEPHALY	0.01444966	0.490117539396032
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01444966	0.490117539396032
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.014426778999999999	0.48934143951417175
6Q25 MICRODELETION SYNDROME	0.014424493	0.48926390075581633
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.014414460000000002	0.48892359176081157
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0144089	0.4887350023047937
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.014386884	0.4879882423293104
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0143777	0.48767673053721194
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.014366723	0.4873044020374444
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.014346412999999999	0.48661550781950896
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.014311109	0.48541803261172983
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.48455618558152197
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.0142857	0.48455618558152197
INFANT BOTULISM	0.0142857	0.48455618558152197
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.0142857	0.48455618558152197
WILSON DISEASE	0.0142857	0.48455618558152197
NEUROLEPTIC MALIGNANT SYNDROME	0.0142857	0.48455618558152197
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.0142857	0.48455618558152197
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.0142857	0.48455618558152197
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.0142857	0.48455618558152197
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0142857	0.48455618558152197
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.0142857	0.48455618558152197
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.0142857	0.48455618558152197
HYPOPHOSPHATASIA, ADULT	0.0142857	0.48455618558152197
EXOSTOSES, MULTIPLE, TYPE I	0.0142857	0.48455618558152197
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0142857	0.48455618558152197
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.014268114	0.4839596866294485
KABUKI SYNDROME	0.014263029	0.4837872086827128
FOCAL DERMAL HYPOPLASIA; FDH	0.01425919	0.48365699376874655
MENTAL RETARDATION, X-LINKED 45	0.014257039999999999	0.48358406798989073
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.4831469881822926
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.014222634	0.48241705201439655
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.01418537	0.4811530956314744
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0141756	0.4808217073247669
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.014127204	0.4791801650022064
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.014109179999999999	0.47856880954262637
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.014074759999999999	0.47740131870159547
HALLERMANN-STREIFF SYNDROME; HSS	0.01405563	0.4767524488646134
CHST3-RELATED SKELETAL DYSPLASIA	0.014017499999999999	0.47545911865634755
FONTAINE PROGEROID SYNDROME; FPS	0.01401506	0.4753763563770879
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.014007094000000001	0.47510615788668553
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.014007094000000001	0.47510615788668553
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.013989699	0.4745161374572917
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.013986249000000001	0.4743991170214534
ANGELMAN SYNDROME	0.013986249000000001	0.4743991170214534
NEUROCUTANEOUS MELANOCYTOSIS	0.013986249000000001	0.4743991170214534
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.01398084	0.4742156493294389
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.01398084	0.4742156493294389
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.013964279	0.47365391731844775
CARNOSINASE DEFICIENCY	0.013932159999999999	0.47256447402027596
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.013916928999999998	0.47204785423527473
SPINOCEREBELLAR ATAXIA TYPE 21	0.013900140000000002	0.47147838869982833
GM1 GANGLIOSIDOSIS	0.013834388999999999	0.4692481827065503
LISSENCEPHALY 8; LIS8	0.013789673	0.4677314621822174
NATIVE AMERICAN MYOPATHY	0.013757239999999999	0.4666313683284359
15Q26 OVERGROWTH SYNDROME	0.013755380000000001	0.466568279049984
MEIER-GORLIN SYNDROME 6; MGORS6	0.01375064	0.4664075031468321
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.4646423601088526
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.4646423601088526
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.4646423601088526
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.4646423601088526
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.4646423601088526
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671174	0.463712098522388
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.013660819000000001	0.46336086762003836
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.013628593000000001	0.4622677949924072
HALL-RIGGS SYNDROME	0.013593969	0.46109338468212663
MENKES DISEASE	0.013586849	0.46085188163772983
MOSAIC TRISOMY 14	0.013579093	0.4605888061303784
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.013536794	0.4591540677490661
SPINOCEREBELLAR ATAXIA TYPE 13	0.013494233000000001	0.45771044259842353
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.013475493000000002	0.4570748011585362
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.013468313	0.4568312629761247
SYRINGOMYELIA, ISOLATED	0.013461540000000001	0.4566015298132455
SPINOCEREBELLAR ATAXIA TYPE 8	0.013461540000000001	0.4566015298132455
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.013461540000000001	0.4566015298132455
CHIARI MALFORMATION TYPE I	0.013461540000000001	0.4566015298132455
SPINOCEREBELLAR ATAXIA TYPE 43	0.013461540000000001	0.4566015298132455
SPINOCEREBELLAR ATAXIA TYPE 6	0.013461540000000001	0.4566015298132455
TRISOMY 9P	0.013448494000000002	0.45615902297094196
OROFACIODIGITAL SYNDROME TYPE 6	0.013424083	0.4553310270697099
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.013413309	0.4549655841202251
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.013340999999999999	0.45251293754195343
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.013340999999999999	0.45251293754195343
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.013307183	0.4513658998379691
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.013307183	0.4513658998379691
INFANTILE LIVER FAILURE SYNDROME 1	0.013282073	0.4505141945788671
SECKEL SYNDROME 7; SCKL7	0.013267979	0.4500361406592422
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.013263409	0.449881130980465
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.01325944	0.44974650660080057
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.01325944	0.44974650660080057
KRABBE DISEASE	0.013253094	0.44953125683679174
GERMAN SYNDROME	0.013243814000000001	0.44921648882386994
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.01323018	0.44875403762902344
KLEEFSTRA SYNDROME	0.013229809	0.44874145369229995
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.013167283	0.44662063636730576
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.013122214	0.44509194244765365
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.013111733	0.4447364377554734
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.013051613	0.44269722946486384
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.013051613	0.44269722946486384
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.013029019999999999	0.4419308982454735
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.012992150000000001	0.4406803059355139
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.01299124	0.4406494396756261
PFEIFFER SYNDROME	0.01294239	0.4389924981420885
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.012909309	0.4378704247977497
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.012892023	0.43728410153574904
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.012863633999999999	0.43632117598415027
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.012844893	0.43568550062529604
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.01284347	0.43563723393538356
MONOSOMY 5P	0.012808420000000001	0.4344483741451996
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.01278575	0.43367943116535734
METACHROMATIC LEUKODYSTROPHY	0.012761629	0.43286127176452904
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.012761629	0.43286127176452904
FAMILIAL DYSAUTONOMIA	0.012761629	0.43286127176452904
PELIZAEUS-MERZBACHER DISEASE	0.012761629	0.43286127176452904
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.012761629	0.43286127176452904
GALACTOSE EPIMERASE DEFICIENCY	0.012740654	0.43214982143359865
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.012740654	0.43214982143359865
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.012740654	0.43214982143359865
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.012736519	0.43200956650542716
DILATED CARDIOMYOPATHY WITH ATAXIA	0.012736519	0.43200956650542716
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.012736519	0.43200956650542716
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.012736519	0.43200956650542716
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.012714873	0.4312753565477004
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.012714873	0.4312753565477004
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.012714393000000001	0.4312590754435837
GAUCHER DISEASE TYPE 3	0.01270754	0.4310266287633517
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.012690229	0.4304394575271784
KNIEST-LIKE DYSPLASIA, LETHAL	0.01268839	0.4303770805470315
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.012621729	0.42811600829386576
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.012609410000000001	0.4276981605405055
JOHNSON NEUROECTODERMAL SYNDROME	0.01258868	0.42699502035646797
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012581272999999999	0.42674378256856793
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.012576659999999998	0.4265873143742136
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.012570314	0.4263720646102049
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.012561603	0.4260765964894547
MONOSOMY 22Q13.3	0.012540663	0.4253663333223662
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.012513914000000001	0.4244590348764993
DUCHENNE MUSCULAR DYSTROPHY	0.012513874	0.42445767811782287
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.012510194	0.4243328563195954
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.012506059	0.4241926013914238
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.01247786	0.423236120443538
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.012459853	0.4226253416063954
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.012453503000000001	0.42240995616651905
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.01244335	0.42206557689548513
PRIMARY DYSTONIA, DYT4 TYPE	0.01237685	0.41980996559599176
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.01235294	0.41899896309718154
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.012350604000000001	0.41891972839048053
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.01233253	0.4183066769825551
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.012323029	0.41798441287794624
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.012318079999999999	0.4178165479107102
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.012318079999999999	0.4178165479107102
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.012318079999999999	0.4178165479107102
GENITOPATELLAR SYNDROME; GTPTS	0.012310814	0.41757009269714457
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.012260704	0.41587041326530094
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.01222021	0.41449689861926053
NEUROFERRITINOPATHY	0.01222021	0.41449689861926053
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01222021	0.41449689861926053
CORTICOBASAL SYNDROME	0.01222021	0.41449689861926053
SPINOCEREBELLAR ATAXIA TYPE 17	0.01222021	0.41449689861926053
RHEUMATIC FEVER	0.01222021	0.41449689861926053
ADULT POLYGLUCOSAN BODY DISEASE	0.01222021	0.41449689861926053
ABETA AMYLOIDOSIS, IOWA TYPE	0.01222021	0.41449689861926053
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.012196592999999999	0.41369583437775476
RAMOS-ARROYO SYNDROME	0.0121951	0.4136451933601587
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0121951	0.4136451933601587
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0121951	0.4136451933601587
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0121951	0.4136451933601587
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.0121951	0.4136451933601587
JOUBERT SYNDROME 4	0.0121951	0.4136451933601587
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.0121951	0.4136451933601587
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0121951	0.4136451933601587
CLASSIC MULTIMINICORE MYOPATHY	0.0121951	0.4136451933601587
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.012176874	0.413026986269263
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.012173454	0.4129109834024319
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.012173454	0.4129109834024319
MENTAL RETARDATION, X-LINKED 102	0.012169319	0.41277072847426033
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.012169319	0.41277072847426033
CEREBROFACIOARTICULAR SYNDROME	0.012163364000000001	0.4125687410263133
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.012110869	0.4107881648583899
MELNICK-NEEDLES SYNDROME	0.012088149999999999	0.41001755984916904
BARTH SYNDROME; BTHS	0.012088149999999999	0.41001755984916904
CHROMOSOME 16Q22 DELETION SYNDROME	0.012078024	0.40967409639024166
CHROMOSOME 9P DELETION SYNDROME	0.012078024	0.40967409639024166
FUMARASE DEFICIENCY; FMRD	0.012039854	0.4083794094232995
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.4083794094232995
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.4083794094232995
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.4083794094232995
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.4083794094232995
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.4083794094232995
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.4083794094232995
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.4083794094232995
PALLISTER-KILLIAN SYNDROME	0.011995109	0.40686170524892623
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.01196832	0.4059530500443829
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.01196832	0.4059530500443829
NEMALINE MYOPATHY 3; NEM3	0.01196832	0.4059530500443829
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.01196832	0.4059530500443829
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.01196832	0.4059530500443829
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.01196832	0.4059530500443829
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.01195033	0.40534284782967794
COCKAYNE SYNDROME A; CSA	0.011926209	0.40452468842884964
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01192077	0.4043402031678279
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.01192077	0.4043402031678279
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.011918434	0.40426096846112697
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.011820593	0.4009423028197176
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011773243	0.39933623973654453
BENT BONE DYSPLASIA SYNDROME; BBDS	0.01175792	0.39881649940658764
INFANTILE SYSTEMIC HYALINOSIS	0.01175792	0.39881649940658764
MOSAIC TRISOMY 1	0.011706200000000002	0.39706221043801937
8P23.1 MICRODELETION SYNDROME	0.011696313	0.3967268536121834
CEDNIK SYNDROME	0.011684582999999998	0.39632898413033285
AYME-GRIPP SYNDROME; AYGRP	0.011679439	0.39615450496454957
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.01167338	0.39594898994404387
SNEDDON SYNDROME	0.011666289	0.39570847054968733
PSEUDOACHONDROPLASIA	0.01166456	0.3956498246559005
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.01166456	0.3956498246559005
RAYNAUD-CLAES SYNDROME; MRXSRC	0.011663953000000001	0.3956292358429864
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.011649879	0.39515186030269955
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.011647403	0.3950678769406313
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.0116279	0.3944063553289918
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.0116279	0.3944063553289918
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.0116279	0.3944063553289918
VAN MALDERGEM SYNDROME 2; VMLDS2	0.011617810000000001	0.3940641129528733
VAN MALDERGEM SYNDROME 1; VMLDS1	0.011617810000000001	0.3940641129528733
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01161701	0.39403697777934554
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.01161701	0.39403697777934554
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.01160355	0.39358042848474134
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.011567753	0.3923662312262758
SHPRINTZEN-GOLDBERG SYNDROME	0.01154303	0.3915276526073679
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.011513790000000001	0.39053586201492907
PMM2-CDG	0.011510853000000001	0.39043624200911536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.011503673	0.3901927038267039
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.011503673	0.3901927038267039
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.011503673	0.3901927038267039
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.011503673	0.3901927038267039
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.011503673	0.3901927038267039
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.011503673	0.3901927038267039
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.011503673	0.3901927038267039
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.011503673	0.3901927038267039
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.011503673	0.3901927038267039
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.011503673	0.3901927038267039
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.011503673	0.3901927038267039
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.011503673	0.3901927038267039
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.3898747813498595
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.3898747813498595
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.3898747813498595
RING CHROMOSOME 22 SYNDROME	0.011430733000000002	0.38771865438031233
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.01142043	0.38736918726424197
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.011385199	0.38617418814104726
20Q11.2 MICRODELETION SYNDROME	0.011366664	0.38554550008937644
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.01128151	0.3826571643811501
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.011184764	0.3793756400085068
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.011184764	0.3793756400085068
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.011183854	0.379344773748619
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.011179719	0.3792045188204475
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.011179719	0.3792045188204475
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.011179719	0.3792045188204475
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.01112487	0.3773440974044189
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.011086973	0.37605867031544293
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.011086973	0.37605867031544293
COFFIN-SIRIS SYNDROME 2; CSS2	0.011072663	0.37557328989896555
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.011051623	0.374859634835186
14Q24.1Q24.3 MICRODELETION SYNDROME	0.011027200000000001	0.37403123190635107
HEART AND BRAIN MALFORMATION SYNDROME	0.010988123	0.3727057804364218
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.010959549999999998	0.3717366137949116
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010958119	0.3716880757532639
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.010958119	0.3716880757532639
XYLOSIDASE DEFICIENCY	0.010958119	0.3716880757532639
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.010958119	0.3716880757532639
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010958119	0.3716880757532639
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010958119	0.3716880757532639
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.010958119	0.3716880757532639
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.010958119	0.3716880757532639
NEUROFIBROMATOSIS, TYPE I	0.010958119	0.3716880757532639
FETAL ALCOHOL SYNDROME	0.010948804000000001	0.3713721205765003
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.01086549	0.36854619576738773
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.010847729	0.36794376099610504
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.010839473	0.3676637260052988
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.010828533000000001	0.367292652507307
RECOMBINANT CHROMOSOME 8 SYNDROME	0.010795713	0.3661794320133315
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.010795713	0.3661794320133315
RECOMBINANT 8 SYNDROME	0.010795713	0.3661794320133315
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.010783629999999999	0.36576958913616187
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.010756223999999998	0.3648400059290353
PROTEUS SYNDROME	0.010733620000000001	0.36407330160100915
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.01070843	0.36321888282455445
DYSTONIA 16	0.01068627	0.3624672385178361
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.01068627	0.3624672385178361
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.010686223	0.36246564432639133
%608572 BURN-MCKEOWN SYNDROME	0.01067281	0.3620106892232319
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.01067281	0.3620106892232319
WOODHOUSE-SAKATI SYNDROME	0.01067281	0.3620106892232319
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.010654803000000001	0.3613999103860894
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.01063921	0.3608710119350668
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01063921	0.3608710119350668
AASE-SMITH SYNDROME	0.01063921	0.3608710119350668
HYDROLETHALUS SYNDROME 1	0.01063921	0.3608710119350668
SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	0.0106383	0.360840145675179
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.0106383	0.360840145675179
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 14	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.0106383	0.360840145675179
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.0106383	0.360840145675179
%611945 SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA-NEUROPATHY-POIKILODERMA SYNDROME	0.0106383	0.360840145675179
%613364 SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41	0.0106383	0.360840145675179
PRIMARY LATERAL SCLEROSIS, ADULT	0.0106383	0.360840145675179
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0106383	0.360840145675179
%300750 SPASTIC PARAPLEGIA 34, X-LINKED; SPG34	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0106383	0.360840145675179
EPISODIC ATAXIA, TYPE 1; EA1	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA-PAGET DISEASE OF BONE SYNDROME	0.0106383	0.360840145675179
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 42	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0106383	0.360840145675179
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0106383	0.360840145675179
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.0106383	0.360840145675179
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 41	0.0106383	0.360840145675179
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.0106383	0.360840145675179
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA TYPE 7	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.0106383	0.360840145675179
SPASTIC PARAPLEGIA TYPE 2	0.0106383	0.360840145675179
PRIMARY LATERAL SCLEROSIS	0.0106383	0.360840145675179
CRANIOFRONTONASAL SYNDROME; CFNS	0.010637924	0.360827392143621
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01059269	0.35929310159442884
MONOSOMY 22	0.01055989	0.35818055947979155
POPOV-CHANG SYNDROME; POPCHAS	0.010545554	0.3576942971701745
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.010545554	0.3576942971701745
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.010545554	0.3576942971701745
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.010545554	0.3576942971701745
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.010531244	0.35720891675369704
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.01052012	0.35683160216579385
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.01049053	0.35582793993493655
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.01049053	0.35582793993493655
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.010416700000000001	0.35332370260799545
DEAFNESS-HYPOGONADISM SYNDROME	0.010403250000000001	0.3528674925030603
MILROY DISEASE	0.010403250000000001	0.3528674925030603
HUNTINGTON DISEASE-LIKE 1	0.010342529	0.350807898913338
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.010332819	0.3504785457446451
OTOPALATODIGITAL SYNDROME TYPE 2	0.010287114	0.34892827936203846
2Q32Q33 MICRODELETION SYNDROME	0.010261633999999999	0.34806402408517995
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.010260353	0.34802057388856866
LIGNEOUS CONJUNCTIVITIS	0.010254294	0.347815058868063
STURGE-WEBER SYNDROME	0.010250159	0.3476748039398915
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.010250159	0.3476748039398915
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.010220064	0.3466540126307448
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.010183850000000001	0.345425671163078
RIGID SPINE SYNDROME	0.010160934	0.34464838411737586
ZEBRA BODY MYOPATHY	0.010160934	0.34464838411737586
HYPOPHOSPHATASIA, CHILDHOOD	0.010156799	0.34450812918920437
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.010149532999999999	0.3442616739756386
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.010138204	0.343877405999519
ABLEPHARON MACROSTOMIA SYNDROME	0.010138204	0.343877405999519
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.010134068999999999	0.34373715107134745
MECKEL SYNDROME, TYPE 10; MKS10	0.010109249	0.34289528231264943
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.010109249	0.34289528231264943
ACROOSTEOLYSIS DOMINANT TYPE	0.01009237	0.34232276407018103
FILIPPI SYNDROME	0.010064993	0.3413941645130949
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.01005432	0.34103214737926796
SPINOCEREBELLAR ATAXIA TYPE 35	0.01005432	0.34103214737926796
SPINOCEREBELLAR ATAXIA TYPE 27	0.01005432	0.34103214737926796
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.01005432	0.34103214737926796
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.010033373	0.340321646779411
TRISOMY 8Q	0.010023853999999999	0.3399987721333978
WOLCOTT-RALLISON SYNDROME	0.010023138999999999	0.33997452007205736
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.010015543	0.33971687159941155
PRADER-WILLI-LIKE SYNDROME	0.010015543	0.33971687159941155
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.010015543	0.33971687159941155
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.010015543	0.33971687159941155
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.01	0.3391896690967345
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.01	0.3391896690967345
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.01	0.3391896690967345
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.01	0.3391896690967345
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.01	0.3391896690967345
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.01	0.3391896690967345
BETHLEM MYOPATHY 2; BTHLM2	0.01	0.3391896690967345
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.009998008999999999	0.33912213643361727
CONO-SPONDYLAR DYSPLASIA	0.009998008999999999	0.33912213643361727
KEIPERT SYNDROME; KPTS	0.00998569	0.33870428868025704
PELVISCAPULAR DYSPLASIA	0.00998569	0.33870428868025704
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.009975802999999998	0.3383689318544211
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.009948163000000001	0.3374314116090378
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00991864	0.33643002194896343
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00991864	0.33643002194896343
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.009913469	0.3362546269710735
GLUTAMINE DEFICIENCY, CONGENITAL	0.009913469	0.3362546269710735
FRYNS SYNDROME	0.009913469	0.3362546269710735
TRISOMY 18-LIKE SYNDROME	0.009901150000000001	0.3358367792177133
SIMOSA CRANIOFACIAL SYNDROME	0.009901150000000001	0.3358367792177133
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.009901150000000001	0.3358367792177133
BRANCHIO-OCULO-FACIAL SYNDROME	0.009901150000000001	0.3358367792177133
BARBER-SAY SYNDROME	0.009901150000000001	0.3358367792177133
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.009891263	0.33550142239187736
MENTAL RETARDATION, X-LINKED 90	0.009858903	0.33440380462268027
HEREDITARY FOLATE MALABSORPTION	0.009858903	0.33440380462268027
INFANTILE REFSUM DISEASE	0.009858903	0.33440380462268027
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.009858903	0.33440380462268027
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.33256916162150296
BIOTINIDASE DEFICIENCY	0.009804814	0.33256916162150296
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.33256916162150296
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.33256916162150296
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.33242890669333147
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.33242890669333147
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.009799413	0.3323859652812238
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.009795044000000001	0.3322377733147955
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.009790909	0.332097518386624
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.009790909	0.332097518386624
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.009788573	0.3320182836799229
2Q24 MICRODELETION SYNDROME	0.009753879	0.33084149904195875
LOWRY-MACLEAN SYNDROME	0.009753879	0.33084149904195875
JOUBERT SYNDROME WITH OCULAR DEFECT	0.009743583	0.3304922693586568
JOUBERT SYNDROME	0.009743583	0.3304922693586568
JOUBERT SYNDROME WITH RENAL DEFECT	0.009743583	0.3304922693586568
MAXILLOFACIAL DYSOSTOSIS	0.009741560000000002	0.3304236512885985
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.009741560000000002	0.3304236512885985
%300712 CRANIOFACIOSKELETAL SYNDROME	0.009718934	0.3296562007433002
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.009716079999999998	0.32955939601173995
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.009716079999999998	0.32955939601173995
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00970874	0.329310430794623
DERMOCHONDROCORNEAL DYSTROPHY	0.00970874	0.329310430794623
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00970874	0.329310430794623
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00970874	0.329310430794623
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00970874	0.329310430794623
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00970874	0.329310430794623
ACUTE PROMYELOCYTIC LEUKEMIA	0.00970874	0.329310430794623
JUVENILE HYALINE FIBROMATOSIS	0.00970874	0.329310430794623
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00970874	0.329310430794623
FOCAL PALMOPLANTAR AND GINGIVAL KERATODERMA	0.00970874	0.329310430794623
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00970874	0.329310430794623
HEREDITARY GINGIVAL FIBROMATOSIS	0.00970874	0.329310430794623
ENAMEL-RENAL SYNDROME	0.00970874	0.329310430794623
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00970874	0.329310430794623
OTODENTAL SYNDROME	0.00970874	0.329310430794623
HYPOPLASMINOGENEMIA	0.00970874	0.329310430794623
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.00970874	0.329310430794623
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00967451	0.3281493845573049
TREACHER-COLLINS SYNDROME	0.009634394000000001	0.32678869128075644
17Q24.2 MICRODELETION SYNDROME	0.009630259	0.32664843635258495
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.00961538	0.32614375604393586
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00961538	0.32614375604393586
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.00961538	0.32614375604393586
EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	0.00961538	0.32614375604393586
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00961538	0.32614375604393586
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.00961538	0.32614375604393586
CAMURATI-ENGELMANN DISEASE	0.00961538	0.32614375604393586
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00961538	0.32614375604393586
TYPICAL NEMALINE MYOPATHY	0.00961538	0.32614375604393586
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00961538	0.32614375604393586
EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	0.00961538	0.32614375604393586
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00961538	0.32614375604393586
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00961538	0.32614375604393586
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.00961538	0.32614375604393586
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 TYPE	0.00961538	0.32614375604393586
CZECH DYSPLASIA, METATARSAL TYPE	0.00961538	0.32614375604393586
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00961538	0.32614375604393586
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.00961538	0.32614375604393586
CAMURATI-ENGELMANN DISEASE	0.00961538	0.32614375604393586
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00961538	0.32614375604393586
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00961538	0.32614375604393586
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00961538	0.32614375604393586
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.009567830000000001	0.324530909167381
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.009542349999999998	0.32366665389052235
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.009530793999999999	0.3232746863089142
OGDEN SYNDROME; OGDNS	0.009530793999999999	0.3232746863089142
GOLDBERG-SHPRINTZEN SYNDROME	0.009523574	0.3230297913678264
FAMILIAL VISCERAL MYOPATHY	0.00948183	0.321613878013149
MENTAL RETARDATION, X-LINKED 106; MRX106	0.009474124	0.3213524984541431
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.009474124	0.3213524984541431
2Q23.1 MICRODELETION SYNDROME	0.009469989	0.32121224352597155
5Q14.3 MICRODELETION SYNDROME	0.009469989	0.32121224352597155
POSTENCEPHALITIC PARKINSONISM	0.009469989	0.32121224352597155
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.009469989	0.32121224352597155
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.009454179	0.3206759846591296
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.009442269	0.3202720097632354
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009420303	0.3195269457360975
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.009420303	0.3195269457360975
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.009420303	0.3195269457360975
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009420303	0.3195269457360975
N-ACETYLASPARTATE DEFICIENCY; NACED	0.009420303	0.3195269457360975
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.009420303	0.3195269457360975
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00939519	0.31867513872009484
W SYNDROME	0.009392853999999999	0.3185959040133939
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.009349844	0.3171370492466088
FORSYTHE-WAKELING SYNDROME; FWS	0.009338114	0.31673917976475835
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00933297	0.31656470059897496
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00933297	0.31656470059897496
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00932914	0.3164347909557109
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.3160394314774118
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.3160394314774118
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.009317484000000001	0.3160394314774118
2Q33.1 DELETION SYNDROME	0.009313349	0.31589917654924027
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.009313349	0.31589917654924027
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.009313349	0.31589917654924027
5Q35 MICRODUPLICATION SYNDROME	0.009313349	0.31589917654924027
L-2-HYDROXYGLUTARIC ACIDURIA	0.009313349	0.31589917654924027
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.009313349	0.31589917654924027
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.009313349	0.31589917654924027
ABETA AMYLOIDOSIS, DUTCH TYPE	0.009313349	0.31589917654924027
PINEOBLASTOMA	0.009313349	0.31589917654924027
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.009313349	0.31589917654924027
SCLERODERMA	0.009313349	0.31589917654924027
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00930341	0.31556205593712505
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.009301074000000001	0.3154828212304241
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.31406453354806296
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.31406453354806296
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.31406453354806296
GAUCHER DISEASE TYPE 2	0.00925926	0.31406453354806296
PAINE SYNDROME	0.00925926	0.31406453354806296
CARNOSINEMIA	0.00925926	0.31406453354806296
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.31406453354806296
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.31406453354806296
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.31406453354806296
HYDROXYLYSINURIA	0.00925926	0.31406453354806296
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.31406453354806296
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00923417	0.3132135066682993
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00922215	0.312805800686045
1Q44 MICRODELETION SYNDROME	0.009219123999999999	0.31270316189217623
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.009208153	0.3123310369062103
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.009198029	0.3119876412852168
CHROMOSOME 17P13.1 DELETION SYNDROME	0.009190253999999998	0.311723921317494
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.009108823	0.30896186592307245
NON-DISTAL MONOSOMY 10Q	0.00909342	0.30843941207576275
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00908884	0.30828406320731644
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00908884	0.30828406320731644
DUBOWITZ SYNDROME	0.00906044	0.3073207645470817
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00904871	0.30692289506523124
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00904871	0.30692289506523124
MCDONOUGH SYNDROME	0.00904871	0.30692289506523124
CHARGE-LIKE SYNDROME, X-LINKED	0.00904871	0.30692289506523124
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00904871	0.30692289506523124
14Q11.2 MICRODELETION SYNDROME	0.00903873	0.30658438377547265
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.009037564	0.306544834260056
CARPENTER SYNDROME	0.00902538	0.30613156556722854
DESANTO-SHINAWI SYNDROME	0.009023483	0.30606722128700087
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.009005223	0.3054478609512302
GENITOPATELLAR SYNDROME	0.008998003	0.3052029660101424
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00892857	0.30284787038070304
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00892857	0.30284787038070304
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.008878884	0.301162572590829
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.008878884	0.301162572590829
PEROXISOME BIOGENESIS DISORDER 5B	0.008878884	0.301162572590829
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.008878884	0.301162572590829
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.008878884	0.301162572590829
CEREBELLOPARENCHYMAL DISORDER II	0.008874749	0.3010223176626575
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.008874749	0.3010223176626575
INCONTINENTIA PIGMENTI	0.008808752999999999	0.2987838015224867
600736 VELOFACIOSKELETAL SYNDROME	0.00880429	0.2986324211731688
DERMOTRICHIC SYNDROME	0.008798549	0.2984376923841404
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.008798549	0.2984376923841404
NIJMEGEN BREAKAGE SYNDROME	0.00879256	0.29823455169131835
NANCE-HORAN SYNDROME	0.00879256	0.29823455169131835
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00879256	0.29823455169131835
BREATH-HOLDING SPELLS	0.00877193	0.2975348034039718
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.2975348034039718
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.2975348034039718
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.2975348034039718
HISTIDINEMIA	0.00877193	0.2975348034039718
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.2975348034039718
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.2975348034039718
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.2975348034039718
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.2975348034039718
CAFFEY DISEASE	0.00877193	0.2975348034039718
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.2975348034039718
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.2975348034039718
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.008759063	0.297098368056745
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.008755520000000001	0.2969781931569841
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00875552	0.29697819315698404
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.008712734	0.29552693623878673
SECKEL SYNDROME 9; SCKL9	0.008712734	0.29552693623878673
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.008708599	0.29538668131061524
ALEXANDER DISEASE	0.008662599	0.29382640883277034
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.008662599	0.29382640883277034
MUSCLE-EYE-BRAIN DISEASE	0.008662599	0.29382640883277034
CADASIL	0.008662599	0.29382640883277034
PARTINGTON SYNDROME	0.008662599	0.29382640883277034
WEAVER SYNDROME	0.008637533999999999	0.2929762299271793
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00859108	0.29140055823835737
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.008588743999999999	0.2913213235316563
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.008584609	0.29118106860348486
RUBINSTEIN-TAYBI SYNDROME	0.008537163	0.28957174929948853
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.008494383	0.28812069589509265
WEBB-DATTANI SYNDROME; WEDAS	0.008494383	0.28812069589509265
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.008494383	0.28812069589509265
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.28812069589509265
OROFACIODIGITAL SYNDROME XIV; OFD14	0.008482064000000001	0.2877028481417324
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.008482064000000001	0.2877028481417324
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.008482064000000001	0.2877028481417324
BARAITSER-WINTER SYNDROME 2; BRWS2	0.008477929	0.2875625932135609
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.008477929	0.2875625932135609
LATERAL MENINGOCELE SYNDROME	0.00843149	0.28598743030924256
COFFIN-SIRIS SYNDROME 6; CSS6	0.008384044	0.2843781110052462
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.008376464	0.28412100523607087
CORNELIA DE LANGE SYNDROME 3	0.008344483	0.2830362427553326
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00833611	0.28275223924539794
SYDENHAM CHOREA	0.00833333	0.28265794451738907
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00833333	0.28265794451738907
MYXOPAPILLARY EPENDYMOMA	0.00833333	0.28265794451738907
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00833333	0.28265794451738907
HUNTINGTON DISEASE-LIKE 1	0.00833333	0.28265794451738907
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00833333	0.28265794451738907
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.00833333	0.28265794451738907
DEAFNESS, X-LINKED 5; DFNX5	0.00833333	0.28265794451738907
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.00833333	0.28265794451738907
SPINOCEREBELLAR ATAXIA 41; SCA41	0.00833333	0.28265794451738907
KURU, SUSCEPTIBILITY TO	0.00833333	0.28265794451738907
ATAXIA-PANCYTOPENIA SYNDROME	0.00833333	0.28265794451738907
PLAGUE	0.00833333	0.28265794451738907
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.00833333	0.28265794451738907
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00833333	0.28265794451738907
DISTAL HEREDITARY MOTOR NEUROPATHY TYPE 5	0.00833333	0.28265794451738907
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00833333	0.28265794451738907
NOONAN SYNDROME 6; NS6	0.008299504	0.28151060154270235
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00826886	0.28047118872072235
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.008267163000000001	0.2804136282338767
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.008267163000000001	0.2804136282338767
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.008267163000000001	0.2804136282338767
HEREDITARY HYPEREKPLEXIA	0.008263198999999999	0.2802791734490467
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.008259942999999999	0.2801687332927888
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.008259942999999999	0.2801687332927888
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.008259942999999999	0.2801687332927888
LATERAL MENINGOCELE SYNDROME	0.008255423999999999	0.28001545348132395
CAREY-FINEMAN-ZITER SYNDROME	0.00818825	0.2777369807981336
DISTAL TRISOMY 17Q	0.008182773	0.27755120661636934
AMYLOIDOSIS	0.00816718	0.2770223081653468
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00816718	0.2770223081653468
PYRUVATE DEHYDROGENASE DEFICIENCY	0.008131213	0.2758023446825066
MESOMELIA-SYNOSTOSES SYNDROME	0.00812773	0.2756842049207602
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00812118	0.2754620356875018
MUCOLIPIDOSIS TYPE IV	0.00812118	0.2754620356875018
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.008112813	0.27517823569136857
19P13.13 MICRODELETION SYNDROME	0.008107573	0.27500050030476186
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.008059213999999999	0.27336021298397695
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.008037443	0.2726217631553865
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.008022569	0.27211725244157203
FEMORAL-FACIAL SYNDROME	0.00802185	0.27209286470436395
MEIER-GORLIN SYNDROME 1; MGORS1	0.00802185	0.27209286470436395
POTOCKI-SHAFFER SYNDROME	0.007991609	0.27106712122604854
OROFACIODIGITAL SYNDROME TYPE 1	0.007991609	0.27106712122604854
OROFACIODIGITAL SYNDROME I; OFD1	0.007991609	0.27106712122604854
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.007983523000000001	0.27079285245961693
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.007983523000000001	0.27079285245961693
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.007983523000000001	0.27079285245961693
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.007983523000000001	0.27079285245961693
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.007983523000000001	0.27079285245961693
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.007983523000000001	0.27079285245961693
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.007983523000000001	0.27079285245961693
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.007983523000000001	0.27079285245961693
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.007983523000000001	0.27079285245961693
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.007983523000000001	0.27079285245961693
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.007983523000000001	0.27079285245961693
SALLA DISEASE	0.007983523000000001	0.27079285245961693
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.007970539	0.27035244859326174
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.26975632274982414
300270 ADRENOMYODYSTROPHY	0.007952964	0.26975632274982414
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.26975632274982414
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.007948829	0.26961606782165265
BOWEN-CONRADI SYNDROME	0.007948829	0.26961606782165265
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.007948829	0.26961606782165265
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.26961606782165265
ADRENOMYODYSTROPHY	0.007948829	0.26961606782165265
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.26961606782165265
COG8-CDG	0.007948829	0.26961606782165265
DPM1-CDG	0.007948829	0.26961606782165265
CROME SYNDROME	0.007948829	0.26961606782165265
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.007948829	0.26961606782165265
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.007948829	0.26961606782165265
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.26961606782165265
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.007948829	0.26961606782165265
HEREDITARY METHEMOGLOBINEMIA	0.007948829	0.26961606782165265
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007948829	0.26961606782165265
4Q21 MICRODELETION SYNDROME	0.007948829	0.26961606782165265
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.26961606782165265
LISSENCEPHALY 5; LIS5	0.007948829	0.26961606782165265
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.26961606782165265
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00793651	0.26919822006829247
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00793651	0.26919822006829247
BARBER-SAY SYNDROME; BBRSAY	0.00793651	0.26919822006829247
BRANCHIOOTIC SYNDROME 2	0.00793651	0.26919822006829247
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.00793651	0.26919822006829247
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00793651	0.26919822006829247
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00793651	0.26919822006829247
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00793651	0.26919822006829247
184705 STEINFELD SYNDROME	0.00793651	0.26919822006829247
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00793651	0.26919822006829247
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00793651	0.26919822006829247
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00793651	0.26919822006829247
POLYVALVULAR HEART DISEASE SYNDROME	0.00793651	0.26919822006829247
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.00793651	0.26919822006829247
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00793651	0.26919822006829247
NEU-LAXOVA SYNDROME 2; NLS2	0.00793651	0.26919822006829247
VAN BOGAERT-HOZAY SYNDROME	0.00793651	0.26919822006829247
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00793651	0.26919822006829247
WOLFRAM-LIKE SYNDROME	0.00793651	0.26919822006829247
FIBROCHONDROGENESIS 1; FBCG1	0.00793651	0.26919822006829247
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00793651	0.26919822006829247
KENNERKNECHT SYNDROME	0.00793651	0.26919822006829247
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00793651	0.26919822006829247
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00793651	0.26919822006829247
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00793651	0.26919822006829247
RESTRICTIVE DERMOPATHY, LETHAL	0.00793651	0.26919822006829247
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.007926623	0.2688628632424565
POTOCKI-SHAFFER SYNDROME	0.007926623	0.2688628632424565
CK SYNDROME	0.007926623	0.2688628632424565
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.007909748999999999	0.2682905145948226
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00786946	0.2669239533369988
OMODYSPLASIA 1; OMOD1	0.00786946	0.2669239533369988
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00786946	0.2669239533369988
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00786946	0.2669239533369988
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.00785773	0.26652608385514837
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00785773	0.26652608385514837
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.00785773	0.26652608385514837
LEPRECHAUNISM	0.00785773	0.26652608385514837
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00783091	0.26561637716263087
DYSTONIA, DOPA-RESPONSIVE; DRD	0.00783091	0.26561637716263087
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.007829344	0.26556326006045033
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.007824603999999999	0.26540248415729845
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.007824603999999999	0.26540248415729845
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.007815084	0.2650795755923184
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.007815084	0.2650795755923184
DUANE RETRACTION SYNDROME	0.007803493	0.2646864208468684
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.007721779999999999	0.26191480030377823
OSTEOGENESIS IMPERFECTA	0.007721779999999999	0.26191480030377823
BRITTLE CORNEA SYNDROME 2; BCS2	0.007721779999999999	0.26191480030377823
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.007721779999999999	0.26191480030377823
SCARF SYNDROME	0.00770987	0.261510825407884
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.0076720899999999995	0.26022936683803655
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.007669754	0.2601501321313356
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.007669754	0.2601501321313356
TOLUENE EMBRYOPATHY	0.0076413539999999995	0.25918683347110083
FIBULAR HEMIMELIA	0.00762881	0.2587613539501859
CHARLIE M SYNDROME	0.007598049999999999	0.25771800652804433
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.25737047279308783
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.25737047279308783
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.25737047279308783
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.25737047279308783
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.25737047279308783
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2572302178649163
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2572302178649163
FRIED SYNDROME	0.007578064	0.2570401020553876
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.007567259	0.2566736076179286
THAUVIN-ROBINET-FAIVRE SYNDROME	0.007566153999999999	0.25663612715949335
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.007566153999999999	0.25663612715949335
POTOCKI-LUPSKI SYNDROME	0.0075649229999999994	0.25659437291122755
HYPERTRICHOSIS CUBITI	0.007558934	0.25639123221840554
DISTAL TRISOMY 15Q	0.007554799	0.25625097729023405
ERYTHROKERATODERMIA VARIABILIS	0.00751366	0.254855584910537
OSTEOGLOSPHONIC DYSPLASIA	0.00751366	0.254855584910537
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00751366	0.254855584910537
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0074960240000000004	0.254257390010118
SPINOCEREBELLAR ATAXIA 44; SCA44	0.007481150000000001	0.2537528792963035
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.007481150000000001	0.2537528792963035
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.007481150000000001	0.2537528792963035
SPINOCEREBELLAR ATAXIA 13	0.007481150000000001	0.2537528792963035
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.007481150000000001	0.2537528792963035
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.007481150000000001	0.2537528792963035
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.007481150000000001	0.2537528792963035
MULTIPLE METAPHYSEAL DYSPLASIA	0.0074621	0.25310672297667425
OROFACIODIGITAL SYNDROME XVI; OFD16	0.007442104000000001	0.2524284793143484
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.007442104000000001	0.2524284793143484
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.007442104000000001	0.2524284793143484
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.007442104000000001	0.2524284793143484
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.007442104000000001	0.2524284793143484
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.007442104000000001	0.2524284793143484
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.007437969000000001	0.25228822438617693
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00742912	0.2519880754479932
FACIOCARDIORENAL SYNDROME	0.00742912	0.2519880754479932
TETRASOMY 18P	0.007426069	0.2518845886799518
2Q37 MICRODELETION SYNDROME	0.0074096529999999996	0.2513277749191626
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.2512516946763842
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.2512516946763842
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.2512516946763842
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.2512516946763842
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.2512516946763842
KID SYNDROME	0.00740741	0.2512516946763842
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.007406244	0.2512121451609675
1Q21.1 MICRODELETION SYNDROME	0.007385633	0.2505130413339922
TETRASOMY 5P	0.007385633	0.2505130413339922
FRONTOOCULAR SYNDROME	0.007385203999999999	0.25049849009718794
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.007385203999999999	0.25049849009718794
HADZISELIMOVIC SYNDROME	0.007385203999999999	0.25049849009718794
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.007325112999999999	0.24846026545661878
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.007305084	0.24778090246838497
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00728379	0.2470586319870104
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00728379	0.2470586319870104
INTERMEDIATE NEMALINE MYOPATHY	0.0072790500000000005	0.24689785608385853
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0072790500000000005	0.24689785608385853
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0072790500000000005	0.24689785608385853
NEUTRAL LIPID STORAGE MYOPATHY	0.0072790500000000005	0.24689785608385853
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.0072790500000000005	0.24689785608385853
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0072790500000000005	0.24689785608385853
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.0072790500000000005	0.24689785608385853
ALAGILLE SYNDROME	0.00726953	0.24657494751887843
CENANI-LENZ SYNDROME	0.00726953	0.24657494751887843
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00726953	0.24657494751887843
CINCA SYNDROME	0.007267634	0.24651063715761767
ABRUZZO-ERICKSON SYNDROME	0.00726473	0.24641213647771196
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00726473	0.24641213647771196
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.007263499	0.24637038222944616
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00725751	0.24616724153662417
RING CHROMOSOME 13 SYNDROME	0.0071801899999999995	0.24354462701516819
RING CHROMOSOME 6 SYNDROME	0.0071801899999999995	0.24354462701516819
STROMME SYNDROME; STROMS	0.00717297	0.24329973207408034
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00717297	0.24329973207408034
WAARDENBURG-SHAH SYNDROME	0.00717297	0.24329973207408034
WAARDENBURG SYNDROME	0.00717297	0.24329973207408034
ADULT SYNDROME	0.00717297	0.24329973207408034
DONNAI-BARROW SYNDROME	0.007165523	0.243047137527504
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.0071242	0.24164550405789556
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.0071242	0.24164550405789556
TREACHER COLLINS SYNDROME 3; TCS3	0.0071242	0.24164550405789556
TREACHER COLLINS SYNDROME 2; TCS2	0.0071242	0.24164550405789556
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.0071242	0.24164550405789556
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.0071242	0.24164550405789556
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.007095799999999999	0.24068220539766083
PTERYGIUM COLLI, ISOLATED	0.007095799999999999	0.24068220539766083
OROFACIAL CLEFT 15	0.007095799999999999	0.24068220539766083
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.23886584471964784
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.23886584471964784
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.23886584471964784
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.23886584471964784
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.23886584471964784
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.23886584471964784
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.23886584471964784
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.23886584471964784
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.23886584471964784
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.23886584471964784
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.23886584471964784
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.23886584471964784
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.23886584471964784
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.23886584471964784
17P11.2 MICRODUPLICATION SYNDROME	0.007023504	0.23822999976595907
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.007019368999999999	0.23808974483778758
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.007013808999999999	0.23790115538176979
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00701338	0.23788660414496557
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00701338	0.23788660414496557
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00701338	0.23788660414496557
SECKEL SYNDROME 5; SCKL5	0.00701338	0.23788660414496557
BARDET-BIEDL SYNDROME	0.00701338	0.23788660414496557
ISOLATED CLEFT LIP	0.006976199999999999	0.23662549695526386
LOEYS-DIETZ SYNDROME 3; LDS3	0.006976199999999999	0.23662549695526386
ACHONDROGENESIS TYPE 1B	0.006976199999999999	0.23662549695526386
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00697529	0.23659463069537612
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00695047	0.235752761936678
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	0.00689655	0.23392385124090842
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.00689655	0.23392385124090842
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00689655	0.23392385124090842
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00689655	0.23392385124090842
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00689655	0.23392385124090842
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 57	0.00689655	0.23392385124090842
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.006888193000000001	0.2336403904344443
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.006884650000000001	0.23352021553468333
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.006876283	0.2332364155385501
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.006868233999999999	0.23296340177389407
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.006868233999999999	0.23296340177389407
ADAMS-OLIVER SYNDROME 5; AOS5	0.006864098999999999	0.23282314684572258
LOEYS-DIETZ SYNDROME 5	0.006860689999999999	0.2327075170875275
MILLER-DIEKER SYNDROME	0.006845638999999999	0.23219700271656998
CEREBROOCULONASAL SYNDROME	0.006839649999999999	0.23199386202374794
BALLER-GEROLD SYNDROME	0.006839649999999999	0.23199386202374794
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.006783694	0.23009589231135033
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.006779558999999999	0.22995563738317878
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00673116	0.22831399330371754
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00673116	0.22831399330371754
JOUBERT SYNDROME 24	0.0066965340000000005	0.22713951515550318
EHLERS-DANLOS SYNDROME, TYPE VI	0.006686959999999999	0.22681477496630992
COSTELLO SYNDROME; CSTLO	0.006684624	0.22673554025960896
DISTAL MONOSOMY 6P	0.006684624	0.22673554025960896
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.006668184000000001	0.22617791244361396
15Q OVERGROWTH SYNDROME	0.006664049	0.22603765751544241
KABUKI SYNDROME 1	0.006635843	0.2250809391347882
MICRO SYNDROME	0.006635843	0.2250809391347882
2Q31.1 MICRODELETION SYNDROME	0.006572523	0.22293319015006768
ADAMS-OLIVER SYNDROME 2; AOS2	0.006551453	0.22221851751728083
WALKER-WARBURG SYNDROME	0.006551453	0.22221851751728083
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.006487983	0.22006568068752386
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0064762529999999995	0.21966781120567339
FANCONI ANEMIA	0.006450374	0.21879002226101793
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.006450373999999999	0.21879002226101793
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.006450373999999999	0.21879002226101793
ICF SYNDROME	0.006450373999999999	0.21879002226101793
DISTAL MONOSOMY 3P	0.0064462389999999994	0.21864976733284644
WILSON-TURNER SYNDROME	0.006406123	0.21728907405629797
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.006406123	0.21728907405629797
KAGAMI-OGATA SYNDROME	0.006406123	0.21728907405629797
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.006406123	0.21728907405629797
PALLISTER-HALL SYNDROME	0.006406123	0.21728907405629797
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00636676	0.2159539217618325
BASAL CELL NEVUS SYNDROME	0.00636676	0.2159539217618325
ELSAHY-WATERS SYNDROME; ESWS	0.0063644240000000005	0.21587468705513155
3C SYNDROME	0.0063644240000000005	0.21587468705513155
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.006342639000000001	0.2151357623610043
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.006295303	0.213530174143368
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.0062953029999999995	0.21353017414336797
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.0062953029999999995	0.21353017414336797
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.0062953029999999995	0.21353017414336797
15Q14 MICRODELETION SYNDROME	0.0062953029999999995	0.21353017414336797
MEND SYNDROME	0.0062953029999999995	0.21353017414336797
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0062953029999999995	0.21353017414336797
MEND SYNDROME; MEND	0.0062953029999999995	0.21353017414336797
DISTAL 16P11.2 MICRODELETION SYNDROME	0.0062953029999999995	0.21353017414336797
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00623814	0.21159126423791033
FRASER SYNDROME	0.00623814	0.21159126423791033
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00623814	0.21159126423791033
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.006215183000000001	0.21081258651456497
XQ21 MICRODELETION SYNDROME	0.006215183	0.21081258651456494
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.006215183	0.21081258651456494
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.006215183	0.21081258651456494
PETTIGREW SYNDROME	0.006215183	0.21081258651456494
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0061789639999999995	0.20958407545206345
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006166573	0.20916378553308573
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00615098	0.20863488708206318
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00615098	0.20863488708206318
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00615098	0.20863488708206318
MIRAGE SYNDROME; MIRAGE	0.006142613	0.20835108708592995
CHROMOSOME 18P DELETION SYNDROME	0.006094424	0.20671656598951968
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.0060902890000000005	0.2065763110613482
ARTERIAL TORTUOSITY SYNDROME	0.006078549999999999	0.2061781363087955
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.006013083000000001	0.20395756330211998
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.006013083000000001	0.20395756330211998
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.006013083000000001	0.20395756330211998
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.006013083	0.20395756330211992
AICARDI-GOUTIÈRES SYNDROME	0.006013083	0.20395756330211992
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.006010034	0.20385414437201235
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.006010034	0.20385414437201235
BRESEK SYNDROME	0.006010034	0.20385414437201235
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.006010034	0.20385414437201235
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.006010034	0.20385414437201235
CHAR SYNDROME	0.006010034	0.20385414437201235
HARROD SYNDROME	0.006005899	0.20371388944384086
16Q24.3 MICRODELETION SYNDROME	0.006005899	0.20371388944384086
FRAGILE X SYNDROME	0.006005899	0.20371388944384086
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.006005899	0.20371388944384086
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.0059489	0.2017805422489564
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.005946564	0.20170130754225538
JOUBERT SYNDROME 10	0.005946564	0.20170130754225538
OPITZ G/BBB SYNDROME	0.005946564	0.20170130754225538
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00593717	0.20138267276710592
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00593717	0.20138267276710592
PROTEUS SYNDROME	0.005930698999999999	0.20116318313223336
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00590482	0.200285394187578
PROGEROID SYNDROME, PETTY TYPE	0.00590482	0.200285394187578
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.005864704	0.19892470091102948
RING CHROMOSOME 12 SYNDROME	0.005864704	0.19892470091102948
MEIER-GORLIN SYNDROME 7	0.005864704	0.19892470091102948
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.005864704	0.19892470091102948
EVEN-PLUS SYNDROME	0.005864704	0.19892470091102948
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.005864704	0.19892470091102948
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0058605689999999995	0.198784445982858
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.0058605689999999995	0.198784445982858
3-HYDROXYISOBUTYRIC ACIDURIA	0.0058605689999999995	0.198784445982858
ADAMS-OLIVER SYNDROME 1; AOS1	0.005838853	0.19804786169744754
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00581887	0.19737005898169155
CRANIOFRONTONASAL DYSPLASIA	0.00581887	0.19737005898169155
GENITOPALATOCARDIAC SYNDROME	0.00581887	0.19737005898169155
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00580122	0.19677138921573584
BEHR SYNDROME	0.00580122	0.19677138921573584
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00580122	0.19677138921573584
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00580122	0.19677138921573584
DYSTONIA 16; DYT16	0.00580122	0.19677138921573584
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00580122	0.19677138921573584
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00580122	0.19677138921573584
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00580122	0.19677138921573584
MAST SYNDROME	0.00580122	0.19677138921573584
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0057611039999999995	0.19541069593918733
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0057611039999999995	0.19541069593918733
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.005759873	0.19536894169092153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.005759873	0.19536894169092153
CENTRAL BILATERAL MACROGYRIA	0.005759873	0.19536894169092153
SEVERE CANAVAN DISEASE	0.005759873	0.19536894169092153
CANAVAN DISEASE	0.005759873	0.19536894169092153
VICI SYNDROME	0.005759873	0.19536894169092153
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.005759873	0.19536894169092153
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.005759873	0.19536894169092153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.005759873	0.19536894169092153
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.005759873	0.19536894169092153
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.005759873	0.19536894169092153
HARTNUP DISEASE	0.005759873	0.19536894169092153
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.005759873	0.19536894169092153
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.005759873	0.19536894169092153
ISOLATED GLYCEROL KINASE DEFICIENCY	0.005759873	0.19536894169092153
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.005759873	0.19536894169092153
TAY-SACHS DISEASE	0.005759873	0.19536894169092153
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.005759873	0.19536894169092153
SCHIZENCEPHALY	0.005759873	0.19536894169092153
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.005759873	0.19536894169092153
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.005756969	0.19527044101101582
OCULOFACIOCARDIODENTAL SYNDROME	0.005753884	0.1951658009980995
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.005753884	0.1951658009980995
DISTAL TRISOMY 18Q	0.005753884	0.1951658009980995
12Q14 MICRODELETION SYNDROME	0.005753884	0.1951658009980995
ALAZAMI-YUAN SYNDROME	0.005753884	0.1951658009980995
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.005753884	0.1951658009980995
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.005749749	0.195025546069928
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.005673764	0.1924482133692965
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.005673764	0.1924482133692965
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.005673764	0.1924482133692965
MARINESCO-SJOGREN SYNDROME; MSS	0.005673764	0.1924482133692965
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.005673764	0.1924482133692965
SPINOCEREBELLAR ATAXIA 5; SCA5	0.005673764	0.1924482133692965
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.005669629000000001	0.192307958441125
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.005669629000000001	0.192307958441125
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.005669629000000001	0.192307958441125
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.005669629000000001	0.192307958441125
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.005669629000000001	0.192307958441125
INHERITED CREUTZFELDT-JAKOB DISEASE	0.005669629000000001	0.192307958441125
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.005669629000000001	0.192307958441125
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.005669629000000001	0.192307958441125
HUNTINGTON DISEASE; HD	0.005669629000000001	0.192307958441125
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00564514	0.19147731686047395
GORLIN SYNDROME	0.00564514	0.19147731686047395
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00564514	0.19147731686047395
FRONTONASAL DYSPLASIA 1; FND1	0.00564514	0.19147731686047395
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00564514	0.19147731686047395
SAUL-WILSON SYNDROME; SWILS	0.005601194	0.18998671394066147
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.005601194	0.18998671394066147
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.005597059	0.18984645901248995
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00554887	0.1882119379160797
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00554887	0.1882119379160797
SHORT SYNDROME	0.00554887	0.1882119379160797
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00554887	0.1882119379160797
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00554887	0.1882119379160797
LERI PLEONOSTEOSIS	0.00549746	0.1864681638272534
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00549746	0.1864681638272534
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00549746	0.1864681638272534
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0054855500000000005	0.1860641889313592
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.005471664	0.18559319015685147
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.005471664	0.18559319015685147
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.005471664	0.18559319015685147
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.005471664	0.18559319015685147
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.005471664	0.18559319015685147
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.0054675290000000005	0.18545293522867998
SECONDARY SYRINGOMYELIA	0.0054675290000000005	0.18545293522867998
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00546448	0.18534951629857235
LIMB-MAMMARY SYNDROME	0.00546448	0.18534951629857235
BLOOM SYNDROME	0.00546448	0.18534951629857235
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00546448	0.18534951629857235
WOODHOUSE-SAKATI SYNDROME	0.00546448	0.18534951629857235
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00546448	0.18534951629857235
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00546448	0.18534951629857235
WOOLLY HAIR, HYPOTRICHOSIS, EVERTED LOWER LIP, AND OUTSTANDING EARS	0.00546448	0.18534951629857235
3M SYNDROME	0.00546448	0.18534951629857235
CRANIOECTODERMAL DYSPLASIA 4	0.00546448	0.18534951629857235
WEAVER-WILLIAMS SYNDROME	0.00546448	0.18534951629857235
SCHIZOPHRENIA 1; SCZD1	0.00546448	0.18534951629857235
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00546448	0.18534951629857235
RODRIGUES BLINDNESS	0.00546448	0.18534951629857235
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00546448	0.18534951629857235
THREE M SYNDROME 2; 3M2	0.00546448	0.18534951629857235
TRISOMY 5P	0.00546448	0.18534951629857235
BLOOM SYNDROME	0.00546448	0.18534951629857235
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00546448	0.18534951629857235
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.005420993	0.1838744821845714
49,XXXXY SYNDROME	0.005420993	0.1838744821845714
48,XXXY SYNDROME	0.005420993	0.1838744821845714
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.005420993	0.1838744821845714
8P11.2 DELETION SYNDROME	0.005420993	0.1838744821845714
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00541292	0.1836006543647096
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00540101	0.1831966794688154
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00540101	0.1831966794688154
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00538928	0.1827988099869649
SIALIDOSIS TYPE 2	0.005360472999999999	0.18182170630719793
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.005360472999999999	0.18182170630719793
DIGEORGE SYNDROME; DGS	0.005360472999999999	0.18182170630719793
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.005360472999999999	0.18182170630719793
IMMUNODEFICIENCY 49; IMD49	0.005360472999999999	0.18182170630719793
DISTAL MONOSOMY 19P13.3	0.005360472999999999	0.18182170630719793
HEMIFACIAL MICROSOMIA	0.00531915	0.1804200728375895
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.00531915	0.1804200728375895
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00531915	0.1804200728375895
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00531915	0.1804200728375895
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00531915	0.1804200728375895
MICROTIA - EYE COLOBOMA - IMPERFORATION OF THE NASOLACRIMAL DUCT	0.00531915	0.1804200728375895
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00531915	0.1804200728375895
CHANARIN-DORFMAN SYNDROME	0.00531915	0.1804200728375895
MICROPHTHALMIA-MICROTIA-FETAL AKINESIA SYNDROME	0.00531915	0.1804200728375895
DIABETIC EMBRYOPATHY	0.00531915	0.1804200728375895
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00531915	0.1804200728375895
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00531915	0.1804200728375895
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00531915	0.1804200728375895
COXOAURICULAR SYNDROME	0.00531915	0.1804200728375895
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00531915	0.1804200728375895
MEIER-GORLIN SYNDROME 8; MGORS8	0.00531915	0.1804200728375895
MICROTIA-EYE COLOBOMA-IMPERFORATION OF THE NASOLACRIMAL DUCT SYNDROME	0.00531915	0.1804200728375895
COXOAURICULAR SYNDROME	0.00531915	0.1804200728375895
MICROTIA-ANOTIA	0.00531915	0.1804200728375895
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00531915	0.1804200728375895
OCULOAURICULOFRONTONASAL SYNDROME	0.00531915	0.1804200728375895
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.00531915	0.1804200728375895
DISTAL MONOSOMY 17Q	0.00531915	0.1804200728375895
MEIER-GORLIN SYNDROME 2; MGORS2	0.00531915	0.1804200728375895
HAND-FOOT-GENITAL SYNDROME	0.00531915	0.1804200728375895
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00531915	0.1804200728375895
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00531915	0.1804200728375895
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00531915	0.1804200728375895
OTOMANDIBULAR SYNDROME	0.00531915	0.1804200728375895
PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA	0.00531915	0.1804200728375895
ISOLATED ARRHINIA	0.00531915	0.1804200728375895
ISOTRETINOIN SYNDROME	0.00531915	0.1804200728375895
DIAMOND-BLACKFAN ANEMIA 10	0.00531915	0.1804200728375895
GOLDENHAR SYNDROME	0.00531915	0.1804200728375895
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00531915	0.1804200728375895
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.005244963	0.1779037264394616
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.005218454	0.17700456854565302
ACHALASIA-MICROCEPHALY SYNDROME	0.005215549999999999	0.17690606786574734
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.005215549999999999	0.17690606786574734
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.005214319	0.17686431361748153
NODULAR NEURONAL HETEROTOPIA	0.005214319	0.17686431361748153
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.005214319	0.17686431361748153
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.005214319	0.17686431361748153
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.005214319	0.17686431361748153
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.005214319	0.17686431361748153
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.005214319	0.17686431361748153
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.005214319	0.17686431361748153
AUTISM	0.005214319	0.17686431361748153
BANGSTAD SYNDROME	0.005214319	0.17686431361748153
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.005214319	0.17686431361748153
CEREBROTENDINOUS XANTHOMATOSIS	0.005214319	0.17686431361748153
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.005214319	0.17686431361748153
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.005214319	0.17686431361748153
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.005214319	0.17686431361748153
ANGELMAN SYNDROME (TYPE 2)	0.005214319	0.17686431361748153
XERODERMA PIGMENTOSUM	0.005214319	0.17686431361748153
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.005214319	0.17686431361748153
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.005214319	0.17686431361748153
SYMMETRICAL THALAMIC CALCIFICATIONS	0.005214319	0.17686431361748153
MENTAL RETARDATION, X-LINKED 82	0.005214319	0.17686431361748153
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.005214319	0.17686431361748153
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.005214319	0.17686431361748153
KRABBE DISEASE	0.005214319	0.17686431361748153
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.005214319	0.17686431361748153
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.005214319	0.17686431361748153
EPILEPSY, READING	0.005214319	0.17686431361748153
EPILEPSY, BENIGN OCCIPITAL	0.005214319	0.17686431361748153
PHAKOMATOSIS PIGMENTOVASCULARIS	0.005214319	0.17686431361748153
LINEAR NEVUS SEBACEUS SYNDROME	0.005214319	0.17686431361748153
ANGELMAN SYNDROME (TYPE 1)	0.005214319	0.17686431361748153
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.005214319	0.17686431361748153
PRIMARY CUTIS VERTICIS GYRATA	0.005214319	0.17686431361748153
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00520833	0.1766611729246595
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00520833	0.1766611729246595
RUIJS-AALFS SYNDROME; RJALS	0.00520833	0.1766611729246595
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00520833	0.1766611729246595
FRYNS-SMEETS-THIRY SYNDROME	0.00520833	0.1766611729246595
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00520833	0.1766611729246595
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00520833	0.1766611729246595
SPINOCEREBELLAR ATAXIA TYPE 20	0.00512821	0.1739435852958565
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 28	0.00512821	0.1739435852958565
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 14	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 23	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 18	0.00512821	0.1739435852958565
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00512821	0.1739435852958565
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 25	0.00512821	0.1739435852958565
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 2	0.00512821	0.1739435852958565
MULTIPLE SYSTEM ATROPHY	0.00512821	0.1739435852958565
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.00512821	0.1739435852958565
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.00512821	0.1739435852958565
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00512821	0.1739435852958565
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 41	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 31	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00512821	0.1739435852958565
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 14	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00512821	0.1739435852958565
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 15	0.00512821	0.1739435852958565
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00512821	0.1739435852958565
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 39	0.00512821	0.1739435852958565
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 26	0.00512821	0.1739435852958565
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00512821	0.1739435852958565
SUSAC SYNDROME	0.00512821	0.1739435852958565
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00512821	0.1739435852958565
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00512821	0.1739435852958565
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA TYPE 30	0.00512821	0.1739435852958565
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00512821	0.1739435852958565
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 31	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00512821	0.1739435852958565
CREUTZFELDT-JAKOB DISEASE; CJD	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00512821	0.1739435852958565
BOUCHER-NEUHAUSER SYNDROME	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00512821	0.1739435852958565
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 20	0.00512821	0.1739435852958565
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00512821	0.1739435852958565
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00512821	0.1739435852958565
ARNOLD-CHIARI MALFORMATION TYPE I	0.00512821	0.1739435852958565
MYOTONIA PERMANENS	0.0050796	0.17229478431437725
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.00505564	0.17148208586722147
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00505564	0.17148208586722147
CENTRAL CORE DISEASE	0.00505564	0.17148208586722147
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.004943539	0.16767973575768017
MUENKE SYNDROME	0.004941203	0.16760050105097918
RUVALCABA SYNDROME	0.004941203	0.16760050105097918
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00492611	0.16708856208341147
CONGENITAL PATELLA DISLOCATION	0.00492611	0.16708856208341147
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00492611	0.16708856208341147
IMMUNODEFICIENCY 9; IMD9	0.00492611	0.16708856208341147
SPINOCEREBELLAR ATAXIA TYPE 36	0.00492611	0.16708856208341147
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q	0.00492611	0.16708856208341147
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.00492611	0.16708856208341147
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00492611	0.16708856208341147
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.00492611	0.16708856208341147
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00492611	0.16708856208341147
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.00492611	0.16708856208341147
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00492611	0.16708856208341147
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00492611	0.16708856208341147
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.00492611	0.16708856208341147
POSTERIOR MENINGOCELE	0.00492611	0.16708856208341147
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.00492611	0.16708856208341147
POLYGLUCOSAN BODY MYOPATHY 2; PGBM2	0.00492611	0.16708856208341147
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.00492611	0.16708856208341147
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.00492611	0.16708856208341147
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00492611	0.16708856208341147
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.00492611	0.16708856208341147
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.00492611	0.16708856208341147
WILSON DISEASE	0.00492611	0.16708856208341147
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00492611	0.16708856208341147
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00492611	0.16708856208341147
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.00492611	0.16708856208341147
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.00492611	0.16708856208341147
PRIMARY DYSTONIA, DYT2 TYPE	0.00492611	0.16708856208341147
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00492611	0.16708856208341147
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00492611	0.16708856208341147
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00492611	0.16708856208341147
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.00492611	0.16708856208341147
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00492611	0.16708856208341147
ADULT-ONSET NEMALINE MYOPATHY	0.00492611	0.16708856208341147
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.00492611	0.16708856208341147
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9	0.00492611	0.16708856208341147
DIAPHANOSPONDYLODYSOSTOSIS	0.004879573999999999	0.16551010903930288
ROTHMUND-THOMSON SYNDROME	0.004879573999999999	0.16551010903930288
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.004879573999999999	0.16551010903930288
MARDEN-WALKER SYNDROME	0.004875439	0.1653698541111314
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.004875438999999999	0.16536985411113136
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.004863134	0.16495248122330786
SPINOCEREBELLAR ATAXIA 47; SCA47	0.004858999	0.16481222629513637
COG5-CDG	0.004858999	0.16481222629513637
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.004856663000000001	0.1647329915884354
HELSMOORTEL-VAN DER AA SYNDROME	0.004856663000000001	0.1647329915884354
ZTTK SYNDROME; ZTTKS	0.004856663000000001	0.1647329915884354
3Q29 MICRODUPLICATION SYNDROME	0.004856663000000001	0.1647329915884354
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.004819054	0.16345733316192945
PERMANENT CONGENITAL HYPOTHYROIDISM	0.004819054	0.16345733316192945
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.004819054	0.16345733316192945
PRIMARY CONGENITAL HYPOTHYROIDISM	0.004819054	0.16345733316192945
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.004819054	0.16345733316192945
CONGENITAL HYPOTHYROIDISM	0.004819054	0.16345733316192945
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.004819054	0.16345733316192945
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.004819054	0.16345733316192945
FAMILIAL THYROID DYSHORMONOGENESIS	0.004819054	0.16345733316192945
THYROID ECTOPIA	0.004819054	0.16345733316192945
PERIPHERAL HYPOTHYROIDISM	0.004819054	0.16345733316192945
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.004819054	0.16345733316192945
THYROID HEMIAGENESIS	0.004819054	0.16345733316192945
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004814918999999999	0.16331707823375793
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.004814918999999999	0.16331707823375793
MUCOPOLYSACCHARIDOSIS TYPE 3	0.004814918999999999	0.16331707823375793
MUCOPOLYSACCHARIDOSIS, TYPE II	0.004814918999999999	0.16331707823375793
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.004814918999999999	0.16331707823375793
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00475188	0.16117886047873906
LETHAL KNIEST-LIKE DYSPLASIA	0.00475188	0.16117886047873906
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00475188	0.16117886047873906
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00475188	0.16117886047873906
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00475188	0.16117886047873906
ATELOSTEOGENESIS, TYPE I; AO1	0.00475188	0.16117886047873906
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00475188	0.16117886047873906
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00475188	0.16117886047873906
ATELOSTEOGENESIS TYPE I	0.00475188	0.16117886047873906
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00475188	0.16117886047873906
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00475188	0.16117886047873906
MULTIPLE SYNOSTOSES SYNDROME 2	0.00475188	0.16117886047873906
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.004699409	0.15939909836602156
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.004699409	0.15939909836602156
CONGENITAL HYDROCEPHALUS	0.004699409	0.15939909836602156
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004699409	0.15939909836602156
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.004682933	0.15884024946721784
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004682933	0.15884024946721784
C SYNDROME	0.004682933	0.15884024946721784
OCULOECTODERMAL SYNDROME; OES	0.004682933	0.15884024946721784
SIALURIA	0.004682933	0.15884024946721784
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.004682933	0.15884024946721784
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.004682933	0.15884024946721784
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.004682933	0.15884024946721784
COFFIN-SIRIS SYNDROME	0.004682933	0.15884024946721784
ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKEPHENOMENON	0.0046729	0.15849994047221305
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.0046729	0.15849994047221305
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0046729	0.15849994047221305
ELECTROENCEPHALOGRAPHIC PATTERNS	0.0046729	0.15849994047221305
SCHIZOPHRENIA	0.0046729	0.15849994047221305
BONNEMANN-MEINECKE-REICH SYNDROME	0.0046729	0.15849994047221305
ARGININOSUCCINIC ACIDURIA	0.0046729	0.15849994047221305
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0046729	0.15849994047221305
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.0046729	0.15849994047221305
ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES	0.0046729	0.15849994047221305
SACCHAROPINURIA	0.0046729	0.15849994047221305
ISAAC SYNDROME	0.0046729	0.15849994047221305
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.0046729	0.15849994047221305
ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS	0.0046729	0.15849994047221305
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004671203	0.15844237998536734
11P15.4 MICRODUPLICATION SYNDROME	0.004671203	0.15844237998536734
KBG SYNDROME	0.004671203	0.15844237998536734
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.004671203	0.15844237998536734
SSR4-CDG	0.004671203	0.15844237998536734
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.004671203	0.15844237998536734
MENTAL RETARDATION, X-LINKED 101; MRX101	0.004671203	0.15844237998536734
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.004671203	0.15844237998536734
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.004671203	0.15844237998536734
EMANUEL SYNDROME	0.004671203	0.15844237998536734
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.004671203	0.15844237998536734
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.004671203	0.15844237998536734
EMANUEL SYNDROME	0.004671203	0.15844237998536734
HOLOPROSENCEPHALY 7	0.004671203	0.15844237998536734
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.004671203	0.15844237998536734
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.004671203	0.15844237998536734
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004671203	0.15844237998536734
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.004671203	0.15844237998536734
MACDERMOT-WINTER SYNDROME	0.004671203	0.15844237998536734
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.004671203	0.15844237998536734
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00466734	0.15831135101619528
FLOATING-HARBOR SYNDROME	0.004559374	0.15464925583482544
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004555239	0.15450900090665395
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.004535253	0.15383109643399726
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.004535253	0.15383109643399726
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.004535253	0.15383109643399726
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004535253	0.15383109643399726
16P13.2 MICRODELETION SYNDROME	0.004535253	0.15383109643399726
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.004535253	0.15383109643399726
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0045352529999999995	0.15383109643399723
NIEMANN-PICK DISEASE TYPE C	0.0045352529999999995	0.15383109643399723
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0045352529999999995	0.15383109643399723
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0045352529999999995	0.15383109643399723
FOIX-CHAVANY-MARIE SYNDROME	0.0045352529999999995	0.15383109643399723
L1 SYNDROME	0.0045352529999999995	0.15383109643399723
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.004529814	0.1536466111729755
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.004523343	0.15342712153810303
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.004523343	0.15342712153810303
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.004523343	0.15342712153810303
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.004523343	0.15342712153810303
15Q11Q13 MICRODUPLICATION SYNDROME	0.004523342999999999	0.15342712153810298
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.004523342999999999	0.15342712153810298
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00450775	0.15289822308708048
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00440212	0.14931536261241166
LARON SYNDROME	0.00440212	0.14931536261241166
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00440212	0.14931536261241166
ODONTOCHONDRODYSPLASIA; ODCD	0.00440212	0.14931536261241166
OCCIPITAL HORN SYNDROME	0.004399784	0.1492361279057107
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.004395649	0.14909587297753918
THANATOPHORIC DYSPLASIA	0.004395649	0.14909587297753918
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.004395649	0.14909587297753918
HYPERTELORISM AND TETRALOGY OF FALLOT	0.004334019999999999	0.14700548096586288
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.004334019999999999	0.14700548096586288
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.004334019999999999	0.14700548096586288
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.004334019999999999	0.14700548096586288
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00431758	0.14644785314986788
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00431758	0.14644785314986788
HEREDITARY OROTIC ACIDURIA	0.004315244	0.1463686184431669
311450 PALLISTER W SYNDROME;;W SYNDROME	0.0043111090000000005	0.1462283635149954
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0042734999999999995	0.14495270508848945
COOPER-JABS SYNDROME	0.0042734999999999995	0.14495270508848945
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.0042734999999999995	0.14495270508848945
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0042734999999999995	0.14495270508848945
ACHONDROGENESIS TYPE 2	0.0042734999999999995	0.14495270508848945
AUTOSOMAL DOMINANT CUTIS LAXA	0.0042734999999999995	0.14495270508848945
GAPO SYNDROME	0.0042734999999999995	0.14495270508848945
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.0042734999999999995	0.14495270508848945
FOCAL DERMAL HYPOPLASIA	0.0042734999999999995	0.14495270508848945
ACHONDROGENESIS TYPE 1A	0.0042734999999999995	0.14495270508848945
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0042734999999999995	0.14495270508848945
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0042734999999999995	0.14495270508848945
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.0042734999999999995	0.14495270508848945
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0042734999999999995	0.14495270508848945
MUSCULAR HYPERTONIA, LETHAL	0.0042734999999999995	0.14495270508848945
FLOATING-HARBOR SYNDROME	0.0042734999999999995	0.14495270508848945
ACHONDROGENESIS	0.0042734999999999995	0.14495270508848945
X-LINKED EHLERS-DANLOS SYNDROME	0.0042734999999999995	0.14495270508848945
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0042734999999999995	0.14495270508848945
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.0042734999999999995	0.14495270508848945
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.0042734999999999995	0.14495270508848945
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0042734999999999995	0.14495270508848945
FETAL MINOXIDIL SYNDROME	0.0042734999999999995	0.14495270508848945
HURLER-SCHEIE SYNDROME	0.0042734999999999995	0.14495270508848945
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0042734999999999995	0.14495270508848945
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0042734999999999995	0.14495270508848945
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0042734999999999995	0.14495270508848945
BLADDER EXSTROPHY	0.0042734999999999995	0.14495270508848945
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.0042734999999999995	0.14495270508848945
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.0042734999999999995	0.14495270508848945
CENTRAL CONGENITAL HYPOTHYROIDISM	0.0042734999999999995	0.14495270508848945
HUNTER-MACDONALD SYNDROME	0.0042734999999999995	0.14495270508848945
OROFACIODIGITAL SYNDROME VI	0.004226054	0.14334338578449313
TETRASOMY X	0.004226054	0.14334338578449313
PHENOBARBITAL EMBRYOPATHY	0.004226054	0.14334338578449313
BARATELA-SCOTT SYNDROME	0.004226054	0.14334338578449313
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004221918999999999	0.14320313085632158
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00415799	0.1410347252207531
SOTOS SYNDROME 2	0.00415799	0.1410347252207531
JUVENILE POLYPOSIS OF INFANCY	0.00415799	0.1410347252207531
LIG4 SYNDROME	0.004141514	0.1404758763219493
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.004141514	0.1404758763219493
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004141514	0.1404758763219493
8Q12 MICRODUPLICATION SYNDROME	0.004141514	0.1404758763219493
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.004141514	0.1404758763219493
OCULOSKELETODENTAL SYNDROME; OCSKD	0.004141514	0.1404758763219493
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.004137379	0.1403356213937778
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.004137379	0.1403356213937778
ARTERIAL TORTUOSITY SYNDROME	0.004129784	0.14007800684009886
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.004129784	0.14007800684009886
OPTIC ATROPHY 11; OPA11	0.004129784	0.14007800684009886
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.004129784	0.14007800684009886
HOLOPROSENCEPHALY 5; HPE5	0.004129784	0.14007800684009886
MENTAL RETARDATION, X-LINKED 107; MRX107	0.004129784	0.14007800684009886
HYPOTONIA-CYSTINURIA SYNDROME	0.004129784	0.14007800684009886
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.004125649	0.13993775191192737
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004125649	0.13993775191192737
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.004125649	0.13993775191192737
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.004125649	0.13993775191192737
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.004125649	0.13993775191192737
WARBURG MICRO SYNDROME 3; WARBM3	0.004125649	0.13993775191192737
FRAGILE X MENTAL RETARDATION SYNDROME	0.004125649	0.13993775191192737
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.0040138199999999995	0.13614462776138544
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0040138199999999995	0.13614462776138544
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0040138199999999995	0.13614462776138544
CARPENTER-WAZIRI SYNDROME	0.0040138199999999995	0.13614462776138544
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0040138199999999995	0.13614462776138544
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0040138199999999995	0.13614462776138544
SHORT SYNDROME	0.0040138199999999995	0.13614462776138544
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0040138199999999995	0.13614462776138544
LÉRI-WEILL DYSCHONDROSTEOSIS	0.0040138199999999995	0.13614462776138544
OCULOMAXILLOFACIAL DYSOSTOSIS	0.0040138199999999995	0.13614462776138544
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0040138199999999995	0.13614462776138544
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003993834	0.13546672328872875
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.003993834	0.13546672328872875
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.13546672328872875
HYPERMANGANESEMIA WITH DYSTONIA 2	0.003993834	0.13546672328872875
HYDROCEPHALUS, NORMAL-PRESSURE	0.003993834	0.13546672328872875
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.003993834	0.13546672328872875
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.003993834	0.13546672328872875
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003993834	0.13546672328872875
RIDDLE SYNDROME	0.003993834	0.13546672328872875
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.13546672328872875
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003993834	0.13546672328872875
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003993834	0.13546672328872875
BEHÇET DISEASE	0.003989699	0.13532646836055726
KALLMANN SYNDROME	0.003989699	0.13532646836055726
ALZHEIMER DISEASE 3; AD	0.003989699	0.13532646836055726
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.003989699	0.13532646836055726
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.003989699	0.13532646836055726
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.003989699	0.13532646836055726
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.003989699	0.13532646836055726
SUBEPENDYMOMA	0.003989699	0.13532646836055726
EPENDYMOMA	0.003989699	0.13532646836055726
ATAXIA-TELANGIECTASIA	0.003989699	0.13532646836055726
KUFOR-RAKEB SYNDROME	0.003989699	0.13532646836055726
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.003989699	0.13532646836055726
SPONTANEOUS PERIODIC HYPOTHERMIA	0.003989699	0.13532646836055726
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.003989699	0.13532646836055726
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.003989699	0.13532646836055726
CENTRONUCLEAR MYOPATHY	0.003989699	0.13532646836055726
X-LINKED CENTRONUCLEAR MYOPATHY	0.003989699	0.13532646836055726
DYSEQUILIBRIUM SYNDROME	0.003989699	0.13532646836055726
TENORIO SYNDROME; TNORS	0.003989699	0.13532646836055726
METACHROMATIC LEUKODYSTROPHY	0.003989699	0.13532646836055726
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.003989699	0.13532646836055726
CHOREOATHETOSIS, FAMILIAL INVERTED	0.003989699	0.13532646836055726
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.003989699	0.13532646836055726
FAMILIAL COLORECTAL CANCER TYPE X	0.003989699	0.13532646836055726
LYNCH SYNDROME	0.003989699	0.13532646836055726
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00398426	0.1351419830995355
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00398426	0.1351419830995355
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0039819239999999995	0.13506274839283453
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0039819239999999995	0.13506274839283453
CUTIS LAXA	0.0039819239999999995	0.13506274839283453
NOONAN SYNDROME 5; NS5	0.0039819239999999995	0.13506274839283453
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0039819239999999995	0.13506274839283453
NOONAN SYNDROME 3; NS3	0.0039819239999999995	0.13506274839283453
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00385423	0.1307314998322707
FIBROCHONDROGENESIS	0.00385423	0.1307314998322707
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00385423	0.1307314998322707
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00385423	0.1307314998322707
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.003789673	0.1285417930854829
1Q21.1 MICRODUPLICATION SYNDROME	0.003789673	0.1285417930854829
DISTAL MONOSOMY 15Q	0.003789673	0.1285417930854829
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.003789673	0.1285417930854829
ACROMELIC FRONTONASAL DYSPLASIA	0.003789673	0.1285417930854829
HYPERTELORISM, TEEBI TYPE; TBHS	0.00376969	0.1278639903697269
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00376969	0.1278639903697269
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00376969	0.1278639903697269
OTOPALATODIGITAL SYNDROME TYPE 1	0.00376969	0.1278639903697269
RING CHROMOSOME 1 SYNDROME	0.00376969	0.1278639903697269
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00376969	0.1278639903697269
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.00376969	0.1278639903697269
FRONTOMETAPHYSEAL DYSPLASIA	0.00376969	0.1278639903697269
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00376969	0.1278639903697269
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0036804999999999997	0.12483875771105311
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.0036804999999999997	0.12483875771105311
OROFACIODIGITAL SYNDROME IV; OFD4	0.0036804999999999997	0.12483875771105311
JACOBSEN SYNDROME	0.0036804999999999997	0.12483875771105311
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0036804999999999997	0.12483875771105311
SILLENCE SYNDROME	0.0036804999999999997	0.12483875771105311
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0036804999999999997	0.12483875771105311
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0036804999999999997	0.12483875771105311
CRANIOECTODERMAL DYSPLASIA	0.0036804999999999997	0.12483875771105311
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.0036804999999999997	0.12483875771105311
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0036804999999999997	0.12483875771105311
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0036804999999999997	0.12483875771105311
SUMMITT SYNDROME	0.0036804999999999997	0.12483875771105311
FRONTORHINY	0.0036804999999999997	0.12483875771105311
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.0036804999999999997	0.12483875771105311
VELO-FACIAL-SKELETAL SYNDROME	0.00359596	0.12197124824850933
3Q13 MICRODELETION SYNDROME	0.00359596	0.12197124824850933
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00359596	0.12197124824850933
FEINGOLD SYNDROME 1; FGLDS1	0.00359596	0.12197124824850933
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00359596	0.12197124824850933
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00359596	0.12197124824850933
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00359596	0.12197124824850933
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00358423	0.12157337876665886
ATKIN-FLAITZ SYNDROME	0.00358423	0.12157337876665886
SAY SYNDROME	0.00358423	0.12157337876665886
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00358423	0.12157337876665886
WARBURG MICRO SYNDROME 1	0.00358423	0.12157337876665886
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.00358423	0.12157337876665886
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00358423	0.12157337876665886
DERMATOLEUKODYSTROPHY	0.00358423	0.12157337876665886
LAMBOTTE SYNDROME	0.00358423	0.12157337876665886
THAKKER-DONNAI SYNDROME	0.00358423	0.12157337876665886
NIJMEGEN BREAKAGE SYNDROME	0.00358423	0.12157337876665886
HOLZGREVE SYNDROME	0.00358423	0.12157337876665886
NAKAJO-NISHIMURA SYNDROME	0.00358423	0.12157337876665886
601095 HARROD SYNDROME	0.00358423	0.12157337876665886
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.00358423	0.12157337876665886
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00358423	0.12157337876665886
NEU-LAXOVA SYNDROME	0.00358423	0.12157337876665886
SOMATOMAMMOTROPINOMA	0.00358423	0.12157337876665886
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.00358423	0.12157337876665886
ALAGILLE SYNDROME 1; ALGS1	0.00358423	0.12157337876665886
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00358423	0.12157337876665886
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00358423	0.12157337876665886
ACROMEGALY	0.00358423	0.12157337876665886
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00344828	0.11696209521528877
PSEUDOACHONDROPLASIA	0.00344828	0.11696209521528877
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00344828	0.11696209521528877
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.11696209521528877
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.11696209521528877
CLASSIC GALACTOSEMIA	0.00344828	0.11696209521528877
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00344828	0.11696209521528877
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.11696209521528877
POLYMYOSITIS	0.00344828	0.11696209521528877
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.11696209521528877
OSTEOCHONDRITIS DISSECANS	0.00344828	0.11696209521528877
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00344828	0.11696209521528877
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.11696209521528877
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.11696209521528877
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.11696209521528877
DYSTONIA 23; DYT23	0.00344828	0.11696209521528877
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.11696209521528877
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.11696209521528877
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00344828	0.11696209521528877
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.11696209521528877
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.11696209521528877
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00344828	0.11696209521528877
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.11696209521528877
VON HIPPEL-LINDAU DISEASE	0.00344828	0.11696209521528877
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.11696209521528877
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00344828	0.11696209521528877
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.11696209521528877
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.11696209521528877
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00344828	0.11696209521528877
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.11696209521528877
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.11696209521528877
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.11696209521528877
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.11696209521528877
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.11696209521528877
BENIGN HEREDITARY CHOREA	0.00344828	0.11696209521528877
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00344828	0.11696209521528877
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00344828	0.11696209521528877
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.11696209521528877
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00344828	0.11696209521528877
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.11696209521528877
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00344828	0.11696209521528877
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.11696209521528877
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.11696209521528877
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.11696209521528877
NEUROFIBROMATOSIS TYPE 2	0.00344828	0.11696209521528877
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.11696209521528877
ATAXIA WITH VITAMIN E DEFICIENCY	0.00344828	0.11696209521528877
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.11696209521528877
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.11696209521528877
THORACOMELIC DYSPLASIA	0.00344828	0.11696209521528877
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00344828	0.11696209521528877
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.11696209521528877
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00344828	0.11696209521528877
CYSTINOSIS	0.00344828	0.11696209521528877
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00344828	0.11696209521528877
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00344828	0.11696209521528877
HUNTINGTON DISEASE-LIKE 2	0.00344828	0.11696209521528877
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.11696209521528877
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.11696209521528877
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.11696209521528877
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.11696209521528877
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00344828	0.11696209521528877
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.11696209521528877
SPINOCEREBELLAR ATAXIA TYPE 34	0.00344828	0.11696209521528877
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00344828	0.11696209521528877
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.11696209521528877
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.11696209521528877
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00344828	0.11696209521528877
KENNEDY DISEASE	0.00344828	0.11696209521528877
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00344828	0.11696209521528877
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00344828	0.11696209521528877
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.11696209521528877
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.11696209521528877
X-LINKED ADRENOLEUKODYSTROPHY	0.00344828	0.11696209521528877
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.11696209521528877
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.11696209521528877
NONAKA MYOPATHY	0.00344828	0.11696209521528877
NEMALINE MYOPATHY 6	0.00344828	0.11696209521528877
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.11696209521528877
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00344828	0.11696209521528877
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.11696209521528877
MANGANESE POISONING	0.00344828	0.11696209521528877
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.11696209521528877
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.11696209521528877
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.11696209521528877
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.11696209521528877
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.11696209521528877
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.11696209521528877
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.11696209521528877
MASA SYNDROME	0.00344828	0.11696209521528877
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.11696209521528877
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00344828	0.11696209521528877
ROUSSY-LÉVY SYNDROME	0.00344828	0.11696209521528877
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.11696209521528877
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.11696209521528877
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.11696209521528877
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.11696209521528877
SPONASTRIME DYSPLASIA	0.00344828	0.11696209521528877
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.11696209521528877
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.11696209521528877
MYOTONIA FLUCTUANS	0.00344828	0.11696209521528877
RICHARDS-RUNDLE SYNDROME	0.00344828	0.11696209521528877
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00344828	0.11696209521528877
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.003439913	0.11667829521915553
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.003439913	0.11667829521915553
PRADER-WILLI SYNDROME; PWS	0.003439913	0.11667829521915553
VICI SYNDROME; VICIS	0.003439913	0.11667829521915553
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.003439913	0.11667829521915553
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.003439913	0.11667829521915553
KETOADIPICACIDURIA	0.0034399129999999997	0.11667829521915551
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.0034399129999999997	0.11667829521915551
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0034399129999999997	0.11667829521915551
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0034363700000000002	0.11655812031939455
NOONAN SYNDROME 8; NS8	0.0034363700000000002	0.11655812031939455
DIAMOND-BLACKFAN ANEMIA 1	0.0034363700000000002	0.11655812031939455
8Q21.11 MICRODELETION SYNDROME	0.0034363700000000002	0.11655812031939455
GMS SYNDROME	0.0034363700000000002	0.11655812031939455
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.0034363700000000002	0.11655812031939455
LEGIUS SYNDROME	0.0034363700000000002	0.11655812031939455
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0034363700000000002	0.11655812031939455
ACRORENAL-MANDIBULAR SYNDROME	0.0034363700000000002	0.11655812031939455
NOONAN SYNDROME 4; NS4	0.0034363700000000002	0.11655812031939455
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.003248254	0.11017741994021442
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.003248254	0.11017741994021442
RAHMAN SYNDROME	0.003248254	0.11017741994021442
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.003248254	0.11017741994021442
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.003248254	0.11017741994021442
RICHARDS-RUNDLE SYNDROME; RRNS	0.003248254	0.11017741994021442
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.003248254	0.11017741994021442
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.003248254	0.11017741994021442
LARSEN-LIKE SYNDROME	0.003248254	0.11017741994021442
ATELOSTEOGENESIS TYPE III	0.003248254	0.11017741994021442
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.003248254	0.11017741994021442
MOSAIC TRISOMY 9	0.003248254	0.11017741994021442
ISOLATED SPINA BIFIDA	0.0032441189999999997	0.1100371650120429
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.0032441189999999997	0.1100371650120429
CYSTATHIONINURIA	0.0032441189999999997	0.1100371650120429
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0032441189999999997	0.1100371650120429
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0032441189999999997	0.1100371650120429
GRACILE BONE DYSPLASIA; GCLEB	0.003136153	0.1063750698306731
COWDEN SYNDROME	0.003136153	0.1063750698306731
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.003136153	0.1063750698306731
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.003136153	0.1063750698306731
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0030516130000000003	0.10350756036812932
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0030516130000000003	0.10350756036812932
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.003051613	0.10350756036812932
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.003051613	0.10350756036812932
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.003051613	0.10350756036812932
CHROMOSOME 1P35 DELETION SYNDROME	0.003051613	0.10350756036812932
BOHRING-OPITZ SYNDROME	0.003051613	0.10350756036812932
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.003051613	0.10350756036812932
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.003051613	0.10350756036812932
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.0028984939999999997	0.09831392207388702
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0028984939999999997	0.09831392207388702
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0028984939999999997	0.09831392207388702
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.0028984939999999997	0.09831392207388702
SPINOCEREBELLAR ATAXIA TYPE 7	0.0028984939999999997	0.09831392207388702
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.0028984939999999997	0.09831392207388702
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0028984939999999997	0.09831392207388702
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0028984939999999997	0.09831392207388702
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0028984939999999997	0.09831392207388702
BETA-KETOTHIOLASE DEFICIENCY	0.002894359	0.09817366714571553
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.002894359	0.09817366714571553
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.002894359	0.09817366714571553
EPISODIC ATAXIA, TYPE 6	0.002894359	0.09817366714571553
LISSENCEPHALY 3; LIS3	0.002894359	0.09817366714571553
CYCLIC VOMITING SYNDROME	0.002894359	0.09817366714571553
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.002894359	0.09817366714571553
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002894359	0.09817366714571553
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002894359	0.09817366714571553
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002894359	0.09817366714571553
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.002894359	0.09817366714571553
LISSENCEPHALY, X-LINKED, 1; LISX1	0.002894359	0.09817366714571553
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002894359	0.09817366714571553
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.002894359	0.09817366714571553
CAMOS SYNDROME	0.002894359	0.09817366714571553
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002894359	0.09817366714571553
47,XYY SYNDROME	0.002894359	0.09817366714571553
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.002894359	0.09817366714571553
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.002894359	0.09817366714571553
PRADER-WILLI SYNDROME	0.002894359	0.09817366714571553
CHROMOSOME 16P13.3 DELETION SYNDROME	0.002892023	0.09809443243901453
611961 STEVENSON-CAREY SYNDROME	0.002892023	0.09809443243901453
GABA-TRANSAMINASE DEFICIENCY	0.002892023	0.09809443243901453
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.002892023	0.09809443243901453
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.002892023	0.09809443243901453
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.002892023	0.09809443243901453
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.002892023	0.09809443243901453
MEVALONIC ACIDURIA	0.002892023	0.09809443243901453
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.002892023	0.09809443243901453
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002892023	0.09809443243901453
LUSCAN-LUMISH SYNDROME; LLS	0.002892023	0.09809443243901453
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002718293	0.09220169031779697
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.002718293	0.09220169031779697
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.002718293	0.09220169031779697
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002718293	0.09220169031779697
TRISOMY X	0.002718293	0.09220169031779697
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.002718293	0.09220169031779697
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.002718293	0.09220169031779697
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002718293	0.09220169031779697
19P13.12 MICRODELETION SYNDROME	0.002718293	0.09220169031779697
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0027182929999999997	0.09220169031779696
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.0027182929999999997	0.09220169031779696
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0027182929999999997	0.09220169031779696
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0027182929999999997	0.09220169031779696
XQ25 DUPLICATION SYNDROME	0.0027182929999999997	0.09220169031779696
DISTAL MONOSOMY 1Q	0.0027182929999999997	0.09220169031779696
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.0027026999999999997	0.09167279186677442
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.0027026999999999997	0.09167279186677442
BRUCK SYNDROME 2	0.0027026999999999997	0.09167279186677442
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.0027026999999999997	0.09167279186677442
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0027026999999999997	0.09167279186677442
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.0027026999999999997	0.09167279186677442
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.0027026999999999997	0.09167279186677442
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0027026999999999997	0.09167279186677442
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0027026999999999997	0.09167279186677442
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.0027026999999999997	0.09167279186677442
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0027026999999999997	0.09167279186677442
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.09167279186677442
BRUCK SYNDROME	0.0027026999999999997	0.09167279186677442
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0027026999999999997	0.09167279186677442
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.0027026999999999997	0.09167279186677442
CRANE-HEISE SYNDROME	0.0027026999999999997	0.09167279186677442
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.09167279186677442
CAUDAL REGRESSION SEQUENCE	0.0027026999999999997	0.09167279186677442
INIENCEPHALY	0.0027026999999999997	0.09167279186677442
CLOACAL EXSTROPHY	0.0027026999999999997	0.09167279186677442
ATELOSTEOGENESIS, TYPE II	0.0027026999999999997	0.09167279186677442
MECKEL SYNDROME, TYPE 6; MKS6	0.0027026999999999997	0.09167279186677442
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.0027026999999999997	0.09167279186677442
SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	0.0027026999999999997	0.09167279186677442
TIBIAL HEMIMELIA	0.0027026999999999997	0.09167279186677442
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.0027026999999999997	0.09167279186677442
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0027026999999999997	0.09167279186677442
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.0027026999999999997	0.09167279186677442
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.0027026999999999997	0.09167279186677442
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0027026999999999997	0.09167279186677442
RENAL AGENESIS	0.0027026999999999997	0.09167279186677442
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.09167279186677442
ELLIS-VAN CREVELD SYNDROME	0.0027026999999999997	0.09167279186677442
LAMBERT SYNDROME	0.0027026999999999997	0.09167279186677442
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0027026999999999997	0.09167279186677442
KYPHOMELIC DYSPLASIA	0.0027026999999999997	0.09167279186677442
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.09167279186677442
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0027026999999999997	0.09167279186677442
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0027026999999999997	0.09167279186677442
PRUNE BELLY SYNDROME	0.0027026999999999997	0.09167279186677442
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.0027026999999999997	0.09167279186677442
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.0027026999999999997	0.09167279186677442
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.0027026999999999997	0.09167279186677442
BRACHYDACTYLY TYPE A1	0.0027026999999999997	0.09167279186677442
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.0027026999999999997	0.09167279186677442
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	0.0027026999999999997	0.09167279186677442
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.0027026999999999997	0.09167279186677442
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.0027026999999999997	0.09167279186677442
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.0027026999999999997	0.09167279186677442
ULBRIGHT-HODES SYNDROME	0.0027026999999999997	0.09167279186677442
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.0027026999999999997	0.09167279186677442
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.0027026999999999997	0.09167279186677442
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0027026999999999997	0.09167279186677442
POPLITEAL PTERYGIUM SYNDROME	0.0027026999999999997	0.09167279186677442
STÜVE-WIEDEMANN SYNDROME	0.0027026999999999997	0.09167279186677442
NIEVERGELT SYNDROME	0.0027026999999999997	0.09167279186677442
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0027026999999999997	0.09167279186677442
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0027026999999999997	0.09167279186677442
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.0027026999999999997	0.09167279186677442
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0027026999999999997	0.09167279186677442
ERYTHEMA OF ACRAL REGIONS	0.0027026999999999997	0.09167279186677442
LARYNGEAL ABDUCTOR PARALYSIS	0.0027026999999999997	0.09167279186677442
NAIL-PATELLA SYNDROME	0.0027026999999999997	0.09167279186677442
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0027026999999999997	0.09167279186677442
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0027026999999999997	0.09167279186677442
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.0027026999999999997	0.09167279186677442
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0025947339999999996	0.08801069668540461
TEMTAMY SYNDROME	0.0025947339999999996	0.08801069668540461
CHOPS SYNDROME; CHOPS	0.0025947339999999996	0.08801069668540461
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.08801069668540461
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.08801069668540461
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.08801069668540461
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.08801069668540461
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0025947339999999996	0.08801069668540461
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0025947339999999996	0.08801069668540461
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0025947339999999996	0.08801069668540461
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0025947339999999996	0.08801069668540461
MARINESCO-SJÖGREN SYNDROME	0.0025947339999999996	0.08801069668540461
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0025947339999999996	0.08801069668540461
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.08801069668540461
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002590599	0.08787044175723312
THANATOPHORIC DYSPLASIA TYPE 2	0.002590599	0.08787044175723312
CRANIOSYNOSTOSIS 2	0.002590599	0.08787044175723312
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.002590599	0.08787044175723312
THANATOPHORIC DYSPLASIA TYPE 1	0.002590599	0.08787044175723312
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.002590599	0.08787044175723312
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0025101940000000003	0.08514318722286084
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.0025101940000000003	0.08514318722286084
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0025101940000000003	0.08514318722286084
STEEL SYNDROME; STLS	0.0025101940000000003	0.08514318722286084
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0025101940000000003	0.08514318722286084
ALAZAMI SYNDROME; ALAZS	0.0025101940000000003	0.08514318722286084
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0025101940000000003	0.08514318722286084
SYNDROMIC DIARRHEA	0.0025101940000000003	0.08514318722286084
PENTASOMY X	0.0025101940000000003	0.08514318722286084
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.0025101940000000003	0.08514318722286084
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0025101940000000003	0.08514318722286084
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0025101940000000003	0.08514318722286084
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0025101940000000003	0.08514318722286084
FILIPPI SYNDROME; FLPIS	0.002506059	0.08500293229468933
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002506059	0.08500293229468933
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.002506059	0.08500293229468933
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.002506059	0.08500293229468933
FAMILIAL BENIGN COPPER DEFICIENCY	0.002506059	0.08500293229468933
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002506059	0.08500293229468933
ACROCARDIOFACIAL SYNDROME	0.002506059	0.08500293229468933
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.002506059	0.08500293229468933
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00235294	0.07980929400044705
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00235294	0.07980929400044705
MENTAL RETARDATION, X-LINKED 19	0.00235294	0.07980929400044705
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00235294	0.07980929400044705
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00235294	0.07980929400044705
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00235294	0.07980929400044705
SENGERS SYNDROME	0.00235294	0.07980929400044705
TEMPLE SYNDROME	0.00235294	0.07980929400044705
USHER SYNDROME, TYPE IF	0.00235294	0.07980929400044705
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00235294	0.07980929400044705
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00235294	0.07980929400044705
BETHLEM MYOPATHY 1	0.00235294	0.07980929400044705
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00235294	0.07980929400044705
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.00235294	0.07980929400044705
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00235294	0.07980929400044705
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00235294	0.07980929400044705
260150 PALANT CLEFT PALATE SYNDROME	0.00235294	0.07980929400044705
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00235294	0.07980929400044705
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00235294	0.07980929400044705
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00235294	0.07980929400044705
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00235294	0.07980929400044705
GLYCOGEN STORAGE DISEASE IXA	0.00235294	0.07980929400044705
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00235294	0.07980929400044705
NEMALINE MYOPATHY 1; NEM1	0.00235294	0.07980929400044705
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00235294	0.07980929400044705
LESCH-NYHAN SYNDROME; LNS	0.00235294	0.07980929400044705
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00235294	0.07980929400044705
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.00235294	0.07980929400044705
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00235294	0.07980929400044705
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00235294	0.07980929400044705
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00235294	0.07980929400044705
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00235294	0.07980929400044705
BRUNNER SYNDROME; BRNRS	0.00235294	0.07980929400044705
GILLESPIE SYNDROME; GLSP	0.00235294	0.07980929400044705
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00235294	0.07980929400044705
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00235294	0.07980929400044705
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00235294	0.07980929400044705
MYOPATHY, CENTRONUCLEAR, 5	0.00235294	0.07980929400044705
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00235294	0.07980929400044705
AMISH NEMALINE MYOPATHY	0.00235294	0.07980929400044705
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00235294	0.07980929400044705
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00235294	0.07980929400044705
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00235294	0.07980929400044705
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00235294	0.07980929400044705
%614990 USHER SYNDROME, TYPE IK; USH1K	0.00235294	0.07980929400044705
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00235294	0.07980929400044705
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00235294	0.07980929400044705
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.00235294	0.07980929400044705
SALIH MYOPATHY; SALMY	0.00235294	0.07980929400044705
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00235294	0.07980929400044705
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00235294	0.07980929400044705
TEMPLE SYNDROME	0.00235294	0.07980929400044705
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00235294	0.07980929400044705
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00235294	0.07980929400044705
GLYCOGEN STORAGE DISEASE IXC	0.00235294	0.07980929400044705
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00235294	0.07980929400044705
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00235294	0.07980929400044705
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00235294	0.07980929400044705
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23	0.00235294	0.07980929400044705
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00235294	0.07980929400044705
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00235294	0.07980929400044705
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00235294	0.07980929400044705
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00235294	0.07980929400044705
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00235294	0.07980929400044705
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00235294	0.07980929400044705
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00235294	0.07980929400044705
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00235294	0.07980929400044705
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00235294	0.07980929400044705
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00235294	0.07980929400044705
SILVER-RUSSELL SYNDROME	0.00235294	0.07980929400044705
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00235294	0.07980929400044705
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00235294	0.07980929400044705
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00235294	0.07980929400044705
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00235294	0.07980929400044705
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00235294	0.07980929400044705
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00235294	0.07980929400044705
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00235294	0.07980929400044705
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00235294	0.07980929400044705
MEVALONIC ACIDURIA; MEVA	0.002350604	0.07973005929374605
NOONAN SYNDROME 9; NS9	0.002350604	0.07973005929374605
NOONAN SYNDROME 2; NS2	0.002350604	0.07973005929374605
17P13.3 MICRODUPLICATION SYNDROME	0.002350604	0.07973005929374605
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.002350604	0.07973005929374605
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.002350604	0.07973005929374605
RITSCHER-SCHINZEL SYNDROME 1	0.002350604	0.07973005929374605
NOONAN SYNDROME 11; NS11	0.002350604	0.07973005929374605
CREE MENTAL RETARDATION SYNDROME	0.002350604	0.07973005929374605
COLE-CARPENTER SYNDROME	0.002350604	0.07973005929374605
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002350604	0.07973005929374605
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.002350604	0.07973005929374605
CHROMOSOME 15Q25 DELETION SYNDROME	0.002350604	0.07973005929374605
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.0023464690000000003	0.07958980436557456
CLARK-BARAITSER SYNDROME	0.0023464690000000003	0.07958980436557456
AUTISM, SUSCEPTIBILITY TO, 18	0.0023464690000000003	0.07958980436557456
MALAN OVERGROWTH SYNDROME	0.0023464690000000003	0.07958980436557456
ATKIN-FLAITZ SYNDROME	0.0023464690000000003	0.07958980436557456
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.0023464690000000003	0.07958980436557456
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.0023464690000000003	0.07958980436557456
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0023464690000000003	0.07958980436557456
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0021768739999999996	0.07383731717252846
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.07383731717252846
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.07383731717252846
48,XYYY SYNDROME	0.0021768739999999996	0.07383731717252846
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.0021768739999999996	0.07383731717252846
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0021768739999999996	0.07383731717252846
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0021768739999999996	0.07383731717252846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0021768739999999996	0.07383731717252846
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021768739999999996	0.07383731717252846
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0021768739999999996	0.07383731717252846
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0021768739999999996	0.07383731717252846
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.07383731717252846
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.07383731717252846
KNOBLOCH SYNDROME	0.002172739	0.07369706224435697
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.07369706224435697
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.002172739	0.07369706224435697
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.06950606861196462
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.06950606861196462
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.06950606861196462
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.06950606861196462
BARDET-BIEDL SYNDROME 4; BBS4	0.00204918	0.06950606861196462
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00204918	0.06950606861196462
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.06950606861196462
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.06950606861196462
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00204918	0.06950606861196462
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.06950606861196462
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.06950606861196462
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.06950606861196462
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00204918	0.06950606861196462
OPSISMODYSPLASIA	0.00204918	0.06950606861196462
PYCNODYSOSTOSIS	0.00204918	0.06950606861196462
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.06950606861196462
SPONDYLOPERIPHERAL DYSPLASIA	0.00204918	0.06950606861196462
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00204918	0.06950606861196462
CHITAYAT SYNDROME	0.00204918	0.06950606861196462
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.06950606861196462
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.06950606861196462
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.06950606861196462
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00204918	0.06950606861196462
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.06950606861196462
JEUNE SYNDROME	0.00204918	0.06950606861196462
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.06950606861196462
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.06950606861196462
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.06950606861196462
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00204918	0.06950606861196462
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.06950606861196462
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00204918	0.06950606861196462
SMITH-MAGENIS SYNDROME	0.00204918	0.06950606861196462
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.06950606861196462
LARSEN SYNDROME	0.00204918	0.06950606861196462
2Q37 MONOSOMY	0.00204918	0.06950606861196462
WEILL-MARCHESANI SYNDROME	0.00204918	0.06950606861196462
SATOYOSHI SYNDROME	0.00204918	0.06950606861196462
TETRALOGY OF FALLOT	0.00204918	0.06950606861196462
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.06950606861196462
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.06950606861196462
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.06950606861196462
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.06950606861196462
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.06950606861196462
CAMPTOBRACHYDACTYLY	0.00204918	0.06950606861196462
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.06950606861196462
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00204918	0.06950606861196462
LOWRY-WOOD SYNDROME	0.00204918	0.06950606861196462
GRANGE SYNDROME; GRNG	0.00204918	0.06950606861196462
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.06950606861196462
PROXIMAL SYMPHALANGISM	0.00204918	0.06950606861196462
RHYNS SYNDROME; RHYNS	0.00204918	0.06950606861196462
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.06950606861196462
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00204918	0.06950606861196462
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.06950606861196462
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.06950606861196462
HYPOCHONDROPLASIA	0.00204918	0.06950606861196462
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.06950606861196462
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.06950606861196462
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.06950606861196462
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00204918	0.06950606861196462
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.06950606861196462
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.06950606861196462
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.06950606861196462
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00204918	0.06950606861196462
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.06950606861196462
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.06950606861196462
HAND-FOOT-GENITAL SYNDROME; HFG	0.00204918	0.06950606861196462
ROIFMAN SYNDROME	0.00204918	0.06950606861196462
FEINGOLD SYNDROME	0.00204918	0.06950606861196462
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.06950606861196462
PERIPHERAL DYSOSTOSIS	0.00204918	0.06950606861196462
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.06950606861196462
DYSOSTOSIS, STANESCU TYPE	0.00204918	0.06950606861196462
ACROMICRIC DYSPLASIA	0.00204918	0.06950606861196462
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.06950606861196462
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.00204918	0.06950606861196462
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00204918	0.06950606861196462
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.06950606861196462
CLEIDOCRANIAL DYSPLASIA	0.00204918	0.06950606861196462
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00204918	0.06950606861196462
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.06950606861196462
PYCNODYSOSTOSIS	0.00204918	0.06950606861196462
GREENBERG DYSPLASIA	0.00204918	0.06950606861196462
CAMPOMELIA, CUMMING TYPE	0.00204918	0.06950606861196462
CAMPTOBRACHYDACTYLY	0.00204918	0.06950606861196462
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.06950606861196462
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.06950606861196462
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.06950606861196462
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.06950606861196462
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00204918	0.06950606861196462
EIKEN SYNDROME	0.00204918	0.06950606861196462
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.06950606861196462
METATROPIC DYSPLASIA	0.00204918	0.06950606861196462
ENG-STROM SYNDROME	0.00204918	0.06950606861196462
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00204918	0.06950606861196462
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00204918	0.06950606861196462
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.06950606861196462
HEART-HAND SYNDROME TYPE 3	0.00204918	0.06950606861196462
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00204918	0.06950606861196462
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00204918	0.06950606861196462
HYPOCHONDROPLASIA	0.00204918	0.06950606861196462
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.06950606861196462
RADIO-RENAL SYNDROME	0.00204918	0.06950606861196462
EMERY-NELSON SYNDROME	0.00204918	0.06950606861196462
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.06950606861196462
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00204918	0.06950606861196462
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.06950606861196462
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00204918	0.06950606861196462
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.06950606861196462
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.06950606861196462
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.06950606861196462
ISOLATED BRACHYCEPHALY	0.00204918	0.06950606861196462
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00204918	0.06950606861196462
COOKS SYNDROME	0.00204918	0.06950606861196462
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.06950606861196462
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.06950606861196462
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.06950606861196462
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.06950606861196462
BANKI SYNDROME	0.00204918	0.06950606861196462
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.06950606861196462
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.06950606861196462
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.06950606861196462
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.06950606861196462
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.06950606861196462
SYNDACTYLY, TYPE V	0.00204918	0.06950606861196462
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.06950606861196462
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.06950606861196462
SYMPHALANGISM, DISTAL	0.00204918	0.06950606861196462
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.06950606861196462
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.06663855914942085
MULIBREY NANISM	0.00196464	0.06663855914942085
ISOLATED TRIGONOCEPHALY	0.00196464	0.06663855914942085
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00196464	0.06663855914942085
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.06663855914942085
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00196464	0.06663855914942085
MECKEL SYNDROME 12; MKS12	0.00196464	0.06663855914942085
RETINITIS PIGMENTOSA	0.00196464	0.06663855914942085
CRANIOMETAPHYSEAL DYSPLASIA	0.00196464	0.06663855914942085
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.06663855914942085
MARSHALL SYNDROME	0.00196464	0.06663855914942085
WAARDENBURG SYNDROME TYPE 1	0.00196464	0.06663855914942085
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.06663855914942085
FRONTONASAL DYSPLASIA	0.00196464	0.06663855914942085
MEGALENCEPHALY	0.00196464	0.06663855914942085
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.06663855914942085
DEAFNESS, X-LINKED 7; DFNX7	0.00196464	0.06663855914942085
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00196464	0.06663855914942085
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.06663855914942085
FRONTONASAL DYSPLASIA 2; FND2	0.00196464	0.06663855914942085
PIEBALDISM	0.00196464	0.06663855914942085
ZECHI-CEIDE SYNDROME	0.00196464	0.06663855914942085
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00196464	0.06663855914942085
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00196464	0.06663855914942085
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00196464	0.06663855914942085
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00196464	0.06663855914942085
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00196464	0.06663855914942085
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.06663855914942085
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00196464	0.06663855914942085
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00196464	0.06663855914942085
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.06663855914942085
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.06663855914942085
BOOMERANG DYSPLASIA	0.00196464	0.06663855914942085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.06663855914942085
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00196464	0.06663855914942085
AXENFELD-RIEGER SYNDROME	0.00196464	0.06663855914942085
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00196464	0.06663855914942085
DIAMOND-BLACKFAN ANEMIA 8	0.00196464	0.06663855914942085
JUNG SYNDROME	0.00196464	0.06663855914942085
SCLEROSTEOSIS 1; SOST1	0.00196464	0.06663855914942085
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.06663855914942085
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.06663855914942085
OROFACIODIGITAL SYNDROME XV; OFD15	0.00196464	0.06663855914942085
NON-DISTAL TRISOMY 10Q	0.00180505	0.06122543122030606
HARTSFIELD SYNDROME	0.00180505	0.06122543122030606
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00180505	0.06122543122030606
MESOMELIA-SYNOSTOSES SYNDROME	0.00180505	0.06122543122030606
RESTRICTIVE DERMOPATHY	0.00180505	0.06122543122030606
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00180505	0.06122543122030606
TRISOMY 1Q	0.00180505	0.06122543122030606
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00180505	0.06122543122030606
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00180505	0.06122543122030606
MEESTER-LOEYS SYNDROME; MRLS	0.00180505	0.06122543122030606
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00180505	0.06122543122030606
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00180505	0.06122543122030606
PROTEUS-LIKE SYNDROME	0.00180505	0.06122543122030606
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00180505	0.06122543122030606
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00180505	0.06122543122030606
JUVENILE POLYPOSIS SYNDROME	0.00180505	0.06122543122030606
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00180505	0.06122543122030606
MARFAN SYNDROME; MFS	0.00180505	0.06122543122030606
RUVALCABA SYNDROME	0.00180505	0.06122543122030606
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00180505	0.06122543122030606
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00180505	0.06122543122030606
APERT SYNDROME	0.00180505	0.06122543122030606
WAARDENBURG SYNDROME TYPE 3	0.00180505	0.06122543122030606
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00180505	0.06122543122030606
FRONTOMETAPHYSEAL DYSPLASIA	0.00180505	0.06122543122030606
2P15-16.1 MICRODELETION SYNDROME	0.00180505	0.06122543122030606
CAT-EYE SYNDROME (TYPE I)	0.00180505	0.06122543122030606
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00180505	0.06122543122030606
CAT-EYE SYNDROME	0.00180505	0.06122543122030606
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00180505	0.06122543122030606
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00180505	0.06122543122030606
THOMAS SYNDROME	0.00180505	0.06122543122030606
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.06122543122030606
NOONAN SYNDROME 10; NS10	0.00180505	0.06122543122030606
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00180505	0.06122543122030606
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00180505	0.06122543122030606
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.06122543122030606
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.06122543122030606
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00180505	0.06122543122030606
ACRO-RENAL-MANDIBULAR SYNDROME	0.00180505	0.06122543122030606
MARFAN SYNDROME	0.00180505	0.06122543122030606
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00180505	0.06122543122030606
PAI SYNDROME	0.00180505	0.06122543122030606
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.00180505	0.06122543122030606
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00180505	0.06122543122030606
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.055332689099088485
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.055332689099088485
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.055332689099088485
NASODIGITOACOUSTIC SYNDROME	0.00163132	0.055332689099088485
LICHTENSTEIN SYNDROME	0.00163132	0.055332689099088485
FETAL VALPROATE SYNDROME	0.00163132	0.055332689099088485
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00163132	0.055332689099088485
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00163132	0.055332689099088485
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.055332689099088485
SCHOLTE SYNDROME; SHLTS	0.00163132	0.055332689099088485
RENAL AGENESIS, BILATERAL	0.00163132	0.055332689099088485
MONOSOMY X	0.00163132	0.055332689099088485
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.055332689099088485
TURNER SYNDROME	0.00163132	0.055332689099088485
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.055332689099088485
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.055332689099088485
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.055332689099088485
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.055332689099088485
EPICANTHUS	0.00163132	0.055332689099088485
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.055332689099088485
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.055332689099088485
PENOSCROTAL TRANSPOSITION	0.00163132	0.055332689099088485
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.055332689099088485
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.055332689099088485
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00163132	0.055332689099088485
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00163132	0.055332689099088485
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.055332689099088485
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.055332689099088485
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00163132	0.055332689099088485
WHITE FORELOCK WITH MALFORMATIONS	0.00163132	0.055332689099088485
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.055332689099088485
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00163132	0.055332689099088485
MOSAIC MONOSOMY X	0.00163132	0.055332689099088485
JUBERG-MARSIDI SYNDROME	0.00163132	0.055332689099088485
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.055332689099088485
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.055332689099088485
BRITTLE CORNEA SYNDROME	0.00163132	0.055332689099088485
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.055332689099088485
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.055332689099088485
STICKLER SYNDROME	0.00163132	0.055332689099088485
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.055332689099088485
COFFIN-SIRIS SYNDROME 10; CSS10	0.00163132	0.055332689099088485
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.055332689099088485
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.055332689099088485
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00163132	0.055332689099088485
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.055332689099088485
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.03686900121870847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.03686900121870847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.03686900121870847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.03686900121870847
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.03686900121870847
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.03686900121870847
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.03686900121870847
CLASSIC PHENYLKETONURIA	0.001086973	0.03686900121870847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001086973	0.03686900121870847
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.03686900121870847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.03686900121870847
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.03686900121870847
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.03686900121870847
LEBER CONGENITAL AMAUROSIS	0.001086973	0.03686900121870847
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.03686900121870847
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.03686900121870847
ALSTRÖM SYNDROME	0.001086973	0.03686900121870847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.03686900121870847
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.03686900121870847
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.03686900121870847
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.03686900121870847
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.03686900121870847
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.03686900121870847
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.03686900121870847
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.03686900121870847
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.03686900121870847
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.03686900121870847
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.03686900121870847
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.03686900121870847
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.03686900121870847
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.03686900121870847
NETHERTON SYNDROME	0.001086973	0.03686900121870847
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.03686900121870847
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.03686900121870847
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.03686900121870847
ALG3-CDG	0.001086973	0.03686900121870847
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.03686900121870847
PFEIFFER SYNDROME TYPE 2	0.001086973	0.03686900121870847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.03686900121870847
ALG1-CDG	0.001086973	0.03686900121870847
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.001086973	0.03686900121870847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.03686900121870847
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.03686900121870847
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.03686900121870847
GAUCHER DISEASE, TYPE II	0.001086973	0.03686900121870847
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.03686900121870847
MAPLE SYRUP URINE DISEASE	0.001086973	0.03686900121870847
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.03686900121870847
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.03686900121870847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.03686900121870847
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.03686900121870847
2P21 MICRODELETION SYNDROME	0.001086973	0.03686900121870847
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.03686900121870847
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.001086973	0.03686900121870847
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.03686900121870847
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.03686900121870847
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.03686900121870847
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.03686900121870847
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.03686900121870847
COACH SYNDROME	0.001086973	0.03686900121870847
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.03686900121870847
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.03686900121870847
HARTNUP DISORDER	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.03686900121870847
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.03686900121870847
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.03686900121870847
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.03686900121870847
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.03686900121870847
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.03686900121870847
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.03686900121870847
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001086973	0.03686900121870847
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.03686900121870847
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.03686900121870847
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.03686900121870847
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.03686900121870847
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.03686900121870847
CRANIOPHARYNGIOMA	0.001086973	0.03686900121870847
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.03686900121870847
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.03686900121870847
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.03686900121870847
CHÉDIAK-HIGASHI SYNDROME	0.001086973	0.03686900121870847
ELEJALDE DISEASE	0.001086973	0.03686900121870847
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.03686900121870847
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001086973	0.03686900121870847
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.03686900121870847
LEIGH SYNDROME; LS	0.001086973	0.03686900121870847
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.03686900121870847
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.03686900121870847
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.03686900121870847
ARGININOSUCCINIC ACIDURIA	0.001086973	0.03686900121870847
WYBURN-MASON SYNDROME	0.001086973	0.03686900121870847
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001086973	0.03686900121870847
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.03686900121870847
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.03686900121870847
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.03686900121870847
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.03686900121870847
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.03686900121870847
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.03686900121870847
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.03686900121870847
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.03686900121870847
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.03686900121870847
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.03686900121870847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001086973	0.03686900121870847
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.03686900121870847
CITRULLINEMIA, CLASSIC	0.001086973	0.03686900121870847
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.03686900121870847
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.03686900121870847
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.03686900121870847
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.03686900121870847
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.03686900121870847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.03686900121870847
PROPIONIC ACIDEMIA	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.03686900121870847
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.03686900121870847
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.03686900121870847
AICARDI-GOUTIERES SYNDROME 7	0.001086973	0.03686900121870847
PHACE ASSOCIATION	0.001086973	0.03686900121870847
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.03686900121870847
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.03686900121870847
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.03686900121870847
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.03686900121870847
LISSENCEPHALY 1; LIS1	0.001086973	0.03686900121870847
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.03686900121870847
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.001086973	0.03686900121870847
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.03686900121870847
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001086973	0.03686900121870847
CONGENITAL TOXOPLASMOSIS	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.03686900121870847
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.03686900121870847
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.03686900121870847
DPAGT1-CDG	0.001086973	0.03686900121870847
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.03686900121870847
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.03686900121870847
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.03686900121870847
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.03686900121870847
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.03686900121870847
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.03686900121870847
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.03686900121870847
GALACTOSEMIA	0.001086973	0.03686900121870847
FUCOSIDOSIS	0.001086973	0.03686900121870847
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.03686900121870847
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.03686900121870847
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.03686900121870847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.03686900121870847
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.03686900121870847
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.03686900121870847
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.03686900121870847
HYDRANENCEPHALY	0.001086973	0.03686900121870847
TIMOTHY SYNDROME; TS	0.001086973	0.03686900121870847
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.03686900121870847
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.03686900121870847
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.03686900121870847
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.03686900121870847
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.03686900121870847
ISOVALERIC ACIDEMIA	0.001086973	0.03686900121870847
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.03686900121870847
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.03686900121870847
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.03686900121870847
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.03686900121870847
SRD5A3-CDG	0.001086973	0.03686900121870847
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.03686900121870847
SCHINDLER DISEASE, TYPE I	0.001086973	0.03686900121870847
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.03686900121870847
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.03686900121870847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.03686900121870847
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.03686900121870847
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.03686900121870847
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.03686900121870847
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.03686900121870847
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.03686900121870847
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.03686900121870847
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.03686900121870847
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.03686900121870847
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.03686900121870847
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.03686900121870847
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.03686900121870847
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.03686900121870847
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.03686900121870847
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.03686900121870847
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.03686900121870847
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.03686900121870847
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.03686900121870847
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.03686900121870847
LISSENCEPHALY 4	0.001086973	0.03686900121870847
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.03686900121870847
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.03686900121870847
17Q12 MICRODELETION SYNDROME	0.001086973	0.03686900121870847
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.03686900121870847
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.03686900121870847
XP21 MICRODELETION SYNDROME	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.03686900121870847
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.03686900121870847
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.03686900121870847
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.03686900121870847
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.03686900121870847
RFT1-CDG	0.001086973	0.03686900121870847
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.03686900121870847
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.03686900121870847
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.03686900121870847
CITRULLINEMIA TYPE II	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.03686900121870847
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.03686900121870847
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.03686900121870847
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.03686900121870847
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.03686900121870847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001086973	0.03686900121870847
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.03686900121870847
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.03686900121870847
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.03686900121870847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.03686900121870847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.03686900121870847
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.03686900121870847
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.03686900121870847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.03686900121870847
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.03686900121870847
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.03686900121870847
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.03686900121870847
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.03686900121870847
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.03686900121870847
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.03686900121870847
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.03686900121870847
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.03686900121870847
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.03686900121870847
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.03686900121870847
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.03686900121870847
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.03686900121870847
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.03686900121870847
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.03686900121870847
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.03686900121870847
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.03686900121870847
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.03686900121870847
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.03686900121870847
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.03686900121870847
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.03686900121870847
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.03686900121870847
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.03686900121870847
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.03686900121870847
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.03686900121870847
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.03686900121870847
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.03686900121870847
EAST SYNDROME	0.001086973	0.03686900121870847
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.03686900121870847
GRISCELLI SYNDROME	0.001086973	0.03686900121870847
STT3A-CDG	0.001086973	0.03686900121870847
STT3B-CDG	0.001086973	0.03686900121870847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.03686900121870847
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.03686900121870847
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.03686900121870847
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.03686900121870847
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.03686900121870847
COFFIN-SIRIS SYNDROME 5	0.001086973	0.03686900121870847
SULFOCYSTEINURIA	0.001086973	0.03686900121870847
KEUTEL SYNDROME	0.001086973	0.03686900121870847
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.03686900121870847
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.03686900121870847
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.03686900121870847
OPTIC PATHWAY GLIOMA	0.001086973	0.03686900121870847
ALG6-CDG	0.000545554	0.01850462807343999
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.01850462807343999
NAVAJO NEUROHEPATOPATHY	0.000545554	0.01850462807343999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.01850462807343999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.01850462807343999
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.01850462807343999
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.01850462807343999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.01850462807343999
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.01850462807343999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.01850462807343999
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.01850462807343999
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.01850462807343999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.01850462807343999
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.01850462807343999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.01850462807343999
CONGENITAL VARICELLA SYNDROME	0.000545554	0.01850462807343999
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.01850462807343999
JOUBERT SYNDROME 6	0.000545554	0.01850462807343999
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.01850462807343999
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.01850462807343999
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.01850462807343999
JOUBERT SYNDROME 7	0.000545554	0.01850462807343999
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.01850462807343999
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.01850462807343999
JOUBERT SYNDROME 27	0.000545554	0.01850462807343999
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.01850462807343999
JOUBERT SYNDROME 25	0.000545554	0.01850462807343999
8P23.1 DUPLICATION SYNDROME	0.000545554	0.01850462807343999
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.01850462807343999
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.01850462807343999
TYSHCHENKO SYNDROME	0.000545554	0.01850462807343999
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.01850462807343999
ATHYREOSIS	0.000545554	0.01850462807343999
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.01850462807343999
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.01850462807343999
MUCOLIPIDOSIS IV; ML4	0.000545554	0.01850462807343999
REVESZ SYNDROME	0.000545554	0.01850462807343999
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.01850462807343999
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.01850462807343999
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.01850462807343999
HOLOPROSENCEPHALY 11	0.000545554	0.01850462807343999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.01850462807343999
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.01850462807343999
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.01850462807343999
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.01850462807343999
TRANSALDOLASE DEFICIENCY	0.000545554	0.01850462807343999
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.01850462807343999
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.01850462807343999
SENIOR-LOKEN SYNDROME 9	0.000545554	0.01850462807343999
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.01850462807343999
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.01850462807343999
JOUBERT SYNDROME 28	0.000545554	0.01850462807343999
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.01850462807343999
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.01850462807343999
NETHERTON SYNDROME; NETH	0.000545554	0.01850462807343999
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.01850462807343999
DYSKERATOSIS CONGENITA	0.000545554	0.01850462807343999
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.01850462807343999
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.01850462807343999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.01850462807343999
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.01850462807343999
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.01850462807343999
JOUBERT SYNDROME 26	0.000545554	0.01850462807343999
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.01850462807343999
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.01850462807343999
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.01850462807343999
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.01850462807343999
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.01850462807343999
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.01850462807343999
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.01850462807343999
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.01850462807343999
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.01850462807343999
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.01850462807343999
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.01850462807343999
HYDROXYKYNURENINURIA	0.000545554	0.01850462807343999
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.01850462807343999
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.01850462807343999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.01850462807343999
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.01850462807343999
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.01850462807343999
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.01850462807343999
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.01850462807343999
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.01850462807343999
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.01850462807343999
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.01850462807343999
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.01850462807343999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.01850462807343999
JOUBERT SYNDROME 15	0.000545554	0.01850462807343999
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.01850462807343999
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.01850462807343999
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.01850462807343999
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.01850462807343999
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.01850462807343999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.01850462807343999
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.01850462807343999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.01850462807343999
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.01850462807343999
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.01850462807343999
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.01850462807343999
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.01850462807343999
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.01850462807343999
OROTIC ACIDURIA	0.000545554	0.01850462807343999
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.01850462807343999
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.01850462807343999
WOLMAN DISEASE	0.000545554	0.01850462807343999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.01850462807343999
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.01850462807343999
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.01850462807343999
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.01850462807343999
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.01850462807343999
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.01850462807343999
JOUBERT SYNDROME 8	0.000545554	0.01850462807343999
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.01850462807343999
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.01850462807343999
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.01850462807343999
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.01850462807343999
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.01850462807343999
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.01850462807343999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.01850462807343999
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.01850462807343999
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.01850462807343999
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.01850462807343999
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.01850462807343999
PELLAGRA-LIKE SYNDROME	0.000545554	0.01850462807343999
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.01850462807343999
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.01850462807343999
WAARDENBURG-SHAH SYNDROME	0.000545554	0.01850462807343999
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.01850462807343999
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.01850462807343999
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.01850462807343999
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.01850462807343999
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.01850462807343999
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.01850462807343999
FARBER DISEASE	0.000545554	0.01850462807343999
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.01850462807343999
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.01850462807343999
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.01850462807343999
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.01850462807343999
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.01850462807343999
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.01850462807343999
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.01850462807343999
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.01850462807343999
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.01850462807343999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.01850462807343999
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.01850462807343999
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.01850462807343999
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.01850462807343999
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.01850462807343999
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.01850462807343999
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.01850462807343999
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.01850462807343999
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.01850462807343999
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.01850462807343999
BARDET-BIEDL SYNDROME 2	0.000545554	0.01850462807343999
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.01850462807343999
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.01850462807343999
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.01850462807343999
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.01850462807343999
CDAGS SYNDROME	0.000545554	0.01850462807343999
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.01850462807343999
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.01850462807343999
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.01850462807343999
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.01850462807343999
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.01850462807343999
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.01850462807343999
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.01850462807343999
CURRY-JONES SYNDROME	0.000545554	0.01850462807343999
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.01850462807343999
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.01850462807343999
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.01850462807343999
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.01850462807343999
YUNIS-VARON SYNDROME	0.000545554	0.01850462807343999
LOWRY-MACLEAN SYNDROME	0.000545554	0.01850462807343999
PROPIONIC ACIDEMIA	0.000545554	0.01850462807343999
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.01850462807343999
ISOLATED PLAGIOCEPHALY	0.000545554	0.01850462807343999
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.01850462807343999
EPIDERMAL NEVUS SYNDROME	0.000545554	0.01850462807343999
HYDROXYKYNURENINURIA	0.000545554	0.01850462807343999
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.01850462807343999
ARIMA SYNDROME	0.000545554	0.01850462807343999
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.01850462807343999
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.01850462807343999
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.01850462807343999
MECKEL SYNDROME 13; MKS13	0.000545554	0.01850462807343999
TRANSKETOLASE DEFICIENCY	0.000545554	0.01850462807343999
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.01850462807343999
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.01850462807343999
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.01850462807343999
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.01850462807343999
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.01850462807343999
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.01850462807343999
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.01850462807343999
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.01850462807343999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.01850462807343999
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.01850462807343999
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.01850462807343999
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.01850462807343999
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.01850462807343999
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.01850462807343999
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.01850462807343999
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.01850462807343999
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.01850462807343999
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.01850462807343999
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.01850462807343999
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.01850462807343999
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.01850462807343999
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.01850462807343999
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.01850462807343999
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.01850462807343999
SENIOR-LOKEN SYNDROME	0.000545554	0.01850462807343999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.01850462807343999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.01850462807343999
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.01850462807343999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.01850462807343999
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.01850462807343999
SECKEL SYNDROME 8; SCKL8	0.000545554	0.01850462807343999
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.01850462807343999
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.01850462807343999
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.01850462807343999
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.01850462807343999
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.01850462807343999
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.01850462807343999
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.01850462807343999
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.01850462807343999
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.01850462807343999
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.01850462807343999
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.01850462807343999
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.01850462807343999
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.01850462807343999
SEPTOOPTIC DYSPLASIA	0.000545554	0.01850462807343999
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.01850462807343999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.01850462807343999
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.01850462807343999
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.01850462807343999
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.01850462807343999
JOUBERT SYNDROME 21	0.000545554	0.01850462807343999
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.01850462807343999
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.01850462807343999
USHER SYNDROME TYPE 1	0.000545554	0.01850462807343999
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.01850462807343999
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.01850462807343999
AUSTRALIA ANTIGEN	0.000545554	0.01850462807343999
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.01850462807343999
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.01850462807343999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.01850462807343999
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.01850462807343999
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.01850462807343999
CURRARINO SYNDROME	0.000545554	0.01850462807343999
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.01850462807343999
THYROID HYPOPLASIA	0.000545554	0.01850462807343999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.01850462807343999
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.01850462807343999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.01850462807343999
CULLER-JONES SYNDROME; CJS	0.000545554	0.01850462807343999
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.01850462807343999
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.01850462807343999
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.01850462807343999
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.01850462807343999
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.01850462807343999
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.01850462807343999
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.01850462807343999
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.01850462807343999
LIG4 SYNDROME	0.000545554	0.01850462807343999
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.01850462807343999
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.01850462807343999
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.01850462807343999
MICROVILLUS INCLUSION DISEASE	0.000545554	0.01850462807343999
ALSTROM SYNDROME; ALMS	0.000545554	0.01850462807343999
SJÖGREN-LARSSON SYNDROME	0.000541419	0.018364373145268488
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.018364373145268488
ADDISON DISEASE	0.000541419	0.018364373145268488
FETAL GAUCHER DISEASE	0.000541419	0.018364373145268488
INSULINOMA	0.000541419	0.018364373145268488
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.018364373145268488
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.018364373145268488
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.018364373145268488
HADDAD SYNDROME	0.000541419	0.018364373145268488
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.018364373145268488
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.018364373145268488
PFEIFFER SYNDROME TYPE 3	0.000541419	0.018364373145268488
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.018364373145268488
LASSA FEVER	0.000541419	0.018364373145268488
NIPAH VIRUS DISEASE	0.000541419	0.018364373145268488
ENCEPHALITIS LETHARGICA	0.000541419	0.018364373145268488
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.018364373145268488
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.018364373145268488
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.018364373145268488
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.018364373145268488
TRIPLE A SYNDROME	0.000541419	0.018364373145268488
SYSTEMIC SCLEROSIS	0.000541419	0.018364373145268488
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.018364373145268488
SCRUB TYPHUS	0.000541419	0.018364373145268488
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.018364373145268488
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.018364373145268488
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.018364373145268488
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.018364373145268488
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.018364373145268488
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.018364373145268488
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.018364373145268488
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.018364373145268488
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.018364373145268488
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.018364373145268488
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.018364373145268488
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.018364373145268488
GURRIERI SYNDROME	0.000541419	0.018364373145268488
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.018364373145268488
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.018364373145268488
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.018364373145268488
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.018364373145268488
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.018364373145268488
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.018364373145268488
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.018364373145268488
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.018364373145268488
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.018364373145268488
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.018364373145268488
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.018364373145268488
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.018364373145268488
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.018364373145268488
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.018364373145268488
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.018364373145268488
THREONINEMIA	0.000541419	0.018364373145268488
THYROCEREBRORETINAL SYNDROME	0.000541419	0.018364373145268488
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.018364373145268488
ADRENOLEUKODYSTROPHY	0.000541419	0.018364373145268488
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.018364373145268488
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.018364373145268488
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.018364373145268488
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.018364373145268488
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.018364373145268488
INCONTINENTIA PIGMENTI; IP	0.000541419	0.018364373145268488
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.018364373145268488
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.018364373145268488
IMMUNODEFICIENCY 47	0.000541419	0.018364373145268488
FABRY DISEASE	0.000541419	0.018364373145268488
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.018364373145268488
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.018364373145268488
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.018364373145268488
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.018364373145268488
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.018364373145268488
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.018364373145268488
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.018364373145268488
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.018364373145268488
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.018364373145268488
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.018364373145268488
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.018364373145268488
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.018364373145268488
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.018364373145268488
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.018364373145268488
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.018364373145268488
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.018364373145268488
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.018364373145268488
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.018364373145268488
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.018364373145268488
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.018364373145268488
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.018364373145268488
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.018364373145268488
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.018364373145268488
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.018364373145268488
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.018364373145268488
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.018364373145268488
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.000541419	0.018364373145268488
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.018364373145268488
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.018364373145268488
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.018364373145268488
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.018364373145268488
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.018364373145268488
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.018364373145268488
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.018364373145268488
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.018364373145268488
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.018364373145268488
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.018364373145268488
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.018364373145268488
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.018364373145268488
COWDEN SYNDROME 6; CWS6	0.000541419	0.018364373145268488
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.018364373145268488
PERRAULT SYNDROME 3	0.000541419	0.018364373145268488
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.018364373145268488
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.018364373145268488
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.018364373145268488
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.018364373145268488
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.018364373145268488
COWDEN SYNDROME 5; CWS5	0.000541419	0.018364373145268488
TAY-SACHS DISEASE; TSD	0.000541419	0.018364373145268488
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.018364373145268488
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.018364373145268488
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.018364373145268488
SNEDDON SYNDROME	0.000541419	0.018364373145268488
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.018364373145268488
STURGE-WEBER SYNDROME	0.000541419	0.018364373145268488
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.018364373145268488
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.018364373145268488
ALEXANDER DISEASE	0.000541419	0.018364373145268488
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.018364373145268488
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.018364373145268488
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.018364373145268488
PARIETAL FORAMINA	0.000541419	0.018364373145268488
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.018364373145268488
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.018364373145268488
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.018364373145268488
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.018364373145268488
DIAMINOPENTANURIA	0.000541419	0.018364373145268488
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.018364373145268488
DYSOSTEOSCLEROSIS	0.000541419	0.018364373145268488
EPILEPSY-TELANGIECTASIA	0.000541419	0.018364373145268488
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.018364373145268488
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.018364373145268488
FOUNTAIN SYNDROME	0.000541419	0.018364373145268488
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.018364373145268488
1P36 MICRODELETION SYNDROME	0.000541419	0.018364373145268488
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.018364373145268488
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.018364373145268488
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.018364373145268488
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.018364373145268488
PAPILLORENAL SYNDROME	0.000541419	0.018364373145268488
CROUZON SYNDROME	0.000541419	0.018364373145268488
DARIER-WHITE DISEASE; DAR	0.000541419	0.018364373145268488
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.018364373145268488
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.018364373145268488
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.018364373145268488
FLYNN-AIRD SYNDROME	0.000541419	0.018364373145268488
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.018364373145268488
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.018364373145268488
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.018364373145268488
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.018364373145268488
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.018364373145268488
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.018364373145268488
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.018364373145268488
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.018364373145268488
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.018364373145268488
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.018364373145268488
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.018364373145268488
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.018364373145268488
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.018364373145268488
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.018364373145268488
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.018364373145268488
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.018364373145268488
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.018364373145268488
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.018364373145268488
NEURAMINIDASE DEFICIENCY	0.000541419	0.018364373145268488
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.018364373145268488
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.018364373145268488
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.018364373145268488
PHENYLKETONURIA	0.000541419	0.018364373145268488
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.018364373145268488
GITELMAN SYNDROME	0.000541419	0.018364373145268488
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.018364373145268488
RAMON SYNDROME	0.000541419	0.018364373145268488
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.018364373145268488
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.018364373145268488
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.018364373145268488
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.018364373145268488
HYPERPROLINEMIA, TYPE II	0.000541419	0.018364373145268488
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.018364373145268488
BERNARD-SOULIER SYNDROME	0.000541419	0.018364373145268488
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.018364373145268488
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.018364373145268488
HYPER-BETA-ALANINEMIA	0.000541419	0.018364373145268488
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.018364373145268488
HYPERLYSINEMIA, TYPE I	0.000541419	0.018364373145268488
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.018364373145268488
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.018364373145268488
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.018364373145268488
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.018364373145268488
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.018364373145268488
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.018364373145268488
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.018364373145268488
KAPUR-TORIELLO SYNDROME	0.000541419	0.018364373145268488
KIFAFA SEIZURE DISORDER	0.000541419	0.018364373145268488
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.018364373145268488
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.018364373145268488
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.018364373145268488
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.018364373145268488
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.018364373145268488
WOLFRAM SYNDROME	0.000541419	0.018364373145268488
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.018364373145268488
TAKAYASU ARTERITIS	0.000541419	0.018364373145268488
MERCURY POISONING	0.000541419	0.018364373145268488
THYROCEREBRORENAL SYNDROME	0.000541419	0.018364373145268488
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.018364373145268488
VIRAL HEMORRHAGIC FEVER	0.000541419	0.018364373145268488
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.018364373145268488
WHIPPLE DISEASE	0.000541419	0.018364373145268488
WORSTER-DROUGHT SYNDROME	0.000541419	0.018364373145268488
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.018364373145268488
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.018364373145268488
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.018364373145268488
GALACTOSIALIDOSIS	0.000541419	0.018364373145268488
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.018364373145268488
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.018364373145268488
GLIOBLASTOMA	0.000541419	0.018364373145268488
ADIPOSIS DOLOROSA	0.000541419	0.018364373145268488
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.018364373145268488
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.018364373145268488
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.018364373145268488
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.018364373145268488
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.018364373145268488
TYROSINEMIA TYPE 2	0.000541419	0.018364373145268488
CONGENITAL RUBELLA SYNDROME	0.000541419	0.018364373145268488
CRONKHITE-CANADA SYNDROME	0.000541419	0.018364373145268488
PORENCEPHALY	0.000541419	0.018364373145268488
PROLACTINOMA	0.000541419	0.018364373145268488
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.018364373145268488
RAMON SYNDROME	0.000541419	0.018364373145268488
ISOLATED BILIARY ATRESIA	0.000541419	0.018364373145268488
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.018364373145268488
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.018364373145268488
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.018364373145268488
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.018364373145268488
NOCARDIOSIS	0.000541419	0.018364373145268488
LUJO HEMORRHAGIC FEVER	0.000541419	0.018364373145268488
EBOLA HEMORRHAGIC FEVER	0.000541419	0.018364373145268488
RIFT VALLEY FEVER	0.000541419	0.018364373145268488
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.018364373145268488
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.018364373145268488
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.018364373145268488
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.018364373145268488
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.018364373145268488
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.018364373145268488
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.018364373145268488
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.018364373145268488
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.018364373145268488
EPISODIC ATAXIA TYPE 3	0.000541419	0.018364373145268488
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.018364373145268488
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.018364373145268488
HEREDITARY COPROPORPHYRIA	0.000541419	0.018364373145268488
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.018364373145268488
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.018364373145268488
FAMILIAL THROMBOCYTOSIS	0.000541419	0.018364373145268488
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.018364373145268488
MPDU1-CDG	0.000541419	0.018364373145268488
ALG2-CDG	0.000541419	0.018364373145268488
ALG9-CDG	0.000541419	0.018364373145268488
MOGS-CDG	0.000541419	0.018364373145268488
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.018364373145268488
PORPHYRIA VARIEGATA	0.000541419	0.018364373145268488
GRISCELLI SYNDROME TYPE 2	0.000541419	0.018364373145268488
PORPHYRIA	0.000541419	0.018364373145268488
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.018364373145268488
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.018364373145268488
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.018364373145268488
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.018364373145268488
HYPERPROLINEMIA TYPE 1	0.000541419	0.018364373145268488
HYPOPHOSPHATASIA	0.000541419	0.018364373145268488
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.018364373145268488
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.018364373145268488
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.018364373145268488
WHIM SYNDROME	0.000541419	0.018364373145268488
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.018364373145268488
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.018364373145268488
ONDINE SYNDROME	0.000541419	0.018364373145268488
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.018364373145268488
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.018364373145268488
MYASTHENIA GRAVIS	0.000541419	0.018364373145268488
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.018364373145268488
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.018364373145268488
RECURRENT ACUTE PANCREATITIS	0.000541419	0.018364373145268488
NEVUS COMEDONICUS SYNDROME	0.000541419	0.018364373145268488
LHERMITTE-DUCLOS DISEASE	0.000541419	0.018364373145268488
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.018364373145268488
NASU-HAKOLA DISEASE	0.000541419	0.018364373145268488
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.018364373145268488
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.018364373145268488
ROMANO-WARD SYNDROME	0.000541419	0.018364373145268488
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.018364373145268488
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.018364373145268488
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.018364373145268488
BETA-MANNOSIDOSIS	0.000541419	0.018364373145268488
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.018364373145268488
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.018364373145268488
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.018364373145268488
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.018364373145268488
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.018364373145268488
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.018364373145268488
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.018364373145268488
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.018364373145268488
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.018364373145268488
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.018364373145268488
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.018364373145268488
CRISPONI SYNDROME	0.000541419	0.018364373145268488
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.018364373145268488
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.018364373145268488
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.018364373145268488
ROSAÏ-DORFMAN DISEASE	0.000541419	0.018364373145268488
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.018364373145268488
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.018364373145268488
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.018364373145268488
PSEUDO-TORCH SYNDROME 2	0.000541419	0.018364373145268488
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.018364373145268488
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.018364373145268488
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.018364373145268488
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.018364373145268488
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.018364373145268488
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.018364373145268488
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.018364373145268488
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.018364373145268488
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.018364373145268488
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.018364373145268488
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.018364373145268488
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.018364373145268488
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.018364373145268488
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.018364373145268488
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.018364373145268488
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.018364373145268488
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.018364373145268488
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.018364373145268488
MICROSPORIDIOSIS	0.000541419	0.018364373145268488
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.018364373145268488
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.018364373145268488
SANJAD-SAKATI SYNDROME	0.000541419	0.018364373145268488
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.018364373145268488
CITRULLINEMIA TYPE I	0.000541419	0.018364373145268488
AICA-RIBOSIDURIA	0.000541419	0.018364373145268488
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.018364373145268488
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.018364373145268488
MOYAMOYA DISEASE	0.000541419	0.018364373145268488
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.018364373145268488
MOYNAHAN SYNDROME	0.000541419	0.018364373145268488
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.018364373145268488
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.018364373145268488
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.018364373145268488
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.018364373145268488
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.018364373145268488
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.018364373145268488
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.018364373145268488
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.018364373145268488
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.018364373145268488
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.018364373145268488
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.018364373145268488
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.018364373145268488
CENTRAL DIABETES INSIPIDUS	0.000541419	0.018364373145268488
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.018364373145268488
FRONTAL ENCEPHALOCELE	0.000541419	0.018364373145268488
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.018364373145268488
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.018364373145268488
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.018364373145268488
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.018364373145268488
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.018364373145268488
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.018364373145268488
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.018364373145268488
CRIGLER-NAJJAR SYNDROME	0.000541419	0.018364373145268488
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.018364373145268488
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.018364373145268488
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.018364373145268488
EPISODIC ATAXIA TYPE 6	0.000541419	0.018364373145268488
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.018364373145268488
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.018364373145268488
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.018364373145268488
